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ABSTRACT
Overweight and obesity is becoming more prevalent in adults across the United
States. Overweight or obese adults are at an increased risk for the development of
cardiometabolic disorders. Glycemic variability has recently been introduced as a
sensitive measurement of glycemic health as it incorporates oscillations in glucose
concentrations over an extended period. Further, evidence has suggested that glycemic
variability plays a pivotal role in the induction of oxidative stress commonly found in
adults diagnosed with cardiometabolic disorders. Physical activity (PA) and exercise
have been utilized as therapeutic treatments for overweight and obesity related
complications. Therefore, the overall goal of this dissertation was to investigate the
relationship between PA with glycemic variability and oxidative stress, and to examine
the influence of exercise training on glycemic variability and oxidative stress in nondiabetic overweight or obese adults.
Three studies were conducted utilizing different designs to (study 1) inspect the
current findings linking the relationship between sedentary behavior and physical activity
(PA) with, and the influence of exercise on, continuous glucose monitor (CGM) assessed
glycemic variability, (study 2; n=28) examine the cross-sectional relationship between
objectively measured sedentary time and PA with glycemic variability and oxidative
stress, and (study 3; n=8) evaluate the impact of a 12-week aerobic exercise intervention
on glycemic variability and oxidative stress. The first study was a critical review of the
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literature, while the second study utilized baseline data collected from the Weight
Outlooks by Restriction of Diet and Sleep (WORDS) and the Aerobic Treadmill Exercise
and Metabolism (A-TEAM) studies, and the third study utilized data collected for
individuals that completed the A-TEAM study. For study two, objective assessment of
sedentary time and PA was performed, while for study two and three glucose
concentrations and glycemic variability were assessed via CGM and oxidative stress
assessed as nitric oxide and myeloperoxidase concentrations in human serum (WORDS)
or plasma (A-TEAM).
The first study found that a relationship between sedentary behavior and PA with
glycemic control and glycemic variability exists in non-diabetic and diabetic adults.
However, there were differential findings when examining the effect of a single bout of
exercise or repeated bouts of exercise on glycemic control and glycemic variability
between populations, while exercise training improved glycemic control and glycemic
variability in type 2 diabetic adults. In the second study, a relationship was observed
between PA minutes and energy expenditure of varying intensities with glucose
concentrations, but not glycemic variability, and myeloperoxidase concentration, while
fasting glucose concentration correlated with nitric oxide and myeloperoxidase
concentrations, and the oxidative stress ratio in non-diabetic overweight or obese adults.
The third study found that, although myeloperoxidase concentration decreased and the
oxidative stress ratio improved, glucose concentrations and glycemic variability did not
change following exercise training in non-diabetic overweight or obese adults. Yet, CGM
placement at post-intervention, as well as average total daily mealtime changes, may have
influenced our findings.
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Overall, this dissertation found that a relationship exists between PA with glucose
concentrations and oxidative stress. However, glycemic variability may not be positively
influenced by exercise training in non-diabetic overweight or obese adults even in the
presence of improvements in biological markers of oxidative stress. Collectively, habitual
PA may influence glycemic variability differently than structured PA, known as exercise,
in our participants. However, these findings are speculative and further research is needed
in this population.
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CHAPTER 1
INTRODUCTION
Currently, ~70% of adults in the United States are considered overweight or obese
with obesity largely considered the public health crisis of the current generation (Flegal
MF, Kruszon-Moran D, Carroll MD, Fryar CD, & Ogden CL, 2016; Centers for Disease
Control and Prevention 2017; National Institutes of Health 2018). The Centers for
Disease Control and Prevention announced that the medical care cost of obesity and its
associated disorders were $147 billion in 2008 (Finkelstein EA, Trogdon JG, Cohen JW,
& Dietz, W, 2009; Centers for Disease Control and Prevention 2017). Being overweight
or obese leads to an increased risk of development of diseases or diseased states such as
impaired glucose tolerance and cardiovascular disease (Bray GA 2004; O’donovan G,
Kearney EM, Nevill AM, Woolf-May K, & Bird SR, 2005). Moreover, fasting and
postprandial hyperglycemia are independent risk factors for cardiovascular disease with
and without the presence of type 2 diabetes mellitus and are increased in overweight and
obesity (Mokdad AH, Bowman BA, & Ford ES, 2001; Hanire H, Bertrand M, Guerci B,
Anduze Y, Guillaume E, & Ritz P, 2011; Little JP, Jung ME, Wright AE, Wright W, &
Manders RJ, 2014). Unlike hepatic regulation of glucose in a fasted state, and how
effective muscle glucose disposal is in a glucose challenged state, such as during an oral
glucose tolerance test (OGTT), the measurement of glycemic variability allows for the
observation of excursions that consider nadirs, peaks, and troughs of glucose
concentrations rather than a single snapshot of fasting glucose and during an OGTT
1

Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, & DeVries JH,
2010; Anderwald C, Gastaldelli A, Tura A, Krebs M, Promintzer-Schifferl M, KautzyWiller A, Stadler M, DeFronzo RA, Pacini G, & Bischof MG, 2011; Petersen MC,
Vatner DF, & Shulman GI, 2017). Recently, increased glycemic variability has been
shown to be associated with the risk of development of type 2 diabetes mellitus, with
overweight and obese adults having higher glycemic variability compared to normal
weight (Ma C-M, Yin F-Z, Wang R, Qin C-M, Lou D-H, & Lu Q, 2011). Additionally, it
has been suggested that glycemic variability may be a more important clinical
measurement of not only glucose metabolism, but cardiovascular and overall general
health (Monnier L, Colette C, & Owens DR, 2008; Rodbard D 2011; Nusca A,
Tuccinardi D, Albano M, Cavallaro C, Ricottini E, Manfrini S, Pozzilli P, & Di Sciascio
G, 2018). As technology for the assessment of glycemic variability utilizing continuous
glucose monitoring (CGM) continues to increase, the implications of this maker of
metabolic health outside of a clinical setting becomes of further importance.
Furthermore, increased glycemic variability has recently been associated with
oxidative stress and thus linked with increased risk of cardiovascular disease in people
with and without type 2 diabetes mellitus (Saisho Y 2014). Oxidative stress plays a
crucial role in the development of vascular complications leading to increased risk of
development of cardiovascular disease. It is increased in overweight and obese
populations, and further complicated by hyperglycemia (Pitocco D, Tesauro M,
Alessandro R, Ghirlanda G, & Cardillo C, 2013). In 2006, Monnier et al., reported a
strong correlation between glycemic variability assessed by mean amplitude of glucose
excursions (MAGE) and continuous overlapping net glycemic action (CONGA), and

2

activation of oxidative stress in a type 1 and 2 diabetic population, which was the first
study to utilize CGM to assess this relationship (Monnier L, Mas E, Ginet C, Michel F,
Villon L, Cristol JP, & Colette C, 2006). In vitro and in vivo animal studies indicate that
glycemic variability, compared to sustained hyperglycemia, promotes oxidative stress
and worsens vascular damage; however, how glycemic variability and oxidative stress
relate to and interact with each other remains unclear (Saisho Y 2014). Glycemic
variability has previously been shown to be associated with oxidative stress formation in
type 2 diabetes mellitus, but no studies have been performed to examine the relationship
between glycemic variability, specifically in a “free-living” condition, and oxidative
stress in overweight or obese adults not diagnosed with diabetes (Monnier L, Mas E,
Ginet C, Michel F, Villon L, Cristol JP, & Colette C, 2006; Wentholt IME, Kulik W,
Michels RP, Hoekstra JB, DeVries JH, 2008; Siegelaar SE, Barwari T, Kulik W,
Hoekstra JB, & DeVries JH, 2011). Therefore, the potential relationship and clinical
implications of the relationship between glycemic variability and oxidative stress, which
serve as markers for the risk of development of metabolic and cardiovascular disease,
needs to be further explored (Monnier L, Colette C, & Owens DR, 2008; Wentholt IME,
Kulik W, Michels RPJ, Hoekstra JBL, & DeVries JH, 2008).
As of 2015, the Centers for Disease Control and Prevention estimated that
~20.5% of American adults met the minimum guidelines for being physically active
(Centers for Disease Control and Prevention 2017). Decreased physical activity (PA) of
light-intensity (LPA), moderate-intensity (MPA), vigorous-intensity (VPA), a
combination of moderate-to-vigorous-intensity (MVPA), and even total PA are not only
detrimental to fasting (Nygaard H, Grindaker E, Rønnestad BR, Holmboe-Ottesen G, &
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Høstmark AT, 2017), but postprandial glucose concentrations (Høstmark AT, Ekeland
GS, Beckstrøm AC, & Meen HD, 2006), and increase risk for the development of
cardiovascular disease (Carnethon MR, Evans NS, Church TS, Lewis CE, Schreiner PJ
Jacobs Jr DR, Sternfel B, & Sidney S, 2010) with no current knowledge surrounding
whether sedentary time and PA of varying intensities are associated with glycemic
variability or oxidative stress.
Additionally, evidence suggests regular exercise can influence PA and may
provide a protective effect against exercise and non-exercise induced oxidative stress in
healthy weight adults (Radak Z, Chung HY, & Got S, 2008); however, how this
protective effect may be altered in persons with decreased glycemic control at risk for the
development of diabetes remains uncertain (Sen CK, Atalay M, & Hänninen O, 1994;
Atalay M, Laaksonen DE, Niskanen L, Uusitupa M, Hänninen O, & Sen SK, 1997).
Moreover, there remains unclear evidence to suggest how exercise training may influence
glycemic variability and oxidative stress in sedentary, overweight or obese, but otherwise
healthy adults.
SCOPE OF THE STUDY
Therefore, the overall purpose of this dissertation is 1) to examine the current
literature surrounding sedentary time and PA, glycemic variability, and oxidative stress,
2) to determine the associations between sedentary time and PA of varying intensities,
glycemic variability, and oxidative stress in currently overweight or obese adults in a
cross-sectional setting, and 3) to examine the effect a 12-week aerobic exercise
intervention has on glycemic variability and oxidative stress in currently overweight or
obese adults. Our central hypothesis is that the time spent being sedentary and performing
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various intensities of PA will be associated with CGM assessed glycemic variability and
oxidative stress, and that incorporation of an aerobic exercise intervention will decrease
glycemic variability and improve measures of oxidative stress in overweight or obese
adults.
Specific Aim 1
To perform a critical review of the current literature surrounding the relationship
between sedentary time and PA, glycemic variability, and oxidative stress.
Sub-Aim 1.1: To summarize and describe the known relationship between
sedentary time and PA, glycemic variability, oxidative stress.
Sub-Aim 1.2: To summarize how acute exercise affects glycemic variability.
Sub-Aim 1.3: To summarize how repeated bouts of exercise and exercise training
affects glycemic variability.
Specific Aim 2
To examine the cross-sectional associations between sedentary time and PA,
glycemic variability, and biological markers of oxidative stress in overweight or obese
adults.
Sub-Aim 2.1: To examine the associations between daily sedentary time,
glycemic variability, and oxidative stress.
Sub-Aim 2.2: To examine the associations between daily LPA and MVPA,
glycemic variability, and oxidative stress.
Sub-Aim 2.3: To examine the associations between daily total PA, glycemic
variability, and oxidative stress.
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Specific Aim 3
To examine the effect of a 12-week aerobic exercise intervention on glycemic
variability and oxidative stress.
Sub-Aim 3.1: To examine the effect of a 12-week aerobic exercise intervention on
glycemic variability.
Sub-Aim 3.2: To examine the effect of a 12-week aerobic exercise intervention on
oxidative stress.
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CHAPTER 2
LITERATURE REVIEW
OVERVIEW
The prevalence of adults in the United States classified as either overweight or
obese has continued to increase throughout the years, with ~39.8% or 93.9 million
considered obese in 2015-2016 (Hales CM, Carroll MD, Fryar CD, & Ogden CL, 2017).
Overweight and obesity remains a complex public health issue to address and results
from a combination of causes and contributing factors, including, but not limited to
behavioral factors, such as diet and physical activity, genetic and environmental factors,
and even sociodemographic status (Centers for Disease Control and Prevention 2017).
Adults classified as overweight or obese, when compared to healthy weight adults, are at
an increased risk for all cause morbidity and mortality (National Institutes of Health
2013), and are at a greater predisposition for the development of type 2 diabetes mellitus,
and cardiovascular disease risk factors and cardiovascular disease (National Institutes of
Health 1998).
Glycemic variability has recently been thought of as a sensitive measurement for
glycemic control, with excess glycemic variability shown to increase the risk for the
development of type 2 diabetes mellitus in overweight or obese adults and may provide
greater insight into metabolic health compared to fasting blood glucose concentration and
during an OGTT (Umpierrez GE & Kovatchev BP, 2018). Glycemic variability allows
for the inclusion of glucose excursions when measuring glycemic control and allows for a
7

more sensitive analysis compared to other clinical measures of glucose metabolism and
tolerance. As technology has continued to advance, glycemic variability assessment has
become a non-invasive procedure utilizing CGM technology, which allows for the device
be worn during everyday life and aids in the management of not only diabetes, but
assessment for those at risk for the development of type 2 diabetes mellitus (National
Institutes of Health 2017). Thus, glycemic variability measurement utilizing CGM
technology plays an important role in assessment of diabetes risk in overweight or obese
adults by allowing for observation in a “free living” environment in addition to common
clinical measures glycemic health.
Oxidative stress has been utilized as a clinical measurement for the development
of atherosclerosis, which is the leading cause of cardiovascular disease, and has been
associated with the development and progression of cardiovascular disease risk factors,
such as overweight and obesity, hypertension, and dyslipidemia, and cardiovascular
disease (Gracia KC, Llanas-Cornejo D, & Husi H, 2017). Additionally, overweight and
obesity has been recently thought to increase chronic low grade systemic inflammation
and, in turn, induce greater amounts of oxidative stress leading to further overweight and
obesity related complications (Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole
J, Nichols A, Ross JS, Tartaglia LA, & Chen H, 2003). Therefore, oxidative stress
measurement serves as an excellent biological marker for risk of the development of
cardiovascular disease risk factors and cardiovascular disease, especially in an
overweight or obese population. Additionally, increased glycemic variability has been
shown to be associated with greater reactive oxygen species production, oxidative stress,
and vascular damage, compared to chronic hyperglycemia notably found in type 2
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diabetes (Saisho Y 2014). Hence, management of glycemic variability may reduce
oxidative stress and the risk for the development of cardiovascular disease in those at risk
for the development of type 2 diabetes mellitus.
According to the Behavioral Risk Factor Surveillance System, in 2017 greater
than 25% of adults in the United States engage in no leisure time PA with less than 50%
meeting the minimum physical activity guidelines (Centers for Disease Control and
Prevention 2017). Increased sedentary time and decreased PA of any intensity, including
leisure time PA, are known to affect overall health and has been shown to increase the
risk for the development of type 2 diabetes mellitus, and cardiovascular disease risk
factors and cardiovascular disease (Flegal KM, Carroll MD, & Ogden CL, 2002; Carter
S, Hartman Y, Holder S, Thijssen DH, & Hopkins ND, 2017; Joseph JJ, EchouffoTcheugui JB, Golden SH, Chen H, Jenny NS, Carnethon MR, Jacobs Jr D, Burke GL,
Vaidya D, Ouyang P, & Bertoni AG, 2017). Time spent sedentary and performing PA
have been widely studied in regards to their positive effects on overweight or obesity,
glucose tolerance, and cardiovascular health (Jiménez-Pavón D, Ortega FB, Valtueña J,
Castro-Piñero J, Gómez-Martínez S, Zaccaria M, Gottrand F, Molnár D, Sjöström M,
González-Gross M, Castillo MJ, Moreno LA, & Ruiz JR, 2012; Miguel-Berges ML,
Reilly JJ, Moreno Aznar LA, & Jiménez-Pavón D, 2018). However, the relationship
between metabolic and cardiovascular health and PA remains complex with the majority
of data suggesting that PA of any intensity may promote overall health benefits (Ortega
FB, Artero EG, Jiménez-Pavón D, & Ruiz JR, 2018). Therefore, further examination as
to how sedentary time and PA affect glycemic variability and oxidative stress in
overweight or obese adults is required.
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Exercise has often been utilized as a part of the therapeutic method to combat
overweight and obesity, diabetes risk, and cardiovascular disease. Acute and chronic
exercise have both been shown to improve glycemic control and glucose tolerance
(Goodyear LJ & Kahn BB, 1998), but no studies to date have examined the effect of
chronic aerobic exercise on glycemic variability. Additionally, even though acute
exercise is shown to increase oxidative stress post-exercise, physiological adaptations to
chronic aerobic exercise has been shown to decrease oxidative stress at rest and postexercise (Reid MB 1985; Baltaci SB, Mogulkoc R, & Baltaci AK, 2016). Moreover, no
studies have sought to examine how glycemic variability and oxidative stress change in
overweight or obese adults undergoing chronic aerobic exercise. Thus, this dissertation
proposes to fill some of these gaps by direct assessment of changes in clinically relevant
indices of glycemic variability and measurement of biomarkers associated with oxidative
stress in overweight or obese adults undergoing a 12-week aerobic exercise intervention.
OVERWEIGHT, OBESITY, AND CARDIOMETABOLIC RISK
The prevalence of overweight and obesity has continued to increase over the past
several decades, is considered an important public health issue, and has been identified as
1 of the 10 leading health indicators (Office of the Surgeon General 2001; Hedley AA,
Ogden CL, & Johnson CL, 2004; Fryar CD, Carroll MD, & Ogden CL, 2016; Ogden C,
Carroll MD, Lawman HG, Fryar CD, Kruszon-Moran D, Kit BK, & Flegal KM, 2016).
The state of being overweight or obese leads to an increase risk of a number of medical
conditions and substantial health care costs (Birmingham CL, Muller JL, Palepu A,
Spinelli JJ, & Anis AH, 1999; Katzmarzyk PT & Janssen I, 2004; McCormick B & Stone
I, 2007; Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, & Anis AH, 2008).
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This includes, but is not limited to, type 2 diabetes mellitus (Hartemink N, Boshuizen
HC, Nagelkerke NJ, Jacobs MA, & van Houwelingen HC, 2006) and cardiovascular
disease (Wilson PWF, D’Agostino RB, Sullivan L, Parise H, & Kannel WB, 2002).
According to the American Diabetes Associations and the Centers for Disease
Control and Prevention, 30.3 million adults in the United States have diabetes, while an
additional 84.1 million have prediabetes (National Center for Chronic Disease and
Prevention and Health Promotion 2017). Overweight and obesity have been associated
with the development of type 2 diabetes mellitus, which leads to a further increase in all
cause morbidity and mortality for adults in the United States (Mokdad AH, Bowman BA,
Ford ES, Vivicor F, Marks JS, & Koplan JP, 2001). Adults who are obese have 7.37
greater odds of diagnoses of type 2 diabetes mellitus with the diagnosis of type 2 diabetes
mellitus increasing by ~8.2% in recent years (Mokdad AH, Ford ES, & Bowman BA,
2003). Additionally, ~90% of type 2 diabetics have a body mass index (BMI) of ≥23
kg/m2, which, even though this includes adults considered healthy weight, remains one
the most significant contributors to decreased overall health (Kopelman P 2007; Haslam
DW & James WPT, 2005). Furthermore, the increase in relative risk for the development
of type 2 diabetes mellitus has been reported as 1.18 per unit increase of BMI (Hartemink
N, Boshuizen HC, Nagelkerke NJD, Jacobs MAM, & van Houwelingen HC, 2006).
However, the relationship between BMI and the relative risk for type 2 diabetes mellitus
and several studies suggest there may be a threshold effect and certain cut-point of BMI
once considered overweight (Modan M, Karasik A, Halkin H, Fuchs Z, Lusky A, Shitrit
A, & Modan B, 1986).
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Cardiovascular disease is the primary cause of mortality in the United States
(Kochanek KD, Murphy SL, Xu J, & Tejada-Vera B, 2016) and about half of adults in
the United States have been diagnosed with cardiovascular disease risk factors, such as
hypertension or dyslipidemia (Fryar CD, Chen T, & Li X, 2012). The state of being
overweight or obese has been established as a major risk factor for the development of
cardiovascular disease, specifically if excess body fat has been primarily stored centrally
or abdominally (Van Gaal LF, Mertens IL, & De Bock CE, 2006; Din-Dzietham R, Liu
Y, Bielo MV, & Shamsa F, 2007), and has been associated with hypertension,
dyslipidemia, and elevated levels of C-reactive protein, all of which increase the risk for
development of cardiovascular disease (Ritchie SA & Connell JM, 2007). Additionally,
overweight and obese men with cardiovascular disease risk factors and cardiovascular
disease have a higher risk for all cause and cardiovascular disease mortality compared
with healthy weight men (Wei M, Kampert, JB, Barlow CE, Nichaman MZ, Gibbon LW,
Paffenbarger Jr RS, & Blair SN, 1999). Furthermore, it has been hypothesized that being
overweight and obese does not directly translate to increased risk of cardiovascular
disease; however, it may be the interaction of obesity developed insulin resistance and
glucose intolerance related cardiovascular disease risk factors that leads to the
development of cardiovascular disease (Reaven G 2005). Therefore, the development of
type 2 diabetes mellitus may play a contributing factor in the development of
cardiovascular disease risk factors and cardiovascular disease in overweight or obese
adults.
The Framingham Study was among the initial observational longitudinal studies
to examine diabetes and cardiovascular disease, which found a significant increase in
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cardiovascular disease risk factors and mortality in men and women diagnosed with type
2 diabetes mellitus compared to their non-diabetic counterparts (Kannel WB & McGee
DL, 1979). This study pioneered research related to the risk for development of diabetes
and cardiovascular disease. The Multiple Risk Factor Intervention Trial reported that
cardiovascular disease mortality was much higher for diabetic versus nondiabetic men for
every age, race, and income (Stamler J, Vaccaro O, Neaton JD, Wentworth D, & The
Multiple Risk Factor Intervention Trial Research Group, 1993). Furthermore, risk for
cardiovascular disease mortality increased more steeply for diabetic men for each
diagnosis of each additional cardiovascular disease risk factor (Stamler J, Vaccaro O,
Neaton JD, Wentworth D, & The Multiple Risk Factor Intervention Trial Research
Group, 1993). Additionally, hyperglycemia, which normally accompanies type 2 diabetes
mellitus, has major direct and indirect effects on the human vascular tree, which are
considered the major sources of morbidity and mortality in type 2 diabetes mellitus, with
the negative effects of hyperglycemia including macrovascular complications such as
coronary artery disease (Fowler MJ 2008).
GLYCEMIC VARIABILITY
Chronic hyperglycemia is a primary risk factor for the development of
complications in type 2 diabetes mellitus; however, it is believed that frequent or
exacerbated fluctuations in glucose concentrations may independently contribute to
diabetes-related complications (Suh S & Kim JH, 2015). Glycemic variability refers to
the peaks, troughs, and nadirs in glucose concentration levels and alludes to blood
glucose oscillations that occur throughout the day, which includes glycemic excursions
during periods of hypoglycemia and hyperglycemia. Glycemic variability is not always a
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negative consequence of physiological dysfunction, rather sometimes it is a product of
circadian rhythm of endogenous hormones, ingestion of calorie containing items, or PA,
and is observed in individuals with normal glucose tolerance (Wang S, Lv L, Yang Y,
Chen D, Liu G, Chen L, Song Y, He L, Li X, Tian H, Jia W, & Ran X, 2012). However,
glycemic variability has been observed to be increased in sedentary, overweight or obese
individuals (Salkind SJ, Huizenga R, Fonda SJ, Walker MS, & Vigersky RA, 2014), who
have a greater risk for the development of impaired glucose regulation and cardiovascular
disease morbidity and mortality (Nalysnyk L, Hernandez-Medina M, & Krishnarajah G,
2010; Gerbaud E, Darier R, Montaudon M, Beauvieux M-C, Coffin-Boutreux C, Coste P,
Douard H, Ouattara A, & Catargi B, 2019). In order to effectively determine glycemic
control in overweight and obese adults at risk for the development of type 2 diabetes
mellitus or cardiovascular disease, glycemic variability must be assessed.
Intra- versus inter-day variability refers to the outcomes of data either collected on
the same day or on different days, which is of importance when considering glycemic
variability, as variability throughout the day may be more indicative of glucose
metabolism as opposed to over multiple days, or even vice-versa. Even though intra-day
glycemic variability can be useful throughout a 24-hour period, more sensitive measures
are preferred to account for the degree of glucose excursions that occur over more than a
single day. Measuring inter-day glycemic variability in addition to intra-day glycemic
variability allows insight into the differences between day-to-day glycemic profile (Mori
H, Okada Y, Kurozumi A, Narisawa M, & Tanaka Y, 2017). Glycemic variability may
not only be dependent on each individual’s lifestyle but may change day-to-day
depending on their changes in daily lifestyle factors such as diet or PA patterns
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throughout the week (Bennet B & Sothern MS, 2009). With this in mind, measuring
intra- and inter-days glycemic variability provides a greater insight into glycemic health
and how glycemic variability may be influenced by changes in an individual’s daily life.
However, most studies have not examined the intra- and inter-day glycemic variability
during either the same observation period or following a lifestyle intervention. Therefore,
when examining glycemic variability in overweight or obese adults at risk for the
development of impaired glucose tolerance and type 2 diabetes mellitus, it is pertinent to
investigate both the intra- and inter-day glycemic variability that will allow for a more indepth insight into glycemic control.
The MAGE was introduced as a measurement of glycemic variability to aid in the
treatment and further refinement of the characterization of diabetic instability, and has
been shown to be lower in non-diabetic subjects compared to subjects with stable and
unstable type 2 diabetes mellitus (Service FJ, Molnar GD, Rosevear JW, Ackerman E,
Gatewood LC, & Taylor WF, 1970). MAGE has traditionally been estimated with a
graphical approach that represents the arithmetic mean of the difference between
consecutive peaks and troughs exceeding one standard deviation around the respective
24-hour glucose mean (Service FJ & Nelson RL, 1980). Assessment of MAGE over
multiple days allows for an impactful outlook into inter-day glycemic variability and is
considered an essential index for glycemic variability assessment (Monnier L, Colette C,
& Owens DR, 2008; Fritzsche G, Kohnert K-D, Heinke P, Vogt L, & Salzsierder E
2011). In additional to MAGE, CONGA is thought of an important additional measure of
glycemic variability as CONGA can be analyzed in shorter time components throughout
the day from a set 1, 2, 3, or 4 hours at a time with decreased validity for utilization after
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4 hours (Monsod TP, Flanagan DE, Rife F, Saenz R, Caprio S, Sherwin RS, &
Tamborlane WV, 2002). The CONGA equation was originally derived by McDonnell, et
al., to allow for the time periods corresponding to different activities performed
throughout the day (CONGA of 1 hour; CONGA-1), time consuming snacks throughout
the day (CONGA of 2 hour; CONGA-2), or time between standard meals, such as
breakfast, lunch, and dinner (CONGA of 4 hour; CONGA-4) (McDonnell CM, Donath
SM, Vidmar SI, Werther GA, & Cameron FJ, 2005; Rodrigues R, de Medeiros LA,
Cunha LM, Garrote-Filho MDS, Bernardino Neto M, Jorge PT, Resende ES, & PenhaSilva N, 2018). This calculation of CONGA allows for each glucose concentration
observation after the initial observation to be identified and the difference between the
initial observation and the second observation is calculated and is considered the standard
deviation of the differences with higher values indicating increase glycemic variability
(McDonnell CM, Donath SM, Vidmar SI, Werther GA, & Cameron FJ, 2005). Utilizing
both MAGE and CONGA measurements of glycemic variability allow for a broadspectrum approach to establish intra- and inter- day glycemic variability. This method
also allows for a validated inter-day measurement of glycemic variability, while also
incorporating a sensitive measure of intra-day glycemic variability. Measuring both intraand inter-day glycemic variability may also serve as a tool for the examination of time
spent hyperglycemic and hypoglycemic as both are considered to be increased risks for
the development of type 2 diabetes mellitus (Satya Krishna SV, Kota SK, & Modi KD,
2013). In turn, this method permits a greater insight into glycemic variability as not only
an all-encompassing clinical measure, but practical measure of glycemic control and
metabolic health.
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As previously stated, the state of being overweight or obese leads to increased risk
for the development of type 2 diabetes mellitus (Mokdad AH, Bowman BA, Ford ES,
Vivicor F, Marks JS, & Koplan JP, 2001). However, overweight and obesity also leads to
impaired glucose tolerance prior to diagnosis of type 2 diabetes mellitus (Ferrannini E &
Camastra S, 1998). The major limitation of evaluating glucose tolerance, especially in
overweight or obese adults, is a result of only testing fasting blood glucose levels, or
during a glucose challenged state, such as an OGTT, which provides a snapshot of
glycemic health as opposed to observation in a “free-living” environment. Glycemic
variability has been reported to be higher in adults with type 2 diabetes mellitus
compared to adults with normal glucose tolerance (Mazze RS, Strock E, Wesley D,
Borgman S, Morgan B, Bergenstal R, & Cuddihy R, 2008). Previously, Ma et al., found
that glycemic variability was higher in abdominally obese compared to non-abdominally
obese men (Ma C-M, Yin F-Z, Wang R, Qin C-M, Liu B, Lou D-H, & Lu Q, 2011).
Additionally, glycemic variability has been shown to be higher in obese adults who have
normal glucose tolerance and insignificantly different from prediabetic adults (Salkind
SJ, Huizenga R, Fonda SJ, Walker MS, & Vigersky RA, 2014). Thus, glycemic
variability may provide greater insight and be more clinically relevant to evaluate
metabolic health.
OXIDATIVE STRESS
The imbalance between oxidants and antioxidants in favor of the oxidants
potentially leading to vascular damage has primarily been utilized as the definition of
oxidative stress (Keaney Jr JF 2000). Additionally, oxidative stress has been coined a
phenomenon caused by an imbalance between production and accumulation of reactive
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oxygen species in the cells of tissues, as well as the ability of a biological system to
detoxify these reactive products (Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F,
Arcoraci V, Squadrito F, Altavilla D, & Bitto A, 2017). When reactive oxygen species
production increases, creating greater oxidative stress, they increase the risk of harmful
effects on important cellular structures such as proteins, lipids, and nucleic acids (Wu JQ,
Kosten TR, & Zhang XY, 2013). Furthermore, evidence suggests that oxidative stress
may be responsible, with varying degree of importance, for the onset and/or progression
of several diseases, such as type 2 diabetes mellitus and cardiovascular disease
(Taniyama Y & Griendling KK, 2003). Reactive oxygen species, when maintained at low
or moderate levels, are of crucial importance to not only metabolic and cardiovascular,
but overall health (Pacher P, Beckman JS, & Liaudet L, 2007). Moreover, oxidative stress
plays a key role in the risk for the development of type 2 diabetes mellitus, cardiovascular
disease risk factors and cardiovascular disease, as well as all-cause mortality in
overweight or obese adults (Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di
Rosa G, Gitto E, & Arrigo T, 2015).
Nitric oxide is an inorganic free radical gas that is synthesized by vascular
endothelial cells from L-arginine via nitric oxide synthases as a transcellular signal of
oxidative stress (Knowles RG & Moncada S, 1994). Nitric oxide is considered a potent
vasodilator released by vascular endothelial cells and accounts for the relaxation of
vascular tissue, inhibits platelet aggregation and platelet adhesion attributed to
endothelium-derived relaxing factor, and reduces proliferation of the intima of vascular
tissue (Palmer RMJ, Ashton DS, & Moncada S, 1998). Enhanced nitric oxide inhibition
or reduced synthesis of nitric oxide is often associated with cardiovascular disease risk
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factors (Förstermann U, Nakane M, Tracey WR, & Pollock JS, 1993). Additionally,
reactive oxygen species, that contribute to the underlying mechanisms of vascular
dysfunction and oxidative stress, may reduce the amount of bioactive nitric oxide by
chemical inactivation of nitric oxide synthase, which may in-turn cause the nitric oxide
synthase to become dysfunctional and contribute further to oxidative stress (Förstermann
U 2010). Increased bio-active concentrations of nitric oxide are often associated with a
decrease in reactive oxidative species, a subsequent decreased oxidative stress, and, inturn, risk for the development of cardiovascular disease risk factors (Förstermann U &
Münzel T, 2006). Inversely, myeloperoxidase, a heme protein released by leukocytes,
plays a crucial role in inflammation and oxidative stress at the cellular level, which
affects the arterial endothelium and impairment of nitric oxide-induced vascular
relaxation, and has been speculated to be a major oxidative stress pathway (Anatoliotakis
A, Deftereos S, Bouras G, Giannopoulos G, Tsounis D, Angelidis C, Kaoukis A, &
Stafanadis C, 2013). Similarly, to nitric oxide, there exists mechanistic links between
myeloperoxidase activity and manifestations of cardiovascular disease (Brennan M-L &
Hazen SL, 2003). Therefore, evidence suggests determining both nitric oxide and
myeloperoxidase together when examining oxidative stress as nitric oxide may inhibit
production of myeloperoxidase, while myeloperoxidase may decrease nitric oxide
concentrations.
It has been well established that obesity is associated with low-grade chronic
systemic inflammation in adipose tissue, which is a condition influenced by the activation
of adipose tissue immune response that promotes oxidative stress and is associated with
type 2 diabetes mellitus and cardiovascular disease (Alberti K & Zimmet PZ, 1998).
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Susceptibility to oxidative damage during times of increased oxidative stress is even
greater in obesity due to depleted antioxidant sources, which are used to aid in clearance
of reactive oxygen species associated with oxidative stress, compared to healthy weight
(Amirkhizi F, Siassi F, Minaie S, Djalali M, Rahimi A, & Chamari M, 2007). There are
several prevailing theories as to the mechanism involved in the generation of oxidative
stress in obesity, including the release of adipokines (adipose tissue inflammatory
molecules), increased cellular apoptosis (cellular death), and excessive hepatic
lipogenesis (formation of adipose tissue) (Hensley K, Robinson KA, Gabbita SP,
Salsman S, & Floyd RA, 2000). Biomarkers of oxidative damage are higher in
individuals with obesity and correlate directly with BMI and the percentage of body fat
(Pihl E, Zilmer K, Kullisaar T, Kairane C, Mägi A, & Zilmer M, 2006). However, the
evidence remains inconsistent as an inverse relationship between body fat, central
adiposity, and antioxidant capacity has been suggested (Chrysohoou C, Panagiotakos DB,
Pitsavos C, Skoumas I, Papademetriou L, Economou M, & Stefanadis C, 2007). Insulin
resistance is a characteristic feature of type 2 diabetes mellitus and obesity and promotes
oxidative stress-induced atherogenesis even in the absence of hyperglycemia (Yip J,
Facchini FS, & Reaven GM, 1998). Likewise, Du et al., provided evidence that insulin
resistance increases mitochondrial reactive oxygen species production implicated in
hyperglycemia-induced vascular damage and inactivation of enzymes involved in
atherogenesis leading to the development of atherosclerosis related to obesity and type 2
diabetes mellitus (Du X, Edelstein D, Obici S, Higham N, Zou MH, & Brownlee M,
2006; Hulsmans M, Van Dooren E, & Holvoet P, 2012).
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Oxidative stress has been previously shown to be associated with glycemic
variability in type 1 and type 2 diabetes mellitus (Monnier L, Mas E, & Ginet C, 2006;
Rodrigues R, de Medeiros LA, Cunha LM, Garrote-Filho MDS, Bernardino Neto M,
Jorge PT, Resende ES, & Penha-Silva N, 2018). Additionally, a study performed by
Rizzo et al., in patients with type 2 diabetes mellitus inadequately controlled by
metformin found that MAGE correlated with biological markers of oxidative stress
(Rizzo MR, Barbieri M, Marfella R, & Paolisso G, 2012) However, no studies have
sought to examine the relationship in overweight or obese adults, who are at higher risk
for developing cardiometabolic disorders. Hence, when examining the effect of
overweight and obesity-induced oxidative stress, it remains important to not only assess
oxidative stress, but risk factors for the development of type 2 diabetes mellitus, such as
increased glycemic variability, in overweight and obese adults.
GLYCEMIC VARIABILITY AND OXIDATIVE STRESS
Management of glycemic variability may reduce oxidative stress-induced
cardiovascular disease in patients with diabetes (Saisho Y 2014). Ceriello et al., evaluated
the effect of oscillating glucose concentrations on endothelial function and oxidative
stress in normoglycemic and adults diagnosed with type 2 diabetes mellitus and found
that that higher oscillating glucose concentration, increased glycemic variability, results
in greater endothelial dysfunction and oxidative stress than lower oscillating glucose
concentration, decreased glycemic variability, in both normoglycemia and type 2 diabetes
mellitus (Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, Boemi M, &
Giugliano D, 2008). Di Flaviani et al., noted a significant association between intra-day
glycemic variability and oxidative stress in adults with type 2 diabetes mellitus with and
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without metformin administration (Di Flaviani A, Picconi F, Di Stefano P, Giordani I,
Malandrucco I, Maggio P, Palazzo P, Sgreccia F, Peraldo C, Farina F, Frajese G, &
Frontoni S, 2011). Additionally, Monnier et al., reported a strong positive correlation
between inter-day glycemic variability and oxidative stress in adults diagnosed with type
2 diabetes mellitus (Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, & Colette
C, 2006). However, most studies performed to evaluate the relationship between
glycemic variability and oxidative stress have been in diabetic, not overweight or obese,
normoglycemic adults at risk for the development of type 2 diabetes mellitus. Thus, this
creates a gap in the literature that must be addressed when assessing not only if a
relationship exists between glycemic variability and oxidative stress, but to establish to
what extent this relationship exists in overweight or obese adults.
RELATIONSHIP BETWEEN SEDENTARY TIME, PHYSICAL ACTIVITY, GLYCEMIC
VARIABILITY, AND OXIDATIVE STRESS
It has been well established that decreasing sedentary time and increasing PA of
all intensities is beneficial to overall health and may be potentially altered in overweight
or obese adults. Additionally, overweight and obesity increases the risk for the
development of type 2 diabetes mellitus and cardiovascular disease, which is further
exacerbated by physical inactivity (Chan CB, Ryan DAJ, & Tudor-Locke CT, 2004; Van
Gaal FL & Maggioni AP, 2013). However, there is little information regarding the
relationship between sedentary time and physical activity, glycemic variability, and
oxidative stress. Increase sedentary time and decreased PA of any intensity has been
shown to be detrimental to overall health; however, how glycemic variability and
oxidative stress outcomes may be associated with sedentary behavior and PA in
overweight or obese adults remains relatively unknown. It has been reported that active
22

men and women appear to be protected against the hazards of overweight or obesity,
including a stronger protective effect in obese adults compared to their healthy weight or
overweight counterparts when examining diagnosis of type 2 diabetes mellitus,
cardiovascular disease risk factors and cardiovascular disease mortality (Blair SN &
Brodney S, 1999). However, it has been observed that overweight or obese adults tend to
spend more time sedentary and perform less PA than healthy weight adults (Tudor-Locke
C, Brashear MM, Johnson WD, & Katzmarzyk PT, 2010). Cooper et al., found that
healthy weight and overweight adults performed similar amounts of PA, while obese
adults performed less PA than healthy weight or overweight adults (Cooper AR, Page A,
Fox KR, & Mission J, 2000). Even though decreasing sedentary time and increasing PA
is believed to benefit metabolic and cardiovascular health, the results remain
controversial regarding the effect on overweight and obese adults, as the energy cost of
PA is not believed to be a major cause of obesity, rather a primary contributor and
remains a public health strategy of choice in the prevention of obesity (Hill JO &
Melanson EL, 1999).
Sedentary Time, Physical Activity, and Glycemic Variability
Limited data exist regarding the effect of sedentary time and PA on glycemic
variability; however, it is known that decreasing time spent sedentary and increasing PA
improves fasting blood glucose and glucose control during an OGTT or timed feeding in
normoglycemic and diabetic populations (Dunstan DW, Barr EL, Healy GN, Salmon J,
Shaw JE, Balkau B, & Owen N, 2010; Veerman JL, Healy GN, Cobiac LJ, Vos T,
Winkler EA, Owen N, & Dunstan DW, 2012). In nondiabetic adults, sedentary behavior
and decreased PA have been independently associated with increased risk for abnormal
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glucose metabolism, elevated fasting insulin concentration, and impaired glucose
tolerance (Helmerhorst HJ, Wijndaele K, Brage S, Wareham NJ, & Ekelund U, 2009;
Ford ES, Zhao G, & Li C, 2010; Thorp AA, Healy GN, Owen N, Slamon J, Ball K, Shaw
JE, & Dunstan DW, 2010; Lahjibi E, Heude B, Dekker JM, Højlund K, Laville M, Nolan
Jn & Balkau B, 2013). Furthermore, in adults diagnosed with type 2 diabetes mellitus,
more time spent sedentary was predictive of significant increases in time spent in
hyperglycemia (Fritchi C, Park, H, Richardson, A, Park C, Collins EG, Mermelstein R,
Riesche L, & Quinn L, 2016). Swindell et al., evaluated the impact between
accelerometer-based measurement of sedentary time and PA of varying intensities, and
cardiometabolic risk in adults with prediabetes, and found that MVPA and total PA
counts was negatively associated with 2-hour glucose concentration (Swindell N,
Mackintosh K, McNarry M, Stephens JW, Sluik D, Fogelholm M, Drummen M,
MacDonald I, Martinez JA, Handjieva-Darlenska T, Poppitt SD, Brand-Miller J, Larsen
TM, Raben A, & Stratton G, 2018). Even though these studies highlighted that sedentary
time and time spent performing PA are shown to be related to glucose concentration and
glucose tolerance, very few studies have emphasized this relationship with glycemic
variability. Paing et al., sought to examine the associations between objectively measured
sedentary time and breaks in sedentary time with 24-hour glycemic control in type 2
diabetes mellitus and found that increased sedentary time was found to be positively
associated with time spent hyperglycemic, with more breaks in sedentary time positively
associated with time spent euglycemic (Paing AC, McMillan KA, Kirk AF, Collier A,
Hewitt A, & Chastin SFM, 2018). The prevailing theory for the mechanism of action is
that adults, even normoglycemic, overweight or obese adults, that engage in greater
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amounts of PA have increased insulin-stimulated glucose control and skeletal muscle
glucose disposal than those who spend more time performing sedentary behavior (Berger
M, Kemmer FW, Becker K, Herberg L, Schwenen M, Gjinavci A, & Berchtold, 1979;
Hollenbeck CB, Haskell W, Rosenthal M, & Reaven GM, 1985). However, the
relationship between sedentary time and PA of any intensity has only been minimally and
inadequately evaluated in those who have developed impaired glucose metabolism and
has yet to be examined in a population at risk for the development of type 2 diabetes
mellitus, such as sedentary, overweight or obese adults.
Sedentary Time, Physical Activity, and Oxidative Stress
As limited as the data is on the relationship between sedentary time and PA with
glycemic variability, there are even more limited findings available on the relationship
between sedentary time and PA with oxidative stress. Sedentary lifestyle is a major risk
factor for cardiovascular disease and is primarily believed to be due to oxidative stress
induced arterial stiffness (Lessiana G, Santilli F, Boccatonda A, Iodice P, Liana R,
Tripaldi R, Saggini R, & Davi G, 2016). Additionally, those who engage in PA has been
shown to have lower oxidative stress compared to their sedentary counterparts (Carraro
E, Schilirò T, Biorci F, Romanazzi V, Degan R, Buonocore D, Verri M, Dossena M,
Bonetta S, & Gilli G, 2018). Furthermore, Yang et al., examined the association between
PA and oxidative stress in a large sample of generally healthy women and found that
higher levels of PA were associated with a decrease in oxidative stress, with an even
greater association in a subset of women who performed vigorous-intensity PA (Yang S,
Jensen MK, Mallick P, Rimm EB, Willett WC, & Wu T, 2015). However, this is one of
the only studies which directly evaluated how sedentary time and PA of varying
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intensities related to oxidative stress, but only utilized a subjective PA questionnaire to
derive PA intensities, as opposed to objective accelerometry-derived measures of PA.
Therefore, there remains a need to examine how objectively measured sedentary time and
PA relate to oxidative stress, especially in overweight and obese adults at an increased
risk for development of cardiovascular disease.
IMPACT OF AEROBIC EXERCISE ON GLYCEMIC VARIABILITY AND OXIDATIVE STRESS
Aerobic Exercise and Glycemic Variability
Exercise is defined as structured PA performed with an underlying purpose or
goal, and has been shown to influence insulin resistance and glucose tolerance, as well as
is commonly utilized as a treatment for both non-insulin and insulin-dependent type 2
diabetes mellitus (Joslin EP, Root HF, White P, & Marble A, 1935; Goodyear LJ & Kahn
BB, 1998). When discussing glucose homeostasis, even a single bout of exercise can
positively impact whole-body glucose disposal and increase the uptake of glucose into
skeletal muscle (Pruett EDR & Oseid S, 1970; Bogardus C, Thuillex P, Ravussin E,
Vasquez B, Narimiga M, & Azhar S, 1983; Richter EA, Mikines KJ, Galbo H, & Kiens
B, 1989; Wang X, Patterson BW, Smith GI, Kampelman J, Reeds DN, Sullivan SA, &
Mittendorfer B, 2013), which may persist several hours after completion of exercise
(Devlin JT & Horton ES, 1985; Devlin JT, Hirshman MF, Horton ES, & Horton ED,
1987; Mikines KJ, Sonne B, Farrell PA, Tronier B, & Galbo H, 1988). Another study
even sought the impact of frequent breaks from sitting with and without moderate
exercise and found that 24-hour glycemic control was positively impacted, with a more
positive impact in glycemic control found in those undergoing additive exercise,
suggesting that exercise may improve glucose homeostasis in addition to decreasing time
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spent sedentary (Blankenship JM, Granados K, & Braun B, 2014). Furthermore,
epidemiological studies have determined that chronic exercise can reduce the risk for
developing non-insulin-dependent diabetes (Helmrich SP, Ragland DR, Leung RW, &
Paffenbarger RS, 1991; Manson JE, Rimm EB, Stampfer MJ, Colditz GA, Willett WC,
Krolewski AS, Rosner B, Hennekens CH, & Speizer FE, 1991; Manson JE, Nathan DM,
Krolewski AS, Stampfer MJ, Willett WC, & Hennekens CH, 1992). A brief review and
preliminary evidence published by Holloszy et al., suggest that a decline in glucose
tolerance and insulin sensitivity can be prevented by performing regular exercise, and
that prolonged and frequent exercise can normalize glucose tolerance by decreasing
resistance to insulin in some individuals with impaired glucose tolerance (Holloszy JO,
Schultz J, Kusnierkiewicz J, Hagberg JM, & Ehsani AA, 1986). However, no studies
have evaluated glycemic variability following a chronic exercise intervention. Little et
al., examined the impact of acute high-intensity interval training compared to continuous
moderate-intensity exercise on postprandial hyperglycemia following standardized
dietary conditions over 24 hours in overweight or obese adults, and found that overall
postprandial glucose response and area under the curve reduced in both exercise groups
compared to matched control group (Little JP, Jung ME, Wright AE, Wright W, &
Manders RJF, 2014). An additional study by Figueira et al., evaluated the effects of a
single session of aerobic exercise alone or aerobic exercise combined with resistance
exercise on glucose levels and glycemic variability in type 2 diabetes mellitus currently
taking metformin, resulted in no significant differences between either exercise condition
in glucose concentration or glycemic variability, and decreased glucose concentrations
and glycemic variability following both exercise conditions when conventional analysis
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of glycemic variability (e.g. MAGE) was performed (Figueira FR, Umpierre D, Casali
KR, Tetelbom PS, Henn NT, Ribeiro JP, & Schaan BD, 2013). Therefore, these
previously mentioned studies necessitate the further exploration as to how glycemic
variability may be influenced by structured exercise following a chronic exercise
intervention. As well as, the less than ideal literature available regarding alterations in
glycemic variability in adults that are sedentary, overweight or obese and at an increased
risk for the development of type 2 diabetes mellitus undergoing an aerobic exercise
intervention remains to be addressed.
Aerobic Exercise and Oxidative Stress
Cardiovascular disease is a largely preventable condition with many of the
cardiovascular risk factors considered modifiable by leisure time PA, which includes
exercise (Warburton DE, Nicol CW, & Bredin SS, 2006; Hamer M & Chida Y, 2008;
Agarwal S 2012). Exercise has been suggested to induce oxidative stress acutely, which
may subside following chronic physiological adaption to exercise and potentially be
considered an antioxidant (Bouzid MA, Filaire E, Matran R, Robin S, & Fabre C, 2018).
Acutely, accumulating evidence suggests that reactive oxygen species and, in turn,
oxidative stress is generated during exercise and modulate muscle contraction, which
contributes to the development of muscle fatigue (Reid MB 1985). However, oxidative
stress in the context of chronic exercise and cardiovascular health has a differing
relationship. Chronic, moderate aerobic exercise has been demonstrated to be useful in
the prevention of oxidative stress, and, in turn serves as primary and secondary protection
from oxidative stress-induced cardiovascular disease (Baltaci SB, Mogulkoc R, & Baltaci
AK, 2016). Furthermore, it is believed and has been reported that adults who engage in
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regular exercise, due to an adaptive physiological response, accumulate lower levels of
reactive oxygen species and oxidative stress at rest and following a single bout of
exercise compared to untrained adults (Simioni C, Zauli G, Martelli AM, Vitale M,
Sacchetti G, Gonelli A, & Neri LM, 2018). Miyazaki et al., evaluated whether highintensity endurance training would alleviate exercise-induced oxidative stress in
untrained males following 12-weeks during which all participants exercised for 60
minutes a day, 5 days per week at 80% maximal exercise heart rate, and found an
increase in antioxidant enzyme activity and subsequent decrease in oxidative stress
following exercise training at rest and following an exhaustive exercise bout (Miyazaki
H, Oh-ishi S, Ookawara T, Kizaki T, Toshinai K, Ha S, Ji LL, & Ohno H, 2001).
However, the intensity of the exercise in this study was high and may not be
generalizable to those who meet the minimum guideline for participating in exercise.
Medeiros et al., aimed to evaluate oxidative stress in obese adults undergoing 5-8 weeks
of moderate-intensity concurrent training under two differing conditions, 3 days per week
compared to 5 days per week for 70 minutes each session, and found that measures of
oxidative stress decreased in both concurrent training groups, with the group completing
3 days per week eliciting a greater decrease in measures of oxidative stress (Medeiros
NS, de Abreu FG, Colato AS, de Lemos LS, Ramis, TR, Dorneles GP, Funchal C, &
Dani C, 2015).
Additionally, potential changes in glycemic variability due to exercise training
may contribute to this observed reduction in oxidative stress after exercise training,
which has yet to be elucidated. Thus, when examining oxidative stress, it is important to
examine how it changes along with glycemic variability following aerobic exercise
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training, which further implores the inclusion of glycemic variability as an important
marker or overall health due to its potential relationship with oxidative stress.
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CHAPTER 3
GENERAL METHODOLOGY
The first study that comprises this dissertation is a critical review of sedentary
time and PA, glycemic variability assessed via CGM technology, and measures of
oxidative stress in overweight or obese individuals. The second study combines two
clinical trials, Weight Outlooks by Restriction of Diet and Sleep (WORDS) and Aerobic
Treadmill Exercise and Metabolism (A-TEAM) studies, to examine the associations
between sedentary time, PA of varying intensities, glycemic variability, and oxidative
stress prior to either study’s intervention. The WORDS study (ClinicalTrials.gov
identifier: NCT02413866) was designed to examine the effects of chronic moderate sleep
restriction on body composition and energy expenditure in individuals undergoing a
hypocaloric dietary weight loss program, however, we will only be utilizing participants
that completed baseline testing for the measurement of the outcomes pertinent to this
dissertation, while the A-TEAM study (ClinicalTrials.gov identifier: NCT03162991)
examined the effects of a moderate-intensity aerobic treadmill-based exercise
intervention on glucose concentrations utilizing CGM technology in sedentary,
overweight or obese adults. The third study utilized data collected from the A-TEAM
study to examine the effect of a moderate-intensity aerobic treadmill-based exercise
intervention on changes in sedentary time, PA, glycemic variability, and oxidative stress.
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STUDY 1 METHODOLOGY- CRITICAL REVIEW ON CURRENT LITERATURE REVOLVED
AROUND SEDENTARY TIME AND PHYSICAL ACTIVITY, GLYCEMIC VARIABILITY, AND
OXIDATIVE STRESS IN ADULTS
Purpose
This study addresses specific aim 1 and focuses on performing a critical review of
literature on the topics of sedentary time and PA, glycemic variability, and oxidative
stress. A critical review can be considered the summarization and evaluation of the ideas
and information in an article. It predominantly expresses the writer’s point of view in the
light of what the writer has already obtained knowledge on the subject being discussed
and what is acquired from related texts. Additionally, reviewing critically means thinking
carefully and clearly and taking into consideration both the strengths and weaknesses in
the material under review. This critical review focuses primarily on relevant research
based on objectively measured sedentary time and PA, CGM assessed glycemic
variability, and biomarkers of oxidative stress in adults.
Sub-Aim 1.1: To summarize and describe the known relationship between
sedentary time and PA, glycemic variability, oxidative stress.
Sub-Aim 1.2: To summarize how acute exercise affects glycemic variability.
Sub-Aim 1.3: To summarize how repeated bouts of exercise and exercise training
affects glycemic variability.
Study Design
This study is a critical review of the current literature surrounding sedentary time,
PA, glycemic variability, and oxidative stress.

32

Research Design and Methods
Data Sources and Searches
To address sub-aim 1.1, which will be to establish what is known regarding the
relationship between sedentary time and PA, glycemic variability, and oxidative stress,
we plan to search the electronic databases PubMed, Google Scholar, Web of Science,
BioMed Central, Cumulative Index of Nursing and Allied Health Literature (CINAHL),
and SCOPUS databases up until December 2018. A variety of search terms were utilized
for sedentary time, PA, continuous glucose monitoring, glycemic variability, and
oxidative stress (outcome variables of interest). We plan to limit sedentary time and PA
to objectively measured outcomes by validated accelerometry, but plan to include
objectively assessed sedentary time and PA if yielded few search results. Glycemic
variability will include only CGM assessed glycemic variability and oxidative stress will
include any studies that examined the associations between biological markers of
oxidative stress with glycemic variability. Studies will be included even if no relationship
is found between sedentary time and PA and glycemic variability, or between glycemic
variability and oxidative stress as research design and analysis of findings are of
importance for this critical review. The search will be limited to adults; however, will
include adults that are overweight or obese, have impaired glycemic states, diagnosed
with type 1 or 2 diabetes, or cardiovascular disease risk factors in the presence or absence
of medication which may affect outcomes of interest (population). These populations will
be accounted for as age, body weight and health status, and medication usage may alter
the outcome variables of interest, specifically glycemic variability and oxidative stress.
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Similar to sub-aim 1.1, to address sub-aim 1.2, which will be to examine how the
acute response to exercise affects the relationship on glycemic variability, we plan to
search the electronic databases PubMed, Google Scholar, Web of Science, BioMed
Central, CINAHL, and SCOPUS databases up until December 2018. Similar variables as
of interest Sub Aim 1.1 will be utilized as search terms, including continuous glucose
monitoring and glycemic variability; however, to examine the effect on the outcomes of
interest, we will also perform a search to include acute aerobic exercise. Acute exercise
will include monitored, clinically validated submaximal and maximal bout of exercise,
including, but not limited to upper arm and lower leg ergometry, and treadmill based
aerobic activity, and high-intensity interval training (HIIT) (treatments). We plan to limit
glycemic variability to include only CGM assessed glycemic variability.
Lastly, to address sub-aim 1.3, which will be to examine how repeated bouts of
exercise or exercise training affects glycemic variability, we will perform the same search
as sub-aims 1.1 and 1.2, on the electronic databases PubMed, Google Scholar, Web of
Science, BioMed Central, CINAHL, and SCOPUS databases up until December 2018.
The same outcome variables of interest will be utilized as search terms, continuous
glucose monitoring and glycemic variability as sub-aims 1.1 and 1.2; however, to expand
upon findings from aim 1.2, we plan to examine the effect of repeated bouts of exercise
and exercise training on glycemic variability, and a search including any repeated type of
exercise, including short-term and chronic aerobic exercise interventions (treatment) on
glycemic variability. This includes standardized or individualized and monitored exercise
interventions, including HIIT training, performed in adults that do not have any
limitations in their ability to perform aerobic exercise or have any contraindications to
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perform aerobic exercise based on the criteria established by the American College of
Sports Medicine, unless under clinical supervision during the exercise intervention
(American College of Sports Medicine 2017).
For sub-aims 1.1, 1.2, and 1.3, we will limit the date range to December 2018 and
will not place any language restrictions. We will include any duration of acute
submaximal and maximal bouts of exercise and will define the acute response as
immediately post-exercise up to 48 hours post-exercise, as long as the exercise bout is
monitored and clinically validated. If studies included longer acute-phase durations past
48 hours post-exercise, they will be evaluated and included accordingly. Additionally, we
will include repeated exercise and exercise interventions of all lengths in duration as long
as they meet the minimum guidelines established for being considered physically active
by the American College of Sports Medicine (American College of Sports Medicine
2017). Our secondary search strategy will include scanning bibliographies of the
retrieved articles and searching for unpublished studies using key trial registries
(clinicaltrials.gov and https://www.isrctn.com/).
Data Extraction and Study Quality
Initial selection will be based on title and abstract. The original article will be
obtained and subsequently determined if the research study met the inclusion criteria
established for the critical review. One reviewer will select the study independently and,
if unsure about the reliability of the study in question, will seek a second reviewer to aid
in the decision to include or exclude the article in the critical review. If there is
disagreement between the primary and secondary reviewer, a third reviewer will be
selected to provide a resolution to the inclusion or exclusion of the article in question for
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the critical review. Reasons for exclusion will be documented and are available from the
authors upon request.
Even though not a systematic review, data extraction and quality assessment will
be based on the template from the Centre for Review and Dissemination (CRD) for
systematic review guidelines (Tables 3.1. and 3.2.) (Centre for Reviews and
Dissemination 2009). Extracted data will include details of the population, treatment,
outcome variables of interest, and areas of potential bias. Biases evaluated in randomized
controlled trials included adequate sequence generation, follow-up and exclusion biases,
and intention to treat analysis. In non-randomized control trials, we plan to evaluate any
baseline differences in participants, biases in allocation, follow-up and exclusion, and if
analytical method was specified in the study protocol.
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Table 3.1. Article Evaluation and Data Extraction Form (Sub-Aim Aim 1.1)
Article Details
• Study ID (First Author Name and Publication Date)
•

Title of the Article

•

Country

•

Language

•

Database

Study Details
• Aim of the Study
•

Study Design

•

Setting of the Study

•

Duration of the Study

Methods
• Inclusion and/or Exclusion Criteria
•

Outcome Measures

•

Outcome Measure Method

•

Outcome Evaluation Method

•

Statistical Analysis

Participant Characteristics
• Number Enrolled and Number Analyzed
Enrolled:
Analyzed:
• Age
•

Sex Composition (M/F), n (%)

•

Race Composition

•

Weight and BMI
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Results
• Primary Findings
•

Additional Findings

Conclusions
• Areas of Bias:
• Strengths:
• Weaknesses:
Additional Comments
•

Reason for Exclusion:
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Table 3.2. Article Evaluation and Data Extraction Form (Sub-Aims 1.2 and 1.3)
Article Details
• Study ID (First Author Name and Publication Date)
•

Title of the Article

•

Country

•

Language

•

Database

Study Details
• Aim of the Study
•

Study Design

•

Setting of the Study

•

Duration of the Study

Methods
• Inclusion and/or Exclusion Criteria
•

Randomization (If More than One Treatment)

•

Allocation

•

Blinding

•

Outcome Measures

•

Outcome Measure Method

•

Outcome Evaluation Method

•

Statistical Analysis

•

Notes

Participant Characteristics
• Number Enrolled, Number Randomized, and Number Analyzed
Enrolled:
Randomized:
Analyzed:
39

•

Age

•

Sex Composition (M/F), n (%)

•

Race Composition

•

Weight and BMI

•

Noted Differences between Randomization Groups

•

Intervention Type and Intervention Descriptions

•

Control Type and Control Description (If a Control Group is Included)

•

Follow-Up Description

Results
• Primary Findings
•

Additional Findings

Conclusions
• Areas of Bias:
• Strengths:
• Weaknesses:
Additional Comments
•

Reason for Exclusion:
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Strengths and Limitations of Study 1
Overall, there is a lack of well-documented studies that examine the relationship
between sedentary time and PA with glycemic variability and oxidative stress, with even
less information regarding the effect of acute and chronic aerobic exercise on glycemic
variability. This study aims to be among the first to critically examine the current
literature available regarding sedentary time and PA with glycemic variability and
oxidative stress and compile a critical review to examine the current known information
and delineate the gaps in the literature that need to be addressed. Specifically, this critical
review aims to be the first to address this relationship in adults in a non-treatment and
completing a treatment procedure (acute aerobic exercise and chronic aerobic exercise
intervention). This critical review plans to include information from multiple sources,
including PubMed, Google Scholar, Web of Science, BioMed Central, CINAHL, and
SCOPUS databases up until December 2018. Additionally, a variety of search terms for
each outcome variable of interest will be utilized to fully assess the relationship between
sedentary time, PA, glycemic variability, and oxidative stress, as well as how glycemic
variability may be altered due to acute and chronic aerobic exercise. There are several
limitations to this study. The first will the primary use of objectively assessed sedentary
time and PA; however, subjectively assessed sedentary time and PA will be incorporated
as a secondary measure to fully elucidate this relationship, but have been shown to often
lack validity, reliability, and reproducibility (Prince SA, Adamo KB, Hamel ME, Hardt J,
Gorber SC, & Tremblay M, 2008). Additionally, only compiling articles utilizing CGM
assessed glycemic variability has an inherent limitation as other clinical measures of
glycemic variability exist. CGM assessed glycemic variability will be utilized as opposed
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to other clinical measurements, such as fasting glucose concentrations and the glucose
response during a glucose challenged state, as they may not be truly representative of
glycemic variability that occurs over an extended period of time, or in a “free-living”
environment, which will allow for greater insight into glycemic health. Furthermore, the
accuracy of CGM measurements have been validated with clinical measures, such as
venous blood sampling, in normo-glycemic individuals (Akintola AA, Noordam R,
Jansen SW, de Craen AJ, Ballieux BE, Cobbaert CM, Mooijaart SP, Pijl H, Westendorp
RG, & van Heemst D, 2015). We plan to include studies that examined the relationship
between sedentary time and PA, continuous glucose monitor assessed glycemic, and
biological markers of oxidative stress, as well as discuss oxidative stress markers that
may have no existing relationship with sedentary time and PA or glycemic variability and
mechanisms as to why when appropriate. Additionally, as the primary outcome variables
of interest aim to address the overall research question regarding how sedentary time and
PA interact with glycemic variability, we plan to incorporate how glycemic variability is
altered following an acute aerobic exercise bout, and chronic aerobic exercise
intervention. Lastly, the inclusion of a adults diagnosed with cardiometabolic disease,
such as diabetes or cardiovascular disease risk factors, is a limitation, but will allow for a
meaningful observation as to how sedentary time and PA relate to glycemic variability
and oxidative stress in non-clinical and clinical populations, as well as provide greater
insight into the acute and chronic response to aerobic exercise. As previously stated, even
the presence of overweight and obesity immediately predisposes individuals to impaired
glucose metabolism and cardiovascular disease risk factors, which will allow us to
examine the relationship between sedentary time and PA with glycemic variability and
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oxidative stress in an at-risk, non-disease state population. Overall, we plan to ensure
included studies did not incorporate an adolescent or aging population to limit the effect
of age on the outcome variables of interest, as well as guarantee that all populations in the
articles included in this critical review are, other than potentially have impaired
cardiometabolic status, otherwise healthy, presented with no complications or
contraindications to exercise as described by the American College of Sports Medicine
(American College of Sports Medicine 2017), or were appropriately monitored by trained
medical staff. Moreover, as this study seeks to be the first to examine the relationship
between objectively measured sedentary time and PA with measures of CGM assessed
glycemic variability and oxidative stress, future studies will be able to utilize this critical
review as a basis for the development of interventions aimed to decrease sedentary time,
increase PA, and improve measures of glycemic variability and oxidative stress in adults
at an increased risk for the development of, or in the presence of, metabolic and
cardiovascular disease.
STUDY 2 METHODOLOGY- SEDENTARY TIME AND PHYSICAL ACTIVITY’S ASSOCIATION
WITH GLYCEMIC VARIABILITY AND OXIDATIVE STRESS
Purpose
This study addresses Specific Aim #2, which was to examine the cross-sectional
associations between sedentary time and PA, glycemic variability, and biological markers
of oxidative stress in overweight or obese adults.
Sub-Aim 2.1: To examine the associations between daily sedentary time,
glycemic variability, and oxidative stress.
Sub-Aim 2.2: To examine the associations between daily LPA and MVPA,
glycemic variability, and oxidative stress.
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Sub-Aim 2.3: To examine the associations between daily total PA, glycemic
variability, and oxidative stress.
Hypothesis
Sedentary time will be positively associated with glycemic variability and
oxidative stress, while PA of varying intensities and total PA will be negatively
associated with glycemic variability and oxidative stress.
Study Design
This study utilized a cross-sectional design.
Study Population and Enrollment Process
For both the WORDS and A-TEAM studies, 28 participants were recruited from
the Columbia, South Carolina metropolitan area. The WORDS study openly recruited
from January 2015 to October 2016, while the A-TEAM study openly recruited from
October 2017 to December 2018. Participants were required to be currently healthy,
sedentary, overweight or obese adults (males and females), age 35-55 years, have
25≤BMI≤40 kg/m2, be weight stable (±2%) during the previous 3 months, have ˂120
minutes of resistance or endurance exercise per week during the previous 3 months, and
for females, be eumenorrheic, or post-menopausal for ≥1 year. Also, potential
participants self-reporting medical conditions (e.g. diabetes), cardiovascular diseases,
chronic or recurrent respiratory conditions (e.g. uncontrolled asthma or chronic
obstructive pulmonary disease), active cancer, and eating, or neurological disorders,
medications that affect metabolism (e.g. thyroid medications, statins), psychological
issues, including but not limited to untreated depression and attention deficit disorder,
excessive caffeine use (>500 mg/day), smoking during the past year, pregnant or lactating
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females, unwillingness to provide informed consent were additional criterion for
exclusion from the study. All participants in the studies met in the same laboratory
setting, with the same research staff, which conducted all pertinent tests towards this
dissertation in the same manner during the time of recruitment through study termination.
Sedentary Time and Physical Activity
Sedentary time and PA will be measured for all participants at 7 consecutive days
and all participants were instructed to continue their normal daily routine during
monitoring. Participants wore the Sensewear Mini Armband on the left arm at the midpoint between the olecranon and acromion processes. Participants recorded when they
removed the monitor for any activities that required water-based activities, such as
showering/bathing or swimming. Participants were instructed to record times they
removed and replaced the monitor if removed over the 7-day wear time period. Data will
be considered valid for analysis if participants wore the monitor for at least 5 days
including a weekend day, with a minimum wear time of 20 hours each day.
Sedentary time and PA levels will be assessed using manufacture provided
software (BodyMedia Sensewear Version 7.0). The Sensewear Mini Armband provides
objectively measured PA. Sedentary time will be set as <1.5 metabolic equivalents
(METs) (excluding sleep time), light-intensity PA as 1.5≤3.0 METs, moderate-intensity
PA as 3.0≤6.0 METs, and vigorous-intensity PA as ≥6.0 METs, moderate-to-vigorousintensity PA as ≥3.0 METs, and total PA intensity as ≥1.5 METs. In addition to time
spent sedentary and performing PA of varying intensity, total daily energy expenditure
(TDEE) and physical activity energy expenditure (PAEE) for total PA (≥1.5 METs) and
moderate-to-vigorous-intensity PA (≥3.0 METs) will be analyzed. Time spent sedentary
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and performing PA, TDEE, and PAEE will be calculated for each valid day of wear time
and will be analyzed as an average of those days. Estimated PA time and energy
expenditure during non-wear times will be excluded from analysis.
Glycemic Variability
Glycemic variability will be assessed by a CGM (Dexcom G4 Platinum
Professional, San Diego, CA, USA). Participants had a sensor inserted under the skin on
the preferred side of the abdomen, approximately 2 cm to the side of the umbilicus, and
were required to carry a recording device for 7 consecutive days. The participants were
trained to manually perform a capillary blood measurement (fingerstick) using a provided
glucometer twice a day during wear time per manufacturer’s instructions. The CGM
device was blinded so that participants could not see the live readings to deter any
alterations in diet, PA, or general lifestyle. Data was considered valid for analysis if
participants wore the monitor for 5 days including a weekend day, with a minimum of 20
hours’ data each day.
Software provided by the manufacturer (Dexcom Studio 12.0.4.6) was used to
download and export the CGM data to Excel datafiles. The data were assessed in 5minute intervals per 24-hour period. CGM data was transferred into and glycemic
variability was analyzed per day using the EasyGV Version 9.0.R2, which is an Excelenabled workbook that utilizes macros to calculate glycemic variability (University of
Oxford, Oxford, England, UK). The MAGE and the CONGA-4 will be calculated and
utilized as measurements of inter- and intra-day glycemic variability for each valid day of
wear time and will be analyzed as an average of those days. Additionally, day-to-day
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variability will be assessed as the standard deviation and coefficient of variation between
the valid days analyzed.
Oxidative Stress
Oxidative stress will be assessed in serum (n=20; WORDS study) and plasma
(n=8; A-TEAM study) from all participants who completed the studies and had fasting
venous blood samples available at the end of the 7-day monitoring period. Prior to
analysis, as samples are collected, they will be centrifuged at 3,000 rpm at 4 degrees
Celsius for 20 minutes and stored at -80 degrees Celsius until all samples are collected.
Once all sample were collected and ready for analysis, samples will be thawed and recentrifuged to separate any particulate. Two biological biomarkers or oxidative stress,
nitric oxide and myeloperoxidase, will be measured using two separate enzyme-linked
immunoabsorbant assays (ELISA). The nitric oxide ELISA kit (ThermoFicher Scientific,
Waltham, MA) will be quantitatively determined by the concentrations of nitrate and
nitrite in serum and plasma samples. This ELISA utilized the enzyme nitrate reductase to
convert nitrate to nitrite, which was then detected as a colored azo dye product of the
Griess reaction which absorbs light at 540 nm. The interaction of nitrate and nitrite
concentrations measured will determine the concentration of nitric oxide in both serum
and plasma (Fareed D, Tqbal O, Tobu M, Hoppensteadt DA, & Fareed J, 2004). Proper
sample dilution and preparation will allow for a low percent coefficient of variation, and
both human serum and plasma samples have ≥90% sample recovery for both nitrite and
nitrate concentrations which will be utilized to calculate nitric oxide, alleviating potential
error due to intra-assay and inter-assay variability per manufacturer’s product information
sheet. The myeloperoxidase serum/plasma ELISA kit (Eagle Biosciences, Inc., Nashua,
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NH) will be utilized to quantify the determination of myeloperoxidase utilizing a two-site
“sandwich” technique that binds to different epitopes of myeloperoxidase. Antibodies
bind to myeloperoxidase and, after several incubation periods and plate washes, will be
ready to analyze by detecting the immunocomplex and the absorbency of the sample.
Intra-assay and inter-assay variability for concentrations of myeloperoxidase were
comparable in serum and plasma utilized per manufacturer’s product information sheet in
which they measured two sample extracts in a single assay with twelve replicate
determinations for intra-assay variability, and by measuring two controls in duplicate in
six individual assays.
Fasting Glucose Concentration and Oral Glucose Tolerance Test
For the WORDS study, on the final day of 7-day CGM monitoring period each
participant completed an OGTT at baseline and post-intervention. Following an overnight
fast (~12 hours other than water), participants reported to an approved clinical site and
performed a venous blood sample collection in which a catheter was inserted into the
antecubital space of the arm. Time was recorded when am initial venous blood sample
was collected to establish fasting blood glucose time point. Following the venous blood
collection, participants were then instructed to consume a standard 10-ounce, 75-gram
glucose infused drink (Azer Scienmtific, Morgantown, PA) within 5 minutes of the
venous blood collection and time consumption completed was recorded and utilized as
time point zero (0-). Every 30-minute interval was then recorded until 2 hours was
complete (30-,60-,90-,120-minutes post-consumption), which is the standard procedure
for a 75-gram OGTT (Institute for Quality and Efficiency in Healthcare 2011). During
the 2-hour OGTT, participants were instructed to limit their movement, unless necessary,
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to limit the impact of muscle contraction on glucose concentrations. All venous blood
samples were collected into 1.5 mL centrifuge tubes and placed on ice until completion
of the 2-hour OGTT and subsequently stored at -80 degrees Celsius until all samples are
collected. Fasting and 30-,60-,90-, and 120-minute post-consumption concentrations of
blood glucose were analyzed utilizing a YSI 2300 STAT Plus (YSI Life Sciences, Yellow
Spring, OH), which was calibrated according to manufacturer instruction prior to
analysis.
For the A-TEAM study, on the final day of 7-day CGM monitoring period, while
participants were still wearing the CGM monitor, each participant completed an OGTT at
baseline and post-intervention. Following an overnight fast (~12 hours other than water),
participants reported to an approved clinical site and performed a venous blood sample
collection. Time was recorded and matched with the CGM to the venous blood collection
to establish fasting blood glucose time point. Following the venous blood collection,
participants were then instructed to consume a standard 10-ounce, 75-gram glucose
infused drink (Azer Scienmtific, Morgantown, PA) within 5 minutes of the venous blood
collection and time consumption completed was recorded and utilized as time point zero
(0-). Every 30-minute interval was then recorded until 2 hours was complete (30-,60-,90,120-minutes post-consumption), which is the standard procedure for a 75-gram OGTT
(Institute for Quality and Efficiency in Healthcare 2011). During the 2-hour OGTT,
participants were instructed to limit their movement, unless necessary, to limit the impact
of muscle contraction on glucose concentrations. As CGM assessed glucose
concentrations have been validated with venous blood glucose concentrations (Kovatchev
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B, Anderson S, Heinemann L, & Clarke W, 2008), no subsequent blood draws were
performed at each time point after fasting.
Software provided by the manufacturer (Dexcom Studio 12.0.4.6) was used to
download and export the CGM data to Excel datafiles. Time points recorded during the
OGTT were identified and matched with exported CGM data for time point 0 and
subsequent 30-,60-,90-,120-minute post-consumption time points. If any of the time
points fell between CGM concentration readings, as the CGM assesses every 5 minutes,
the average between the previous and following CGM concentration readings were
calculated. Additionally, OGTT area under the curve (AUC) was calculated utilizing the
equation Glucose AUC=1/2×30×(y0-+2y30-+2y60-+2y90-+y120-), where y represents glucose
concentration at the different time points (Tai MM 1994).
Statistical Analysis
Descriptive statistics were calculated and reported as means and standard
deviations. To address all sub-aims, the average of valid daily sedentary time, and LPA,
MPA, VPA, and MVPA, total PA time, TDEE, and PAEE (≥1.5 and ≥3.0 METs) will be
calculated. Furthermore, the average of valid daily glycemic variability assessed via
MAGE, CONGA-4, and MODD will be calculated, and fasting concentrations of nitric
oxide and myeloperoxidase will be measured. To address sub-aim 2.1, Pearson product
correlations between sedentary time and MAGE, CONGA-4, and MODD, and nitric
oxide and myeloperoxidase will be performed. To address sub-aim 2.2, Pearson product
correlations will be performed between LPA and MVPA time, TDEE, and PAEE (≥3.0
METs) between both measures MAGE and CONGA-4 and nitric oxide and
myeloperoxidase. To address sub-aim 2.3, Pearson product correlations will be
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performed between total PA time and PAEE (≥1.5 METs) and MAGE and CONGA-4,
and nitric oxide and myeloperoxidase. Furthermore, to address the relationship between
daily glycemic variability and oxidative stress, Pearson product correlations will be
performed between both measures of glycemic variability and oxidative stress (i.e.
MAGE and nitric oxide, MAGE and myeloperoxidase, CONGA-4 and nitric oxide, and
CONGA-4 and myeloperoxidase). Additionally, for sub-aims 2.1 and 2.2, and 2.3, age,
sex, race, and/or BMI will be adjusted for to examine the role of participant
characteristics on the associations between measures of glycemic variability and
oxidative stress. Lastly, as we are including participants from two different studies, with
slightly different methodology, we plan to adjust for study involvement (WORDS and ATEAM) for all three sub-aims to assess whether sample type may affect the associations
of interest. Lastly, to assess potential day-to-day variability of sedentary and PA
measures and variation in glycemic variability on their relationship with oxidative stress,
Pearson product correlations will be performed between the standard deviation and
coefficient of variation for sedentary and PA measures and measures of glycemic
variability with fasting oxidative stress concentrations.
Statistical Power
There is currently no info in the literature examining the relationship between
sedentary time, PA of varying intensities, and measures of glycemic variability and
oxidative stress. Therefore, power analysis calculations were performed using G*Power
3.0.10 and found that when testing for the sensitivity of a required significant correlation,
28 participants would allow for 80% power with a medium- to large-correlation (-1.0-0.3; 0.3-1.0) with alpha set to 0.05 when testing for the correlation between the outcome
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variables of interest, sedentary time and PA of varying intensities with glycemic
variability and oxidative stress. As this is the first study to examine the relationship
between daily sedentary time, PA of varying intensities, measures of glycemic variability,
and fasting concentrations of biomarkers associated with oxidative stress, results will be
utilized to provide evidence for power calculations for future studies.
Strengths and Limitations of Study 2
This study is among the first to examine the relationship between sedentary time,
PA of varying intensities, glycemic variability, and oxidative stress. The use of CGM
technology to assess glycemic variability is another strength, which allows for the
observation of a “free-living” condition as opposed to standard clinical measures. The
strengths of this study also included the use of trained staff for the placement and
implementation of not only the Sensewear Mini Armband, but also the Dexcom CGM
device, trained phlebotomists completed the blood collection and processing prior to
analysis of oxidative stress biomarkers, nitric oxide and myeloperoxidase. There are
limitations for this proposed study, including the demographics of the population, which
is considered a convenience sample, and only makes the results generalizable to
sedentary, overweight or obese individuals that are between the ages of 35 and 55 years.
Additionally, undiagnosed diabetics were not excluded from the study, which may
influence the results. In order to limit this, no participants were currently taking diabetic
medications during measurement time period. Following completion of the 7-day
monitoring period, each participant’s CGM glucose levels were analyzed and none of the
completers fell into the prescribed diabetic range (fasting blood glucose ≥126 mg/dL).
Furthermore, diet was not fully taken into account, as only self-report dietary intake was
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provided, which has been known to be unreliable. In order to limit this, we recommended
that each participant attempt to maintain their daily dietary routines during the 7-day
monitoring process. However, not controlling for diet may also be considered a strength
as their “normal” dietary patterns may provide an insightful examination into the “freeliving” glycemic variability observed. For females, current cycle of menstruation was not
taken into account, as current cycle in the menstrual period may influence hormones
associated with glucose metabolism and cardiovascular outcomes. Past research has
found that both glucose metabolism and oxidative stress may be altered during various
phases of the menstrual cycle (Widom B, Diamond MP, Simonson DC, & 1992; Browne
RW, Bloom MS, Schisterman EF, Hovey K, Trevisan M, Wu C, Liu A, & WactawskiWende J, 2008). As we have no way of retroactively examining menstrual cycle in
female participants, this limitation will persist, but provide future directions for the
consideration of menstrual cycle phase in subsequent research studies.
STUDY 3 METHODOLOGY-THE IMPACT OF AEROBIC EXERCISE TRAINING ON PA,
GLYCEMIC VARIABILITY, AND OXIDATIVE STRESS
Purpose
This study addressed Specific Aim #3, which was to examine the effect of a 12week aerobic exercise intervention on glycemic variability and oxidative stress.
Sub-Aim 3.1: To examine the effect of a 12-week aerobic exercise intervention on
glycemic variability.
Sub-Aim 3.2: To examine the effect of a 12-week aerobic exercise intervention
on oxidative stress.
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Hypothesis
An aerobic treadmill-based intervention aimed at increasing structured PA
through aerobic-exercise training will positively impact and improve measures of
glycemic variability through reduction of glycemic variability assessed as MAGE and
CONGA-4, and measured biomarkers of oxidative stress by increasing concentrations of
circulating nitric oxide and decreasing circulating concentrations of myeloperoxidase.
Study Design
This study utilized an interventional design.
Study Population and Enrollment Process
For the A-TEAM study, eight participants were recruited from the Columbia,
South Carolina metropolitan area between October 2017 and December 2018. Potential
participants were required to be currently healthy, sedentary, overweight or obese adults
(males and females), age 35-55 years, have 25≤ BMI≤40 kg/m2, be weight stable (±2%)
during the previous 3 months, have ˂120 minutes of reported resistance or endurance
exercise per week during the previous 3 months, and for females, be eumenorrheic, or
post-menopausal for ≥1 year. Also, potential participants self-reporting medical
conditions (e.g. diabetes), cardiovascular diseases, chronic or recurrent respiratory
conditions (e.g. uncontrolled asthma or chronic obstructive pulmonary disease), active
cancer, and eating, or neurological disorders, medications that affect metabolism (e.g.
thyroid medications, statins), psychological issues, including but not limited to untreated
depression and attention deficit disorder, excessive caffeine use (>500 mg/day), smoking
during the past year, pregnant or lactating females, and unwillingness to provide
informed consent were additional criterion for exclusion from the study.
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All participants answered a medical history questionnaire and underwent a series
of medical tests to identify and medical conditions that could potentially interfere with
participation in the exercise intervention, which included resting blood pressure, resting
electrocardiogram (ECG), graded exercise test, and CGM assessed fasting glucose
concentrations. If potential participants are found to fall in the range of diabetic without
prior diagnosis following the week wearing the CGM, they were provided the daily
glucose concentrations obtained from the CGM and instructed to see a physician.
Study Intervention
Participants completed a 12-week moderate-intensity aerobic treadmill-based
exercise intervention. Participants walked 3 times a week on treadmills in a controlled
research facility under trained supervision. The exercise volume was achieved by varying
the duration, speed, and grade to reach each participant’s energy expenditure goal
according to body weight (10-12 kcal per kg of body weight each week). Weekly energy
expenditure was determined by multiplying each participant’s body weight by the energy
expenditure goal (10-12 kcal per kg of body weight each week) and was closely
monitored throughout the 12-week intervention. Adherence to the exercise prescription
(weekly energy expenditure of 10-12 kcal per kg of body weight each week) was
monitored by calculating the amount of energy expenditure each exercise session using
the standard American College of Sports Medicine formula: {0.1×(speed[miles per hour]
×26.8)+1.8×(speed[miles per hour] ×26.8)×grade(%)+3.5}×body weight(kg)÷5(L per
minute)×time(minutes) (American College of Sports Medicine 2017). 12 weeks of
aerobic exercise training has been extensively studied and is considered an appropriate
duration for physiological adaptations to aerobic exercise to occur (Ho SS, Dhaliwal SS,
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Hills AP, & Pal S, 2012). The prescribed training volume, 10-12 kcal per kg of body
weight each week, is considered a higher volume of aerobic exercise energy expenditure
compared to past guidelines, which suggest 8 kcal per kg of body weight each week
should elicit physiological alterations; however, as that study design also noted
physiological changes at 12 kcal per kg of body weight each week, and utilized a 6 month
intervention, 10-12 kcal per kg of body weight each week for 12 weeks of moderateintensity aerobic exercise was assigned (Morss GM, Jordan AN, Skinner JS, Dunn AL,
Church TS, Earnest CP, Kampert JB, Jurca R, & Blair SN, 2004; Sisson SB, Katzmarzyk,
Earnest CP, Bouchard C, Blair SN, & Church TS, 2009; Rosenkilde M, Reichkendler
MH, Auerbach P, Bonne TC, Sjödin A, Ploug T, & Stallknecht BM, 2015).
Due to the physically inactive state of the participants, the exercise intensity and
weekly energy expenditure was gradually increased to reduce risk of injury. Training
intensity increased during the first 4 weeks of aerobic treadmill-based exercise
intervention until the target level of 50-55% of participant’s heart rate reserve (HRR) was
met, which was determined during the baseline graded exercise test. Participants began at
a weekly energy expenditure of 6-8 kcal/kg of body weight during the first week of the
intervention and then progressed until their weekly energy expenditure (10-12 kcal/kg of
body weight) was attained by week 4. Each exercise session began and ended with a 3minute warm-up and cool-down. Heart rate (HR) monitors (FT1; Polar, Lake Success,
NY, USA) were worn to monitor exercise intensity continuously throughout each
exercise session and HR was recorded every five minutes. If HR monitors were unable to
detect HR, manual palpation at the radial artery was measured for 30-60 seconds. Blood
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pressure was measured before, during warm-up, at the mid-point of the exercise session,
during cool-down, and following each exercise session.
Compliance to the weekly weigh-ins and prescribed exercise intervention
(frequency, intensity, and duration) for each participant was reviewed weekly and any
participant missing an exercise session without notifying study personnel was contacted
via phone or e-mail to reschedule and encourage further attendance.
Glycemic Variability
Glycemic variability will be assessed by a CGM (Dexcom G4 Platinum
Professional, San Diego, CA, USA). Participants had a sensor inserted under the skin on
the preferred side of the abdomen, approximately 2 cm to the side of the umbilicus, and
were required to carry a recording device for 7 consecutive days at baseline and endintervention. The participants were trained to manually perform a capillary blood
measurement (fingerstick) using a provided glucometer twice a day during wear time per
manufacturer’s instructions. The CGM device was blinded so that participants could not
see the live readings to deter any alterations in diet, PA, or general lifestyle. Data was
considered valid for analysis if participants wore the monitor for 5 days including a
weekend day, with a minimum of 20 hours’ data each day.
Software provided by the manufacturer (Dexcom Studio 12.0.4.6) was used to
download and export the CGM data to Excel datafiles. The data were assessed in 5minute intervals per 24-hour period. CGM data was transferred into and glycemic
variability was analyzed per day using the EasyGV Version 9.0.R2, which is an Excelenabled workbook that utilizes macros to calculate glycemic variability (University of
Oxford, Oxford, England, UK). The MAGE and the CONGA-4 will be calculated and
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utilized as measurements of intra-day glycemic variability for each valid day of wear
time and will be analyzed as an average of those days. Additionally, day-to-day
variability will be assessed as the standard deviation and coefficient of variation between
the valid days analyzed.
Oxidative Stress
Oxidative stress will be assessed in plasma (n=8) from all participants who
completed the studies and had fasting venous blood samples available at the end of the 7day monitoring period at baseline and end-intervention. Prior to analysis, as samples are
collected, they will be centrifuged at 3,000 rpm at 4 degrees Celsius for 20 minutes and
stored at -80 degrees Celsius until all samples are collected. Once all sample were
collected and ready for analysis, samples will be thawed and re-centrifuged to separate
any particulate. Two biological biomarkers or oxidative stress, nitric oxide and
myeloperoxidase, will be measured using two separate enzyme-linked immunoabsorbant
assays (ELISA). The nitric oxide ELISA kit (ThermoFicher Scientific, Waltham, MA)
will be quantitatively determined by the concentrations of nitrate and nitrite in serum and
plasma samples. This ELISA utilized the enzyme nitrate reductase to convert nitrate to
nitrite, which was then detected as a colored azo dye product of the Griess reaction which
absorbs light at 540 nm. The interaction of nitrate and nitrite concentrations measured
will determine the concentration of nitric oxide in both serum and plasma (Fareed D,
Tqbal O, Tobu M, Hoppensteadt DA, & Fareed J, 2004). Proper sample dilution and
preparation will allow for a low percent coefficient of variation, and both human serum
and plasma samples have ≥90% sample recovery for both nitrite and nitrate
concentrations which will be utilized to calculate nitric oxide, alleviating potential error
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due to intra-assay and inter-assay variability per manufacturer’s product information
sheet. The myeloperoxidase serum/plasma ELISA kit (Eagle Biosciences, Inc., Nashua,
NH) will be utilized to quantify the determination of myeloperoxidase utilizing a two-site
“sandwich” technique that binds to different epitopes of myeloperoxidase. Antibodies
bind to myeloperoxidase, after several incubation periods and plate washes, will be ready
to analyze by detecting the immunocomplex and the absorbency of the sample. Intraassay and inter-assay variability for concentrations of myeloperoxidase were comparable
in serum and plasma utilized per manufacturer’s product information sheet in which they
measured two sample extracts in a single assay with twelve replicate determinations for
intra-assay variability, and by measuring two controls in duplicate in six individual
assays for inter-assay variability. Additionally, all samples were collected within 10 to 14
days following the final bout of exercise to limit the effect of acute exercise on markers
of oxidative stress, as well as within a time frame that does not allow for the effect of
detraining on the markers of oxidative stress utilized in this study (Maeda S, Miyauchi T,
Kakiyama T, Sugawara J, Iemitsu M, Irukayama-Tombe Y, Murakami H, Kumagi Y,
Kuno S, Matsuda M, 2001).
Cardiorespiratory Fitness (CRF)
CRF for all participants was measured at baseline and end-intervention using a
maximal graded exercise test. A ramped medium protocol was determined to be ideal for
these participants as it is an incremental protocol where speed and grade increase every
30-60 seconds until each participant reached volitional fatigue. Volume of oxygen
consumed (V̇O2) via a metabolic cart (True Max 2400; ParvoMedics, Sandy, UT, USA)
and heart rate via standard 12-lead electrocardiogram (Q-Stress®; Cardiac Science,
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Bothell, WA, USA) were monitored continuously during the progression of the test.
Blood pressure was measured, and rating of perceived exertion was obtained every twominutes during the test. Two of four generally recognizable criteria for the test to be
considered satisfactory needed to be achieved: a respiratory exchange ratio greater than
or equal to 1.10; a rating of perceived exertion greater than or equal to 17 on the Borg
scale ranging from 6-20; achieving a maximum heart rate greater than 90% age-predicted
maximum heart rate (220-age); and/or a plateau in V̇o2. Peak oxygen consumption
(V̇O2peak) was determined by the highest 30-second average V̇O2 value measured during
the test.
Sedentary Time and Physical Activity
Sedentary time and PA will be measured for all participants for 7 consecutive
days at baseline and post-intervention and all participants were instructed to continue
their normal daily routine during monitoring. Participants wore the Sensewear Mini
Armband on the left arm at the mid-point between the olecranon and acromion processes.
Participants recorded when they removed the monitor for any activities that required
water-based activities, such as showering/bathing or swimming. Participants were
instructed to record times they removed and replaced the monitor if removed over the 7day wear time period. Data will be considered valid for analysis if participants wore the
monitor for at least 5 days including a weekend day, with a minimum wear time of 20
hours each day.
Sedentary time and PA levels will be assessed using manufacture provided
software (BodyMedia Sensewear Version 7.0). The Sensewear Mini Armband provides
objectively measured PA. Sedentary time will be set as <1.5 metabolic equivalents
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(METs) (excluding sleep time), light-intensity PA as 1.5≤3.0 METs, moderate-intensity
PA as 3.0≤6.0 METs, and vigorous-intensity PA as ≥6.0 METs, moderate-to-vigorousintensity PA as ≥3.0 METs, and total PA intensity as ≥1.5 METs. In addition to time
spent sedentary and performing PA of varying intensity, total daily energy expenditure
(TDEE) and physical activity energy expenditure (PAEE) for total PA (≥1.5 METs) and
moderate-to-vigorous-intensity PA (≥3.0 METs) will be analyzed. Time spent sedentary
and performing PA, TDEE, and PAEE will be calculated for each valid day of wear time
and will be analyzed as an average of those days. Estimated PA time and energy
expenditure during non-wear times will be excluded from analysis.
Fasting Glucose Concentration and Oral Glucose Tolerance Test
On the final day of 7-day CGM monitoring period, while participants were still
wearing the CGM monitor, each participant completed an OGTT at baseline and postintervention. Following an overnight fast (~12 hours other than water), participants
reported to an approved clinical site and performed a venous blood sample collection.
Time was recorded and matched with the CGM to the venous blood collection to
establish fasting blood glucose time point. Following the venous blood collection,
participants were then instructed to consume a standard 10-ounce, 75-gram glucose
infused drink (Azer Scienmtific, Morgantown, PA) within 5 minutes of the venous blood
collection and time consumption completed was recorded and utilized as time point zero
(0-). Every 30-minutes interval was then recorded until 2 hours was complete (30-,60,90-,120-minutes post-consumption), which is the standard procedure for a 75-gram
OGTT (Institute for Quality and Efficiency in Healthcare 2011). During the 2-hour
OGTT, participants were instructed to limit their movement, unless necessary, to limit the
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impact of muscle contraction on glucose concentrations. As CGM assessed glucose
concentrations have been validated with venous blood glucose concentrations (Kovatchev
B, Anderson S, Heinemann L, & Clarke W, 2008), no subsequent blood draws were
performed at each time point after fasting.
Software provided by the manufacturer (Dexcom Studio 12.0.4.6) was used to
download and export the CGM data to Excel datafiles. Time points recorded during the
OGTT were identified and matched with exported CGM data for time point 0 and
subsequent 30-,60-,90-,120-minute post-consumption time points. If any of the time
points fell between CGM concentration readings, as the CGM assesses every 5 minutes,
the average between the previous and following CGM concentration readings were
calculated. Additionally, OGTT area under the curve (AUC) was calculated utilizing the
equation Glucose AUC=1/2×30×(y0-+2y30-+2y60-+2y90-+y120-), where y represents glucose
concentration at the different time points (Tai MM 1994).
Caloric Intake Recording
Caloric intake will be recorded for all participants for 7 consecutive days at
baseline and post-intervention and all participants were instructed to continue their
normal daily dietary routine during this time. All participants self-reported caloric
consumption, including any calorie containing beverages or snacks, for one week during
baseline and post-intervention testing. They were instructed on using the MyFitnessPal
application (MyFitnessPal, Inc.) that is available on smartphone devices or computer
based. If a smartphone or computer was unavailable, participants were provided a selfreport paper form to record any calorie containing food or drink consumed, including
portion size, calories, and macronutrient breakdown (carbohydrate, protein, and fat)
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utilizing The Calorie King® Calorie Counter (Borushek A 2015). Caloric intake and
macronutrient breakdown will be calculated for each valid recording day and will be
analyzed as an average of those valid days.
Statistical Analysis
Baseline descriptive statistics will be calculated and reported as means and
standard deviations. Change values will be calculated by subtracting baseline values from
post-intervention values. Paired sample t-tests will be utilized to determine how
participant characteristics, clinical measurements of glycemic health, fitness, and lifestyle
factors changed from baseline to post-intervention (body weight, CRF, sedentary and PA
measures, fasting glucose concentration, 120-minute OGTT concentration, glucose AUC,
and caloric intake). To address sub-aim 3.1, a repeated measure analysis of variance
(ANOVA) will be performed from baseline to end-intervention for the MAGE and
CONGA-4 to establish changes in glycemic variability. To address sub-aim 3.2, similar
to sub-aim 3.1, a repeated measure ANOVA will also be performed to analyze changes in
nitric oxide and myeloperoxidase. For each sub-aim, separate models will be performed
for both measures of glycemic variability and oxidative stress. Additionally, for sub-aim
3.1 and 3.2, change in body weight, sedentary and PA measures, CRF, fasting glucose
concentration, 120-minute OGTT concentration, glucose AUC, and/or caloric intake will
be adjusted for to examine the role of participant characteristics, as well as clinical
measurements of glycemic health, fitness, and lifestyle factors as covariates on the
changes in measures of glycemic variability and oxidative stress. Lastly, to explore a
potential relationship between glycemic variability and oxidative stress following aerobic
exercise training, Pearson product correlation will be performed between change in
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measurements of glycemic variability and change in measurements of oxidative stress,
which will also be adjusted for using the previously mentioned variables as covariates.
Statistical Power
There is currently no literature examining the effect of a chronic aerobic
treadmill-based exercise intervention on changes in glycemic variability and oxidative
stress, or the associations that exist between these two variables. To date, one study has
examined the influence of aerobic exercise, 7 days of structured aerobic exercise, on
glycemic variability and control assessed by CGM technology in adults with type 2
diabetes mellitus not using exogenous insulin (Mikus CR, Oberlin DJ, Libla J, Boyle LJ,
& Thyfault JP, 2012). Therefore, this study was utilized for sample size estimations.
Sedentary, overweight or obese adults diagnosed with type 2 debates mellitus (n=13;
age=53.0±2.0 years; BMI=34.1±1.3 kg/m2) underwent glycemic variability and control
assessment utilizing CGM technology during 3 days of habitual activity and during the
final 3 days of a 7 day aerobic exercise training program, which consisted of 60 minutes
of supervised exercise for 7 consecutive days at 60-75% HRR, and found that “freeliving” glycemic excursions were lower for the 3 days while completing the aerobic
exercise program compared to the 3 days of habitual activity (maximum blood glucose:
13.6±1.2 mmol/l to 10.9±0.8 mmol/l, p<0.01; ∆min–max blood glucose:10.0±1.1 mmol/l
to 6.9±0.7 mmol/l, p<0.01; number of glucose excursion per day: 0.8±0.2 to 0.2±0.1,
p=0.02). Additionally, another study that examined basal nitric oxide production in
hypercholesterolemic patients (n=9; age=44.0±3.0; BMI=27.0±1.0 kg/m2) undergoing 4
weeks of home-based cycle training 3 times per week at 65% V̇O2max for 30 minutes each
session found that basal nitric oxide production increased following training (ΔNOx
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indicated net extraction=6.8±4.0 nmol/100mL/min) (Lewis TV, Dart AM, Chin-Dusting
JPF, & Kingwell BA, 1999). Therefore, further power analysis calculations were
performed using G*Power 3.0.10 and found that when testing for the sensitivity of
required effect size, 8 participants would allow for 20% power with a small- to mediumeffect size (0.1-0.3) with alpha set to 0.05 when testing for the difference between two
dependent means, baseline compared to end-intervention for measures of glycemic
variability and oxidative stress. Thus, this study will also serve to provide additional
resources for future effect size examining alterations in measures of glycemic variability
and oxidative stress following an aerobic treadmill-based exercise intervention in
sedentary, overweight or obese adults.
Strengths and Limitations of Study 3
This study is among the first to examine the effects of exercise on glycemic
variability and how glycemic variability relates to oxidative stress both before and after
becoming physically active. The strengths of this study included the use of center-based,
individually designed aerobic treadmill-based intervention in overweight or obese
individuals that was intended to not only meet a desired intensity, but volume of exercise
quantified by estimated caloric expenditure each week. In addition, each exercise session
was performed under supervision in a laboratory setting which allowed for adherence to
exercise protocol to be monitored. The use of CGM technology to assess glycemic
variability is another strength. There are limitations for this proposed study, including the
demographics of the population, which only makes the results generalizable to
individuals that are between the ages of 35 and 55 years. Additionally, undiagnosed
diabetics were not excluded from the study, which may influence the results. In order to
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limit this, each participant’s CGM glucose levels were analyzed prior to the intervention,
and none of the completers fell into the prescribed diabetic range. Furthermore, diet was
not fully taken into account, as only self-report dietary intake was provided at baseline
and end-intervention, which has been known to be unreliable. In order to limit this, we
recommended that each participant attempt to maintain their daily dietary routines
throughout the intervention and not participate in any other interventions that may have
affected their weight. For females, current cycle of menstruation was not taken into
account, as current cycle in the menstrual period may influence hormones associated with
glucose metabolism and cardiovascular outcomes. Past research has found that both
glucose metabolism and oxidative stress may be altered during various phases of the
menstrual cycle (Widom B, Diamond MP, Simonson DC, 1992; Browne RW, Bloom
MS, Schisterman EF, Hovey K, Trevisan M, Wu C, Liu A, Wactawski-Wende J, 2008).
As we have no way of retroactively examining menstrual cycle in female participants,
this limitation will persist, but provide future directions for the consideration of menstrual
cycle phase in subsequent research studies. Lastly, the small sample size (n=8) may limit
the statistical power needed to detect a true effect size of the outcomes of interest.
However, this study was designed to add to the mostly non-existent literature and aid in
the prediction of future effect sizes for studies wishing to examine the effect of exercise
on glycemic variability and oxidative stress.
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CHAPTER 4
MANUSCRIPT 1-GLYCEMIC VARIABILITY: IMPORTANCE, RELATIONSHIP
WITH PHYSICAL ACTIVITY, AND THE INFLUENCE OF EXERCISE-A CRITICAL
REVIEW OF THE LITERATURE1

1

Sparks, JR, Kishman, EE, Sarzynski, MA, Davis, JM, Grandjean, PW, & Wang, X. To
be submitted to Scientific Journal of Research and Reviews
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ABSTRACT
Glycemic variability has recently been thought of as a potentially more sensitive
assessment of glycemic health as opposed to traditional clinical measures of glucose
metabolism and glucose tolerance. The ability for glycemic variability to consider all
glucose concentrations in a given distribution and account for the oscillations that occur
in these distributions provide clinicians with more in-depth insight into how individuals
regulate and/or maintain their glycemic health. With the advancement of continuous
glucose monitoring (CGM) technology to allow examination of real-time, free-living
glucose concentrations over a single or multiple days, more reliable assessment and
treatment of dysregulated glycemic health, specifically in impaired glucose tolerant and
type 1 and type 2 diabetic adults, is possible. CGM assessment along with lifestyle
management techniques implemented to influence glucose concentrations, such as
sedentary behavior and physical activity, including structured physical activity, known as
exercise, allow for a greater perspective to be established linking lifestyle factors with
glycemic health. Therefore, the aim of this review is to critically evaluate and provide
evidence regarding the importance of glycemic variability, how glycemic variability is
measured, the relationship glycemic variability possesses with sedentary time and
physical activity, the influence of a single bout or repeated bouts of exercise, as well as
exercise training on glycemic variability in non-diabetic adults, and adults diagnosed with
type 1 or type 2 diabetes. Additionally, this review plans to provide strengths and
limitations of the studies discussed, which will allow insight into future design of
research studies aimed to examine glycemic variability as a primary outcome of interest.
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INTRODUCTION
Glycemic variability has been considered a novel and sensitive measure of
glycemic health in addition to clinical assessment of glucose metabolism and tolerance
(Monnier L, Colette C, & Owens DR, 2008). Glycemic variability accounts for glucose
fluctuations throughout the day or during specified durations (Hirsch IB & Brownlee M,
2005). Glycemic variability has been observed to be greater in overweight to obese
adults, as well as in adults diagnosed with type 1 and type 2 diabetes, compared to
healthy, normal weight adults (Buscemi S, Cosentino L, Rosafio G, Morgana M, Mattina
A, Sprini D, Verga S, & Rini GB, 2013). As glycemic variability has been related to risk
of the development of cardiovascular disease risk factors, specifically increased
endothelium-derived oxidative stress (Saisho Y 2014), the clinical implications for the
assessment of glycemic variability have become of great importance.
The use of continuous glucose monitoring (CGM) allows for the inclusion and
evaluation of all glucose concentration oscillations over an extended monitoring period
(Standl E, Schnell O, & Ceriello A, 2011). CGM assesses real-time glucose
concentrations and instantaneously allows for users and practitioners to make more
informed decisions throughout the day on how to balance self-management techniques to
maintain glycemic control (Hirsch IB, Armstrong D, Bergenstal RM, Buckinghom B,
Childs BP, Clarke WL, & Wolpert H, 2008). In addition, CGM measurements can take
place every few minutes, over multiple hours throughout the day, for several days to aid
in assessment of habitual glycemic health (Vincze G, Barner JC, & Lopez D, 2004).
CGM works through a sensor inserted in subcutaneous tissue and measures interstitial
fluid concentration of glucose, which circulates in the fluid between cells (Nielsen JK,
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Djurhuus CB, Gravholt CH, Carus AC, Granild-Jensen J, Orskov H, & Christiansen JS,
2005). CGM-measured glucose concentrations have been validated against venous blood
glucose concentrations (Bailey TS 2017). Even though a delay may occur between
measurements of glucose concentrations, with the delay occurring in interstitial fluid
assessment compared to venous blood assessment, this delay has been shown to be
minimal and often varies marginally by individual (Garg SK, Voelmle M, & Gottlieb PA,
2010). Thus, when utilized in research, CGM measured glucose concentrations can aid in
establishment of time spent at hypo-, hyper-, and euglycemia, and allows for the
assessment of glycemic variability (Klonoff DC 2005).
Decreased sedentary time and increased physical activity of any intensity have
been shown to be beneficial for overall health, specifically glycemic health (Høstmark
AT, Ekeland GS, Beckstrøm AC, & Meen HD, 2006; Carnethon MR, Evans NS, Church
TS, Lewis CE, Schreiner PJ Jacobs Jr DR, Sternfel B, & Sidney S, 2010; Nygaard H,
Grindaker E, Rønnestad BR, Holmboe-Ottesen G, & Høstmark AT, 2017). Structured
physical activity, commonly known as exercise, has been shown to have additional
glycemic health benefits beyond non-exercise related physical activity (Boulé NG,
Haddad E, & Kenny GP, 2001). Recently, it has been suggested that even a single bout of
exercise or repeated bouts of exercise improve glycemic variability in healthy and
metabolically compromised adults, with potential improvements following exercise
training noted primarily in type 2 diabetic adults (Blankenship JM, Granados K, & Braun
B, 2014).
Therefore, the aim of this review was to express the importance of glycemic
variability, its relationship with sedentary behavior and physical activity, and how a
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single bout of exercise or repeated bouts of exercise, as well as exercise training
influences glycemic variability in a variety of populations. Further, with more recent
technological advancement of CGM to aid in assessment of glycemic health, glycemic
variability has become an integral assessment for prevention and/or treatment in those at
risk of or currently diagnosed with cardiometabolic diseases. Based on evidence provided
in this review, practical implications for use of glycemic variability in assessment of
glycemic health in relation to physical activity and exercise, will be provided.
METHODS
To address the overall study purpose, we searched the electronic databases
PubMed, Google Scholar, Web of Science, BioMed Central, Cumulative Index of
Nursing and Allied Health Literature (CINAHL), and SCOPUS. We limited the date
range until December 2019 with a secondary search strategy included scanning
bibliographies of the retrieved articles. Initial selection was based on title and abstract.
The original article was obtained and subsequently determined whether the research
study met the inclusion criteria established for the critical review. Articles were reviewed
based on the criteria provided in Table 3.1. and 3.2. and extracted details included
population, treatment, summary results of primary findings, and potential strength and
limitations of each study.
Glycemic variability included only CGM-assessed glycemic variability. Glycemic
variability has commonly been utilized interchangeably with glycemic excursions and
glucose or glycemic control, which were therefore included in the search terms. Further,
multiple brands and models of CGM devices exist that have been proven reliable and
valid compared to venous blood glucose concentrations, including, but not limited to
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Dexcom (San Diego, CA), FreeStyle (Abbott Laboratories; Chicago, IL), Guardian
(Medtronic; Dublin, Ireland), and Eversense (Senseonics Holdings; Germantown, MD).
Hence, it was ensured that the CGM devices utilized in the present review had been
previously tested for accuracy in comparison to blood glucose concentrations.
Sedentary behaviors were included, which comprised of time spent sedentary and
the classical definition of sedentary behavior, which has been expressed as any waking
behavior characterized by an energy expenditure ≤1.5 metabolic equivalents (Tremblay
MS, Aubert S, Saunders TJ, CarsonV, Latimer-Cheung AE, Chastin SFM, Altenberg TM,
& Chinapaw MJM, 2017). Physical activity included outcomes measured by subjectively
validated questionnaires or objectively utilizing accelerometry and/or pedometers.
Exercise has been classically defined as structured physical activity performed with a
purpose or goal (Caspersen CJ, Powell KE, & Christenson GM, 1985). Therefore, we
also examined how a single bout of exercise or repeated bout of exercise, as well as
exercise training, affects glycemic variability. When examining the influence of exercise,
we included any modality or duration of submaximal and maximal bouts of exercise tests
and defined the acute response as immediately post-exercise up to 48 hours post-exercise.
Further, we included exercise interventions of any duration if they met the minimum
guidelines established for being considered physically active by a reputable governing
body, such as the Department of Health and Human Services, American Diabetes
Association, American Heart Association, and/or the American College of Sports
Medicine.
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GENERAL DISCUSSION
Importance of Glycemic Variability
Glycemic control often refers to hemoglobin A1c (HbA1c); however, glycemic
control is often utilized interchangeably with glycemic variability. Yet, these
measurements more so complement each other in addition to portraying similar concepts.
As glycemic variability accounts for oscillations in glucose concentrations over a period
of time, glycemic control has historically been comprised of HbA1c evaluation, which
accounts for the average volume of glucose bound to the hemoglobin of circulating red
blood cells over ~3 months (American Diabetes Association, 2020). Most type 1 and type
2 diabetic patients tend to have HbA1c measured every 3 months in hopes of determining
whether their glycemic control targets have been obtained and/or maintained (Wei N,
Zheng H, & Nathan DM, 2014). Impaired glycemic control assessed by HbA1c has a
strong predictive value for diabetes onset and diabetic complications (Stratton IM, Adler
AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, & Holman RR,
2000; Little RR, Rohlfing CL, Sacks DB, National Glycohemoglobin Standardization
Program Steering Committee, 2011; Laiteerapong N, Ham SA, Gao Y, Moffet HH, Liu
JT, Huang ES, & Karter AJ, 2019). Thus, glycemic control assessed as HbA1c has been
established as a useful tool for a point-of-care opportunity between healthcare providers
and patients for more timely treatments for optimizing glycemic management to deter the
progression of diabetic complications.
However, HbA1c assessed glycemic control has its limitations as a sole measure
of glycemic health, as the cut-point of HbA1c from the diagnostic point of view is still
controversial (Sherwani SI, Khan HA, Ekhzaimy A,Masood A, & Sakharkar MK, 2016).
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The HbA1c test is considered an indirect measure of average glycemia and uncertain
variability is often unaccounted for as red blood cells may be affected by cell turnover,
anemia, blood transfusions, and pregnancy (Jovanovič L, Savas H, Mehta M, Trujillo A,
& Pettitt DJ, 2011; Beck RW, Connor CG, Mullen DM, Wesley DM, & Bergenstal RM,
2017). Additionally, population differences exist in HbA1c, in which ethnicity/race, sex,
and age may influence reference HbA1c concentrations and potential diabetic-related
complications (Cavagnolli G, Pimental AL, Freitas PAC, Gross JL, & Carmargo JL,
2017). Specifically, HbA1c has been observed to be greater in African Americans
compared to Caucasians, males compared to females, as well as increases with age (Ma
Q, Liu H, Xiang G, Shan W, & Xing W, 2016).
Recently, evaluation of HbA1c has been accompanied by further testing, to
examine glucose concentrations in a non-clinical setting, i.e. 24-hour, diurnal, and
nocturnal, in addition to traditional clinical examinations of glycemic health, such as
fasting or in a glucose challenged state (Battelino T, Danne T, Bergenstal RM, Amiel SA,
Beck R, Biester T, Bosi E, Buckingham B, Cefalu WT, Close KL, Cobelli C, Dassau E,
DeVries JH, Donaghue KC, Dovc K, Doyle FJ, Garg S, Grunberger G, Heller S,
Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A,
Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin
CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, &
Phillip M, 2019). The relationship between glucose concentrations and HbA1c within an
individual correlate over time (Chehregosha H, Khamesh ME, Malek M, Hosseinpanah
F, & Hosseinpanah F, 2019). More specifically, the more time-point measurements to
analyze mean glucose concentration utilizing CGM technology, the stronger the
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correlation observed with HbA1c (Hirsch IB, Welsh JB, Calhoun P, Puhr S, Walker TC,
& Price DA, 2019). Additionally, glycemic states, including euglycemia and
hyperglycemia, have been previously reported to strongly correlate with HbA1c (Hirsch
IB, Welsh JB, Calhoun P, Puhr S, Walker TC, & Price DA, 2019). Therefore, with the
advent of new technology, CGM has evolved rapidly in both accuracy and affordability
and allows for evaluation of free-living glucose concentrations and glycemic variability
in addition to glycemic control established as HbA1c.
Glycemic Variability Measures
Currently, several measures of glycemic variability are utilized and range in
sensitivity and specificity (Rodbard D 2018). These include measurements to establish
intra-day and inter-day glycemic variability, with many designed for CGM technology
(Suh S & Kim JH, 2015). Glycemic variability measurements include those commonly
used for ease of analysis, such as the standard deviation (SD) of the mean glucose
concentration and percentage coefficient of variation (%CV). Additionally, more
sensitive analyses of glycemic variability have been adopted, including the mean
amplitude of glycemic excursions (MAGE), continuous overlapping net glycemic action
over an n-hour period (CONGA-n), and the mean of daily differences (MODD). In the
following section, the most frequently used, but not all-inclusive, measurements of
glycemic variability will be discussed, with strengths and limitations listed (Table 4.1.).
Prior to validation of more sensitive measures of glycemic variability, the SD of
mean glucose concentration and %CV were utilized (Kovatchev B, Anderson S,
Heinemann, & Clark W, 2008). Statistically, SD and %CV are often thought of as the
best measurement for variation since they are based on all measurements in a distribution
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(Altman DG & Bland JM, 2005). Additionally, %CV is considered potentially more
inclusive and sensitive compared to SD alone as it incorporates both the mean and SD of
the distribution (Kovatchev B, Anderson S, Heinemann, & Clark W, 2008). Even though
these measurements include all glucose concentrations, there exists an inherent limitation
that does not account for individual physiological differences or differences in lifestyle
factors, such as physical activity, exercise, and dietary consumption, which should be
considered. Even so, a large body of evidence supports that a direct linear relationship
exists between SD and %CV for a large series of CGM data with more sensitive
measures of glycemic variability (Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld
D, Heine RJ, & ADAG Study Group, 2008; Kuenen JC, Borg R, Kuik DJ, Zheng H,
Schoenfeld D, Diamant M, Nathan DM, Heine RJ, & ADAG Study Group, 2011).
One of the initial measurements of intra-day glycemic variability was MAGE
(Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, & Taylor WF,
1970). MAGE is calculated by taking the arithmetic mean of the blood glucose increases
or decreases (from blood glucose nadirs to peaks or vice versa) when both ascending and
descending segments exceeded the value of one SD of the mean blood glucose for the
same 24-hour period (Service FJ & Nelson RL, 1980). MAGE does not account for time
spent in euglycemia, or periods of low-level hypo- or hyper-glycemia (Service FJ,
O’Brien PC, & Rizza RA, 1987). This creates ambiguity as to where glycemic excursions
occur, potentially limiting the ability to measure the magnitude of glycemic excursions
(Rodbard D 2009). However, MAGE provides insight into the extent that glycemic
excursions occur, specifically accounting for postprandial hyperglycemia and fasted-state
hypoglycemia.
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Further consideration for time-dependent glycemic variability, which utilizes the
continuous nature of CGM, was established with other measures. CONGA-n was
formulated to account for each observation after the first n hours of observations
(McDonnell CM, Donath SM, Vidmar SI, Werther GA, & Cameron FJ, 2005). Further,
the difference between the current observation and the observation n hours previous is
calculated with CONGA-n defined as the SD of the differences. (McDonnell CM, Donath
SM, Vidmar SI, Werther GA, & Cameron FJ, 2005). CONGA-n can be calculated from 1
to 24-hour time intervals; yet, has been utilized most frequently for 1- to 4-hour time
intervals to account for time between certain activities throughout the day, with accuracy
decreasing beyond the 4-hour time interval (McDonnell CM, Donath SM, Vidmar SI,
Werther GA, & Cameron FJ, 2005; Kuenen JC, Borg R, Kuik DJ, Zheng H, Schoenfeld
D, Diamant M, Nathan DM, Heine RJ, & ADAG Study Group, 2011; Nathan DM,
Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ, & ADAG Study Group, 2008). For
example, CONGA-1 was initially created as a measurement of glycemic variability to
account for glycemic excursions throughout a 24-hour period, while CONGA-2 accounts
for time between snacks, and CONGA-4 as the variability observed between standard
meals, which include breakfast, lunch, and dinner (McDonnell CM, Donath SM, Vidmar
SI, Werther GA, & Cameron FJ, 2005). CONGA-n continues to be a more promising
measure of intra-day glycemic variability and provides practitioners with more flexibility
in the evaluation of intra-day glycemic variability (McDonnell CM, Donath SM, Vidmar
SI, Werther GA, & Cameron FJ, 2005).
In addition to intra-day glycemic variability, use of CGM allows for analysis of
inter-day glycemic variability. The MODD measure of inter-day glycemic variability was
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designed as a meticulous protocol occurring over two consecutive days during in-house
clinical testing (Service FJ & Nelson RL, 1980; Service FJ, O’Brien PC, & Rizza RA,
1987). MODD is traditionally calculated as the absolute value of the difference between
glucose concentrations measured at the same time over a 24-hour period on two
consecutive days (Service FJ & Nelson RL, 1980; Service FJ, O’Brien PC, & Rizza RA,
1987). MODD may also be calculated as a continuous time series over an extended
period (>2 days), which has been shown to strongly correlate with MODD over the initial
two consecutive days under standardized conditions (Rodbard D 2009).
With the advancement and incorporation of CGM technology, the ability to
design and implement more sensitive and time specific measures of glycemic variability
have become a viable option when delineating glycemic health. In addition to the SD and
%CV of measured glucose concentrations over an extended period, the ability to measure
inter- and intra-day variability has been further incorporated using MAGE, CONGA-n,
and MODD. Even though multiple measures of glycemic variability have been
developed, most of the research has been performed in those with impaired glucose
tolerance or type 1 and type 2 diabetes. Thus, inclusion of these more sensitive measures
should be considered when evaluating the variation in glucose concentrations in other
populations at an increased risk for the development of cardiometabolic disorders, such
as sedentary healthy weight, and/or overweight or obese adults.
Relationship with Sedentary Behavior and Physical Activity
Decreasing sedentary time and increasing physical activity of any intensity is
widely accepted to be beneficial for overall and cardiometabolic health (Young DR,
Hivert MF, Alhassan S, Camhi SM, Ferguson JF, Katzmarzyk PT, Lewis CE, Owen N,
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Perry CK, & Yong CM, 2016; Katzmarzyk PT, Powell KE, Jakicic JM, Troiano RP,
Piercy K, & Tennant B, 2019 2017). Further, sedentary time and physical activity are
independently associated with elevated fasting glucose concentrations, impaired glucose
metabolism, and glucose tolerance in non-diabetic and diabetic adults (Høstmark AT,
Ekeland GS, Beckstrøm AC, & Meen HD, 2006; Helmerhorst HJ, Wijndaele K, Brage S,
Wareham NJ, & Ekelund U, 2009; Dunstan DW, Barr EL, Healy GN, Salmon J, Shaw
JE, Balkau B, & Owen N, 2010; Ford ES, Zhao G, & Li C, 2010; Thorp AA, Healy GN,
Owen N, Slamon J, Ball K, Shaw JE, & Dunstan DW, 2010; Veerman JL, Healy GN,
Cobiac LJ, Vos T, Winkler EA, Owen N, & Dunstan DW, 2012; Lahjibi E, Heude B,
Dekker JM, Højlund K, Laville M, Nolan Jn & Balkau B, 2013; Nygaard H, Grindaker E,
Rønnestad BR, Holmboe-Ottesen G, & Høstmark AT, 2017). In adults diagnosed with
type 2 diabetes, increased time spent sedentary has previously been shown to predict
significant increases in time spent in hyperglycemia (Fritchi C, Park, H, Richardson, A,
Park C, Collins EG, Mermelstein R, Riesche L, & Quinn L, 2016). These findings
highlight the relationship between time spent sedentary and performing physical activity
with glucose concentrations and glucose tolerance. However, there remains limited
evidence of a relationship between sedentary behavior and/or physical activity with
glycemic variability (Table 4.2.).
A prospective repeated measures designed study that included 35 young adults
(18-35 years of age) diagnosed with type 1 diabetes found no relationship between total
physical activity minutes and the SD of the 24-hour mean glucose concentration (β
estimate=2.2031, p=0.127) (Martyn-Nemeth P, Quinn L, Penckofer S, Park C, Hofer V,
& Burke L, 2017). Additionally, a study performed by Paing et al. examined the

79

associations between objectively measured sedentary time with 24-hour glycemic control
in 37 type 2 diabetic adults (>18 years of age) (Paing AC, McMillan KA, Kirk AF,
Collier A, Hewitt A, & Chastin SFM, 2018). This study found that time spent sedentary
was positively associated with poorer CGM-assessed glycemic control, and in those who
spent more time sedentary there was a noted reduction for time spent in euglycemia (β
estimate=-0.44, p=0.04) and a trending relationship with increased time spent
hyperglycemic (β estimate=0.36, p=0.08). However, breaks in sedentary time was
positively associated with time spent in euglycemia (β estimate=0.38, p=0.04). Further, a
cross-sectional study of non-diabetic and diabetic adults participating in the A Estrada
Glycation and Inflammation Study had a subsample of 511 adults (12% diagnosed type 1
and 2 diabetic) complete the International Physical Activity Questionnaire and had valid
CGM monitoring data for analysis (Gude F, Díaz-Vidal P, Rúa-Pérez C, AlonsoSampedro M, Fernández-Merino C, Rey-García J, Cadarso-Suárez C, Pazos-Couselo M,
García-López JM, & Gonzalez-Quintela A, 2017). This study found no relationship
between physical activity status with glycemic variability measures, including the SD of
24-hour mean glucose concentration, MAGE, and CONGA-1 in the non-diabetic adult
population (p≥0.264 for all), but did not report findings in the diabetic population.
These studies highlight the potential importance of sedentary behavior and
physical activity with glycemic control and glycemic variability assessed by CGM in a
variety of populations. Even though most previous findings are limited to glycemic
control assessed as HbA1c, these studies provide insight into how CGM may be
incorporated as a measure of glycemic control and glycemic variability in addition to
traditional clinical measures. However, these studies did not definitively distinguish
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differences between non-diabetic and diabetic adults or utilized subjective rather than
objective assessments of sedentary behavior and physical activity. Hence, evidence
suggests that a potential and impactful relationship between sedentary behavior and
physical activity with CGM-assessed glycemic control and glycemic variability exists in
adults with a compromised metabolic profile, such as type 2 diabetes. However, when
examining non-diabetic adults and/or adults which may utilize other lifestyle
management techniques or medications to influence their glycemic health, such as type 1
diabetics, further consideration for other lifestyle factors, including free-living dietary
patterns or structured physical activity (e.g. exercise), may be pertinent when evaluating
glycemic health with CGM technology.
Influence of Single Bout or Repeated Bouts of Exercise on Glycemic Variability
Exercise has been shown to beneficially influence insulin resistance and glucose
tolerance, and is commonly utilized as a treatment for both non-insulin and insulindependent type 2 diabetes (Joslin EP, Root HF, White P, & Marble A, 1935; Goodyear
LJ & Kahn BB, 1998). Even a single bout of exercise can have a beneficial impact on
glucose homeostasis, whole-body glucose disposal, and increase glucose uptake into
skeletal muscle (Pruett EDR & Oseid S, 1970; Bogardus C, Thuillex P, Ravussin E,
Vasquez B, Narimiga M, & Azhar S, 1983; Richter EA, Mikines KJ, Galbo H, & Kiens
B, 1989; Wang X, Patterson BW, Smith GI, Kampelman J, Reeds DN, Sullivan SA, &
Mittendorfer B, 2013). Further, a single bout of exercise may have persistent effects on
glucose uptake and insulin sensitivity for several hours after completion of exercise
(Devlin JT & Horton ES, 1985; Devlin JT, Hirshman MF, Horton ES, & Horton ED,
1987; Mikines KJ, Sonne B, Farrell PA, Tronier B, & Galbo H, 1988). Yet, few studies
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have examined the impact of a single bout of exercise or repeated bouts of exercise on
CGM-assessed glycemic control and glycemic variability.
Previous studies examining the influence of a single bout of exercise or repeated
bouts of exercise on CGM-assessed glycemic control and glycemic variability in nondiabetic, healthy weight and overweight or obese adults have found comparable and
consistent results (Table 4.3.) (Little JP, Jung ME, Wright AE, Wright W, & Manders JF,
2014; Parker L, Shaw CS, Banting L, Levinger I, Hill KM, McAinch AJ, & Stepto NK,
2017; Figueira FR, Umpierre D, Bock PM, Waclawovsky G, Guerra AP, Donelli A,
Andrades M, Casali KR, & Schaan BD, 2019). Figueira et al., found that a single bout of
moderate-intensity aerobic exercise and eccentric resistance exercise had comparable
decreases in glycemic variability compared to pre-exercise control period 15 young
healthy adults (Figueira FR, Umpierre D, Bock PM, Waclawovsky G, Guerra AP,
Donelli A, Andrades M, Casali KR, & Schaan BD, 2019). Additionally, Little et al.,
found that postprandial glycemic excursions decreased following high-intensity interval
training (HIIT) compared to continuous moderate-intensity exercise and control
conditions, in 10 inactive overweight adults (Little JP, Jung ME, Wright AE, Wright W,
& Manders JF, 2014). Lastly, Parker et al., found that 24-hour average glucose
concentration and hyperglycemic excursions decreased following either low-volume
high-intensity interval exercise or continuous moderate-intensity exercise in 27
overweight or obese normoglycemic adults (Parker L, Shaw CS, Banting L, Levinger I,
Hill KM, McAinch AJ, & Stepto NK, 2017) These studies highlight that a single bout of
moderate-intensity aerobic exercise, HITT, and eccentric resistance exercise improve
glycemic control and glycemic variability. Further, glycemic control and glycemic
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variability were measured in a variety of ways, including 24-hour mean glucose
concentration, SD and %CV of the 24-hour mean glucose concentration, and postprandial
glycemic excursions. Therefore, in normal weight and overweight or obese adults, a
single bout of exercise or single session of repeated bouts of exercise, regardless of
modality or duration, potentially provides beneficial and lasting effects on 24-hour
glycemic control and glycemic variability.
Even though observable effects of a single bout or repeated bouts of exercise on
glycemic control and glycemic variability in adults have been found, the effects on those
with diagnosed glycemic dysfunction may be of greater importance. The ability to
improve glycemic control and glycemic variability with exercise in those who rely on
lifestyle self-management techniques to control their glucose levels, such as adults
diagnosed with type 1 diabetes, potentially has profound implications. Previous research
under free-living or clinic-based conditions have found that increasing structured physical
activity, or exercise, may have differential effects on glycemic control and glycemic
variability, depending on type of exercise, in type 1 diabetic adults (Manohar C, Levine
JA, Nandy DK, Saad A, Man CD, McCrady-Spitzer SK, Basu R, Cobelli C, Carter RE,
Basu A, & Kudva YC, 2012; van Dijk J-W, Eijsvogels TM, Nyakayiru J, Schreuder
THA, Hopman MT, Thijssen DH, & van Loon LJC, 2016). In turn, there are mixed
findings, as one study noted differential changes in free-living glycemic control or
glycemic variability following repeated bouts of exercise, while clinic-based exercise
influenced glycemic control and glycemic variability in type 1 diabetic adults (Manohar
C, Levine JA, Nandy DK, Saad A, Man CD, McCrady-Spitzer SK, Basu R, Cobelli C,
Carter RE, Basu A, & Kudva YC, 2012; van Dijk J-W, Eijsvogels TM, Nyakayiru J,
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Schreuder THA, Hopman MT, Thijssen DH, & van Loon LJC, 2016). van Dijk et al.,
found that glycemic variability increased during a 4-day walking event compared to
habitual physical activity control period in 10 type 1 diabetic adults; however, noted that
insulin dosage decreased and total energy intake, specifically calories composed of
carbohydrates, increased during the 4-day walking event compared to habitual physical
activity (van Dijk J-W, Eijsvogels TM, Nyakayiru J, Schreuder THA, Hopman MT,
Thijssen DH, & van Loon LJC, 2016). Yet, under controlled clinic-based assessment,
Manohar et al., found that intermittent bouts of low-volume and low-intensity walking
decreased post-meal glucose area under the curve and glycemic excursions compared to
inactivity in 12 healthy control and 12 type 1 diabetic adults (Manohar C, Levine JA,
Nandy DK, Saad A, Man CD, McCrady-Spitzer SK, Basu R, Cobelli C, Carter RE, Basu
A, & Kudva YC, 2012). Therefore, alterations in insulin dosage and energy intake in a
free-living condition may limit the impact of increased energy expenditure and exercise
on glycemic control and glycemic variability in type 1 diabetics that may not be
accounted for under clinic-based assessment. Additionally, free-living assessment may be
more pertinent than clinic-based assessment as adults diagnosed with type 1 diabetes rely
more heavily on lifestyle management techniques compared to non-diabetic and noninsulin-treated type 2 diabetic adults to control their blood glucose concentrations.
As previously highlighted, a single bout or repeated bouts of exercise have been
shown to improve overall glycemic health, including glucose concentrations, glycemic
excursions, and glycemic variability in healthy weight, overweight or obese adults, as
well as adults diagnosed with type 1 diabetes. However, the most prevalent population
which could benefit from the effects of exercise on glycemic control and glycemic
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variability are adults diagnosed with type 2 diabetes (Colberg SR, Sigal RJ, Fernhall B,
Regensteiner JG, Blissmer BJ, Rubin RR, Chasan-Taber L, Albright AL, & Braun B,
2010). Previous evidence in adults diagnosed with impaired glucose tolerance and type 2
diabetes, whether insulin-treated or non-insulin treated, suggests improvements in
glycemic control and glycemic variability regardless of modality of exercise (Praet SF,
Manders RJ, Lieverse AG, Kuipers H, Stehouwer CD, Keizer HA, & van Loon LJ, 2006;
Figueira FR, Umpierre D, Casali KR, Tetelbom PS, Henn NT, Ribeiro JP, & Schaan BD,
2013; van Dijk J-W, Manders RJF, Canfora EE, Van Mechelen W, Hartgens F,
Stehouwer CDA, & van Loon LJC, 2013; Farabi SS, Carley DW, Smith D, & Quinn L,
2015). Farabi et al., found that in adults with impaired glucose tolerance or type 2
diabetes, a single 30-minute bout or moderate-intensity exercise significantly and
differentially decreased diurnal CONGA-1 when compared to pre-exercise values and
change values compared to non-diabetic adults (Farabi SS, Carley DW, Smith D, &
Quinn L, 2015). van Dijk et al., noted decreased CONGA-1, CONGA-2, and CONGA-4
following a single bout of 45-60 minutes moderate-intensity aerobic exercise in 60 noninsulin and insulin-treated type 2 diabetic adults (van Dijk J-W, Manders RJF, Canfora
EE, Van Mechelen W, Hartgens F, Stehouwer CDA, & van Loon LJC, 2013).
Additionally, Praet et al., observed decreases in hyperglycemic excursions following a
single session of low-weight/high-volume resistance exercise, which incorporated upperand lower-body, as well as abdominal exercise in 11 insulin-treated type 2 diabetic adults
(Praet SF, Manders RJ, Lieverse AG, Kuipers H, Stehouwer CD, Keizer HA, & van Loon
LJ, 2006). However, Figueira et al., found that despite comparable decreases in glucose
concentrations following either a single 40-minute bout of continuous moderate-intensity
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aerobic exercise or combined aerobic plus whole-body resistance exercise, there were no
changes in 24-hour glucose variance or %CV following either exercise modality in 14
type 2 diabetic adults (Figueira FR, Umpierre D, Casali KR, Tetelbom PS, Henn NT,
Ribeiro JP, & Schaan BD, 2013). Therefore, findings from these studies varied based on
glycemic control and glycemic variability evaluation method, which suggested changes
in only intra-day, but not inter-day, glycemic control and glycemic variability occurred
following a single bout or repeated bouts of exercise. Additionally, those studies that
presented findings extending into the subsequent day following exercise session found
that there were no persistent changes in glycemic control or glycemic variability beyond
the initial 24-hour period (Praet SF, Manders RJ, Lieverse AG, Kuipers H, Stehouwer
CD, Keizer HA, & van Loon LJ, 2006; Figueira FR, Umpierre D, Casali KR, Tetelbom
PS, Henn NT, Ribeiro JP, & Schaan BD, 2013). These studies highlight the importance
of a single bout or repeated bouts of exercise, regardless of modality, on short-term
glycemic control and glycemic variability in type 2 diabetic adults, which would
potentially be the most impacted group to focus on when attempting to improve glycemic
profiles through targeted exercise prescription. Yet, the findings indicate that glycemic
control and glycemic variability may not persist past the subsequent 24-hour monitoring
period, suggesting that continuous participation in exercise programs may be needed to
implant long-term changes in glycemic control and glycemic variability in type 2 diabetic
adults.
Influence of Exercise Training on Glycemic Variability
In the previous section, a single bout of exercise or repeated bouts of exercise
were shown to improve glycemic profiles for varying measurement of glucose
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metabolism, including glycemic excursions and glycemic variability that occur
throughout the day. Even though a single bout or repeated bouts of exercise are beneficial
for glycemic health, additional long-term adaptations and enduring improvements in
glucose metabolism occur due to extended exercise participation. Improvements in
glycemic control due to exercise training are primarily explained by an increase in wholebody glucose disposal and insulin sensitivity (Scheider SH, Amorosa LF, Khachadurian
AK, & Ruderman NB, 1984). Yet, these adaptations are reversible, and the effects of
detraining begin within 5-10 days after cessation of exercise (Mikines KJ, Sonne B,
Farrell PA, Tronier B, & Galbo H, 1988). Therefore, general involvement and, more
importantly, continuation of regular exercise participation are necessary to impact longterm glycemic health.
Epidemiological studies have determined that regular exercise participation
training can reduce the risk for developing non-insulin-dependent diabetes (Manson JE,
Rimm EB, Stampfer MJ, Colditz GA, Willett WC, Krolewski AS, Rosner B, Hennekens
CH, & Speizer FE, 1991; Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett
WC, & Hennekens CH, 1992; Helmrich SP, Ragland DR, Leung RW, Paffenbarger RS,
1991). Furthermore, a brief review and preliminary evidence published by Holloszy et al.,
suggested that a decline in glucose tolerance and insulin sensitivity can be prevented by
performing regular exercise (Holloszy JO, Schultz J, Kusnierkiewicz J, Hagberg JM, &
Ehsani AA, 1986). They also provided evidence that prolonged and frequent exercise can
normalize glucose tolerance by decreasing insulin resistance in some individuals with
impaired glucose tolerance. However, to date, few published studies have evaluated
changes in glycemic control and glycemic variability following exercise training as
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opposed to general participation in exercise. Furthermore, these studies examining the
effects of exercise training on glycemic variability have primarily included adults
diagnosed with type 2 diabetes. Therefore, exercise training interventions of a week or
greater are included in this section to aid the inclusion of pertinent literature, as there are
limited published findings (Table 4.4.).
Despite the limited number of exercise training studies on this topic, the evidence
remains consistent with previous literature observing the influence of a single bout of
exercise or repeated bouts of exercise in non-diabetic, as well as type 1 and type 2
diabetic adults. Mikus et al., suggested that even a week (7 days ) of moderate-intensity
aerobic exercise training (~60 minutes per exercise session) positively influences
glycemic control and glycemic variability in 13 type 2 diabetic adults, in the absence of
alterations to traditional clinic-based assessment of glycemic health, including fasting and
OGTT glucose concentrations (Mikus CR, Oberlin DJ, Libla J, Boyle LJ, & Thyfault JP,
2012). Additionally, studies which incorporated extended exercise programs have found
that alterations in glycemic control and glycemic variability may be intensity dependent
rather than due to general participation in exercise. These studies found that highintensity interval exercise, including HIIT and interval walking, as opposed to lowintensity continuous exercise may be more beneficial for glycemic control and glycemic
variability in type 2 diabetic adults (Karstoft K, Winding K, Knudsen SH, Nielsen JS,
Thomsen C, Pedersen BK, & Solomon TPJ, 2013; Francois ME, Durrer C, Pistawka KJ,
Halperin FA, Chang C, & Little JP, 2017). Karstoft et al., found that CGM-assessed
glycemic control group worsened in a non-exercise control group (n=8), while glycemic
control improved following 4 months of 60 minutes per day of interval walking (n=12)
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with no changes following 4 months of 60 minutes per day of continuous walking (n=12).
Further, Francois et al., found that 12 weeks of prescribed HIIT, which met exercise
prescription criteria established by the American Diabetes Association and the American
College of Sports Medicine, decreased glycemic variability measured as SD of 24-hour
mean glucose concentration and MAGE compared to pre-exercise training values in 53
type 2 diabetic adults (Francois ME, Durrer C, Pistawka KJ, Halperin FA, Chang C, &
Little JP, 2017).
Therefore, these findings provide evidence that regular exercise participation,
specifically high-intensity or interval exercise, has the potential to improve glycemic
control and glycemic variability in type 2 diabetic adults. Additionally, the use of
supervised exercise, including aerobic and resistance, or free-living walking
interventions, support feasibility of implementation of exercise of varying modalities as a
therapeutic for improvements in glycemic control and glycemic variability in adults
diagnosed with type 2 diabetes. Thus, this allows for further consideration to be made for
type 1 diabetic adults and overweight or obese, but otherwise healthy adults, to aid in the
implementation of preventive approaches to decrements in metabolic health as opposed
to treatment in those metabolically compromised.
Strengths and Limitations
Overall, there is a lack of well-documented studies that examine the relationship
between sedentary time and physical activity with CGM-assessed glycemic control and
glycemic variability, and even less information regarding the effect of a single bout or
repeated bouts of exercise and chronic exercise training on these outcomes of interest.
This review aimed to be among the first to critically examine the current literature
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regarding sedentary time and physical activity with glycemic variability and compile
evidence to delineate the gaps in the literature that need to be addressed. This review also
reported findings of a single bout of exercise or repeated bouts of exercise and exercise
training and their respective effects on glycemic control and glycemic variability.
Inclusion of multiple source databases, including PubMed, Google Scholar, Web of
Science, BioMed Central, CINAHL, and SCOPUS up until December 2019 was another
strength. Additionally, a variety of search terms for each outcome variable of interest
were utilized.
There are several limitations to this study. The first was incorporation of
subjectively assessed, in addition to objectively assessed, sedentary time and physical
activity, as subjectively assessed sedentary time and physical activity often lack not only
validity and reliability, but also reproducibility (Prince SA, Adamo KB, Hamel ME,
Hardt J, Gorber SC, & Tremblay M, 2008). Additionally, primarily compiling articles
utilizing CGM assessed glycemic variability is another limitation, as additional measures
of glycemic control and glycemic variability exist. Yet, the accuracy of CGM
measurements have been validated with clinical measures, such as venous blood
sampling and allow for assessment of free-living glycemic control and glycemic
variability (Akintola AA, Noordam R, Jansen SW, de Craen AJ, Ballieux BE, Cobbaert
CM, Mooijaart SP, Pijl H, Westendorp RG, & van Heemst D, 2015). Lastly, the inclusion
of a variety of populations is a limitation but allows for meaningful observations as to
how sedentary time and physical activity relate to glycemic control and glycemic
variability, as well as provides greater insight into the influence of a single bout or
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repeated bouts of exercise, or exercise training on glycemic control on glycemic
variability.
With these strengths and limitations in mind, future studies should potentially
focus on increasing both exercise and non-exercise related physical activity, as well as
selecting and employing an appropriate volume of exercise depending on the population
in question. Further, other exercise characteristics, such as frequency and intensity may
be utilized to tailor exercise interventions to match individual preferences and abilities in
addition to targeting beneficial changes in glycemic control and glycemic variability.
Therefore, practitioners should encourage participants to decrease sedentary behavior and
increase physical activity throughout the day, as well as to implement exercise, regardless
of modality, into their everyday life to improve cardiometabolic health outcomes,
specifically long-term glycemic control and glycemic variability.
CONCLUSION
Although physical activity and exercise are important treatment strategies to
improve long-term glycemic control, the relationship between sedentary time and
physical activity, and the impact of exercise on free-living glycemic control and glycemic
variability remains largely unexplored. The introduction and advancement of CGM
technology enables researchers and practitioners to assess, as well as evaluate how
lifestyle factors impact glycemic health in a free-living environment. As evidenced in this
review, the current literature utilizing CGM technology has demonstrated that potential
relationships exist between glycemic control and glycemic variability with habitual
sedentary time and physical activity. Further, this review found that a single bout of
exercise or repeated bouts of exercise, as well as exercise training, may beneficially
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impact glycemic control and glycemic variability immediately following exercise,
specifically in adults diagnosed with type 2 diabetes.
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Table 4.1. Frequently used measurements of glycemic variability
Author
Glycemic
Calculation
variability
Strengths
Limitations (publication
definition
measurement
date)
Standard
SD of all
Simple,
Does not
Pernick NL
deviation
glucose
classical
account for & Rodbard
(SD)
concentrations
statistical
skewed
D (1986);
in a
method.
distributions Rodbard D
distribution.
or
(1988);
outliers.
Hirsch IB
(2005);
Rodbard D
(2007)
Percentage
(SD÷mean)×100 Simple,
Does not
Pernick NL
coefficient
classical
account for & Rodbard
skewed
D (1986);
of variation
SD and mean
statistical
(%CV)
value of all
method.
distributions Rodbard D
glucose
Incorporates
or
(1988);
concentrations
both the SD
outliers.
Hirsch IB
(2005);
in a distribution. and mean
Rodbard D
value of a
distribution.
(2007)
Mean
Average
Account for
Less
Service FJ
amplitude of amplitude of
physiological efficient to
et al.
glycemic
upstrokes or
fluctuations
calculate
(1970);
excursions
downstrokes
due to
than SD,
Service FJ
(MAGE)
with a
events
while
& Nelson
magnitude >1
throughout
providing
RL (1980);
SD above the
the day.
similar
Service et
mean value for
e.g. meals,
outcomes.
al. (1987)
all glucose
exercise
concentrations.
Continuous
The SD of the
Potential to
Validity and McDonnell
overlapping difference
address a
reliability
CM et al.
net glycemic between two
variety of
decrease
(2005);
action over
glucose
clinical
once time
Kuenen JC
n-hour
concentrations
questions.
frame >4
et al.
(CONGA-n) obtained exactly CONGA-1 to hours in a
(2008);
n hours apart.
CONGA-4
controlled
Nathan DM
valid and
setting.
et al. (2008)
reliable
when
accounting
for
corresponding
times
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between
different
activities.
Service FJ
Originally
Describes
Mean of
Mean of
& Nelson
defined for
between-day
absolute
daily
RL (1980);
two
variability.
differences
differences
consecutive Service et
between glucose Ability to
(MODD)
al.
values obtained permit use of days
(1987)
at the same time data from >2 assuming
similar
unstructured
of day on two
meals,
days.
consecutive
activities,
days under
and therapy
standardized
on both
conditions.
days.
Mean of
absolute
differences in
glucose values
over >2 days
between any
value and the
value exactly 24
hours later.
Table 4.1. provides frequently used measurements of glycemic variability,
which includes calculation definition of each glycemic variability
measurement with further consideration for strengths and limitations of each
glycemic variability measurement.
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Table 4.2. Relationship between sedentary behavior and physical
activity with glycemic control and glycemic variability
Study
Strengths
Author
Primary
design
Conclusion
and
(publication
findings
Number of
limitations
date)
participants
Nondiabetic
Gude F et
CrossNo
Physical
Strengths:
al. (2017)
sectional;
relationship
activity status Large
diverse
N=622
found
may
between
not relate to
sample of
adults
physical
glycemic
activity status variability
Limitations:
with any
indices in non- Crosssectional
glycemic
diabetic
variability
adults.
design;
subjective
indices in
assessment
non-diabetic
of physical
adults.
activity
status
Type 1
diabetes
MartynProspective Total physical Increases in
Strengths:
Nemeth P et repeatedactivity
total physical
Actigraphyal. (2017)
measures
minutes did
activity
assessed
design;
not relate to
performed
physical
throughout the activity
N=35
glycemic
day may not
Limitations:
variability
assessed as
relate to lower Small
the SD of the glycemic
sample size;
24-hour mean variability in
physical
glucose
type 1 diabetic activity was
concentration. adults.
not a
primary
outcome of
this study
Type 2
diabetes
Paing AC et CrossTime spent in Decreasing
Strengths:
al. (2018)
sectional;
euglycemia
sedentary
ActigraphyN=37
negatively
time, breaking assessed
associated
up sedentary
sedentary
with
time, or a
time
sedentary
combination
Limitations:
95

Crossof these
sectional
sedentary
design;
behaviors
small
potentially
influence time sample size
spent in
euglycemia
and glycemic
control
without
impacting
hypo- or
hyperglycemia
in type 2
diabetic
adults.
Table 4.2. presents studies that provided information regarding the
association between sedentary time and physical activity with glycemic
control and glycemic variability in non-diabetic, as well as type 1 and type
2 diabetic adults. The table includes: 1) author information; 2) study design;
3) findings related to the association between sedentary time and physical
activity with glycemic control and glycemic variability; 4) conclusions
derived from the findings between the relationship between sedentary time
and physical activity with glycemic control and glycemic variability; 5)
strength and limitations of each study.
time, but
positively
associated
with breaks in
sedentary
time.
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Table 4.3. Influence of a single bout of exercise or repeated bouts of exercise on
glycemic control and glycemic variability
Author
Strengths and
(publication Study design
Primary findings Conclusion
limitations
date)
Nondiabetic
Figueira FR Randomized
Glucose variance Acute session Strengths:
et al. (2019) crossover trial and glucose
of aerobic and Controlled
design; N=15
%CV and SD
eccentric
laboratory
Two
were lower at 12- exercise
setting
experimental
18 hours postpromotes
Limitations:
Small sample
sessions;
exercise
comparable
size; exercise
aerobic cycle
compared to pre- reductions in
ergometry;
exercise in
glycemic
was of
moderate to
following both
variability
eccentric
high intensity
resistance
the aerobic bout
non-trained
exercise
and eccentric
healthy adults. over an
extended
bouts of exercise.
period
Little JP et
Randomized
Absolute PPG
A single
Strengths:
al. (2014)
counterbalance spike following
session of
Controlled
trial design;
standardized
HIIT exercise laboratory
N=10
breakfast and
improved
setting.
Two 3-day
dinner were
Limitations:
overall
experimental
significantly
Small sample
postprandial
exercise
lower following
glycemia in
size; inclusion
testing
HIIT exercise
overweight or of adults with
periods;
compared to no- obese adults
impaired fating
continuous
exercise control
during the 24
glucose
moderateand following
h following a
intensity
CMI exercise.
single training
(CMI)
session in
exercise; highoverweight or
intensity
obese adults.
interval
training (HIIT)
Parker L et Randomized
24-hour postLV-HIIE
Strengths:
al. (2017)
clinical trial;
Controlled
exercise period
improves
laboratory
N=27
following LVglycemic
setting
4-day
HIIE, mean
control to a
experimental
glucose and peak similar extent Limitations:
design; low
Small sample
glucose
as CMIE in
size;
volume highconcentration,
overweight
participants
intensity
and area under
and obese
interval
the curve were
adults.
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Type 1
diabetes
van Dijk
JW et al.
(2016)

Manohar C
et al. (2012)

exercise (LVHIIE);
continuous
moderateintensity
exercise
(CMIE)

lower compared
to pre-exercise
control and
comparable to
CMIE.
Percent of time
spent
hyperglycemic
was lower in LVHIIE compared
to pre-exercise
control and
comparable to
following CMIE.

LV-HIIE may
be a more
effective
exercise
modality for
incorporation
into exercise
programs
designed to
improve
glycemic
control in
overweight or
obese adults.

were not
blinded
to real-time
CGM readings

Observational
during world’s
largest
walking event:
Nijegen Four
Day Marches;
N=10
40-50 km
walked per
day over 4
days

CONGA-1 and
CONGA-2
measures of
glycemic
variability were
greater during the
4-day walking
event compared
to the habitual
physical activity
control day.

Prolonged
continuous
walking
compared to
habitual
physical
activity
increased
glycemic
variability
measures in
type 1
diabetics.

Strengths:
Examined a
prolonged
exposure to
increase in
physical
activity
Limitations:
Small sample
size; nonstandard
exercise
modality

Center-based
clinical trial;
N=24
Increase daily
energy
expenditure 3fold from
measured
basal
metabolic rate
over three
monitored
days

In healthy
controls %CV
was lower
following meals
with physical
activity
compared to
meals without
physical activity;
however, these
findings were not
observed in type
1 diabetics.
Post-meal
glycemic
excursions were

Performing
low-intensity
physical
activity after
meals, such as
taking a short
walk,
potentially
benefit
healthy and
type 1
diabetics by
lowering
postprandial
glucose
excursions.

Strengths:
Age- and sexmatched
healthy
controls and
type 1
diabetics;
controlled
laboratory
setting
Limitations:
Small sample
size; type 1
diabetics
received
insulin boluses
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prior to their
meals

observed to be
lower in controls
and type 1
diabetics
following meals
with physical
activity.
Type 2
diabetes
Farabi SS et
al. (2015)

Center-based
randomized
clinical crossover trial;
N=37
Two 3-day
experimental
trials both in
morning;
sedentary for
30 minutes;
30-minute
exercise
session

Daytime
CONGA-1
significantly
decreased
following
exercise in
segment 2
compared to
sedentary trial in
the type 2
diabetes/impaired
glucose tolerance
group.

van Dijk
JW et al.
(2013)

Randomized
crossover trial;
total N=60;
non-insulin
treated N=37;
insulin
treated=23
Two 3-day
intervention
periods
separated by a
week;
sedentary
protocol; 4560 minutes of
continuous
cycling

Overall average
24-hour mean
glucose
concertation,
time spent
hyperglycemic,
and CONGA-1,
CONGA-2, and
CONGA-4
measures of
glycemic
variability were
all lower
following a
single bout of
exercise.

Praet SF et
al. (2006)

Interventionbased clinical
trial; N=11

Time spent
hyperglycemic
was significantly
99

A single bout
of early
morning
moderateintensity
exercise
reduced
daytime
glycemic
variability in
type 2 diabetic
and/or
impaired
glucose
tolerant obese
adults.
A single bout
of moderateintensity
exercise
reduces
hyperglycemia
and glycemic
variability
throughout the
subsequent
day following
exercise in
non-insulin
dependent and
insulin
dependent
type 2 diabetic
adults.
As ingle bout
of exercise
reduces the

Strengths:
Controlled
laboratory
setting
Limitations:
Inclusion of
adults with
impaired
glucose
tolerance in the
same group

Strengths:
Use of CGM;
inclusion of
insulin and
non-insulin
treated type 2
diabetics
Limitations:
Only inclusion
of males

Strengths:
Implementation
of resistance

Resistance
exercise and
aerobic
exercise

Figueria FR
et al. (2013)

Randomized
crossover
design
performed 7
days apart;
N=14
Aerobic
exercise;
aerobic plus
resistance
exercise

lower during the
subsequent 24
hours following
exercise
compared to 24
hours prior to
exercise.
No measures of
glycemic
variability
differed between
the 24-hour
period pre- and
post-exercise.
24-hour mean
glucose
concentration
comparably
decreased in both
groups postexercise
compared to preexercise.
Larger sustained
decrease in
glucose
concentrations in
the aerobic plus
resistance group
compared to the
aerobic only
group were
observed in the
first 6-hours
post-exercise.
Changes in
glycemic
variability were
noted in the
aerobic plus
resistance
training group
only when nonconventional
symbolic
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prevalence of
hyperglycemia
in longstanding,
insulintreated, type 2
diabetic male
adults.

and aerobic
exercise
Limitations:
Small sample
size; large
inter-subject
variability

Both aerobic
only and
aerobic plus
resistance
exercise
modalities
decreased
glucose levels
over a short
period of time
following
cessation of
exercise.
Conventional
analyses of
glycemic
variability
may lack
sensitivity to
account for
minor
oscillations in
glucose
concentrations
observed
using nonconventional
analyses.

Strengths:
Implementation
of resistance
and aerobic
exercise; use of
conventional
and nonconventional
methods
Limitations:
Small sample
size; no
resistance
exercise only
group

analysis was
applied.
Table 4.3. presents studies that provided information regarding the influence of a
single bout of exercise or following repeated bouts of exercise on glycemic control
and glycemic variability in non-diabetic, as well as type 1 and type 2 diabetic adults.
The table includes: 1) author information; 2) study design; 3) findings related to the
alterations in glycemic control and glycemic variability; 4) conclusions derived from
the findings on changes in glycemic control and glycemic variability; 5) strength and
limitations of each study.
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Table 4.4. Influence of exercise training on glycemic control and
glycemic variability
Strengths
Author
Study
Primary
Conclusion
and
(publication
design
findings
limitations
date)
Type 2
diabetes
Mikus CR
Clinical
Maximum
7 days of
Strengths:
et al. (2012) controlled
glucose
aerobic
Controlled
trial; N=13
concentration, exercise
exercise
7-day
differences
training
setting
moderatebetween
Limitations:
reduces PPG
intensity
maximum and and glycemic Small sample
continuous
minimum
size; volume
control in
aerobic
glucose
of exercise
free-living
exercise
concentration, individuals
performed
training
and number of with type 2
was above
program
glucose
recommended
diabetes but
excursions all does not
guidelines
decreased
influence
following
responses to
over the final the laboratory
3 days of the
based OGTT
7-day exercise
training
compared to 3
days of
habitual daily
activity.
Kartstoft K Randomized 24-hour mean, In a freeStrengths:
et al. (2013) clinical trial and minimum living setting, Extended
performed
exercise
glucose
continuousover 4
concentrations walking
intervention;
months (16 increased in
exercise may inclusion of a
weeks);
the control
control group;
offset the
total N=32; group, while
applicable to
deleterious
control
24-hour mean, effects of no
a free-living
group N=8; and maximum exercise,
condition for
continuous- glucose
exercise and
while
walking
concentrations intervalglucose
group
control
decreased in
walking
N=12;
the intervalexercise may Limitations:
intervalwalking group superiorly
Small sample
walking
size; limited
only, which
improve
to type
group N=12 differentially measures of
changed when glucose
102

Francois
ME et al.
(2017)

Habitual
daily
activity;
continuouswalking;
intervalwalking
group
Proof-ofconcept,
doubleblind,
randomized
clinical trial;
N=53
3 days per
week for 12
weeks of
highintensity
interval
training
(HIIT);
resistance
and aerobicbased
exercised

compared to
the
continuouswaling group.

concentrations 2diabetic
adults
in type 2
diabetic
adults.

There was a
significant
decrease in
glycemic
control
assessed as
HbA1c, as
well as 24hour mean
glucose
concentration,
SD of the 24hour mean
glucose
concentration,
and MAGE.

Twelve weeks
of lowvolume HIIT
improved
glycemic
control and
glycemic
variability.

Strengths:
Standardized
12-week HIIT
exercise
program
Limitations:
Older sample
limited to
type 2
diabetic
adults; unable
to account for
participant
characteristics
differences

Table 4.4. presents studies that provided information regarding the influence
of exercise training on glycemic control and glycemic variability in type 2
diabetic adults. The table includes: 1) author information; 2) study design; 3)
findings related to the alterations in glycemic control and glycemic
variability; 4) conclusions derived from the findings on changes in glycemic
control and glycemic variability; 5) strength and limitations of each study.
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CHAPTER 5
MANUSCRIPT 2-ASSOCATION OF SEDENTARY TIME AND PHYSICAL
ACTIVITY WITH GLYCEMIC VARIABILITY AND OXIDATIVE STRESS IN
OVERWEIGHT OR OBESE ADULTS2
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ABSTRACT
Introduction: Overweight or obese adults have a higher risk for the development of
cardiometabolic disorders. Glycemic variability acts as a more sensitive analysis of
glycemic health compared to other clinical measures. Oxidative stress plays a key role in
the development of cardiovascular disease. Decreased sedentary time and increased
physical activity (PA) reduce the risk of cardiometabolic diseases. The purpose of this
study was to examine the relationship between sedentary time and PA measures with
glycemic variability and oxidative stress in overweight or obese adults.
Methods: Adults (n=28; BMI=32.3±6.3 kg/m2) completed 7-day accelerometer and
continuous glucose monitor (CGM) monitoring. Time spent sedentary and performing
light- (LPA), moderate-to-vigorous-intensity (MVPA), and total PA, as well as associated
energy expenditure (EE) were measured using a Sensewear Mini Armband. The average
daily sedentary time, PA minutes, and PA EE per day were calculated. The standard
deviation (SD) across all days for these PA variables were used to indicate the
consistency of PA across days. The 24-hour glycemic variability was calculated as mean
amplitude of glycemic excursion (MAGE), continuous overlapping net glycemic action
of 1-hour, 2-hour, and 4-hour (CONGA-1, -2, and -4) and mean of daily differences
(MODD). After a 12-hour fast, a blood sample was collected on either the first or last day
of the monitoring period and concentrations of nitric oxide and myeloperoxidase were
measured, and the oxidative stress ratio was calculated as nitric oxide
concentration÷myeloperoxidase concentration. Pearson product correlations between
measures of sedentary time and PA, glucose concentrations, glycemic variability, and
oxidative stress were performed with and without adjustment for age and/or BMI.
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Results: MVPA was negatively correlated with diurnal glucose concentration (r=-0.42,
p=0.03), while total PA was negatively correlated with 24-hour mean glucose (r=-0.41,
p=0.04). LPA EE was negatively correlated with fasting glucose concentration (r=-0.41,
p=0.03) and diurnal glucose concentration (r=-0.41, p=0.03), while LPA and MVPA EE
were negatively correlated with diurnal glucose concentration (r=-0.42, p=0.03; r=-0.41,
p=0.04). Additionally, the SD across average daily LPA EE negatively correlated with
the oxidative ratio (r=-0.39, p=0.04). Nitric oxide was positively correlated with fasting
glucose concentration (r=0.47, p=0.01), while myeloperoxidase was negatively correlated
with fasting glucose concentration (r=-0.41, p=0.03), MAGE (r=-0.46; p=0.02),
CONGA-2 (r=-0.39, p=0.04), and CONGA-4 (r=-0.38, p=0.04). After adjustment for age,
BMI, and/or time spent sedentary and performing PA, myeloperoxidase continued to be
negatively correlated with fasting glucose concentration and MAGE.
Conclusion: PA of varying intensities, regardless of PA consistency, may impact
glycemic health. The relationship between glycemic variability and oxidative stress may
be more pertinent when evaluating cardiometabolic health, rather than the relationship
between PA measures with these outcomes, in overweight or obese adults.
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INTRODUCTION
The prevalence of adults in the United States classified as overweight or obese
continues to increase, with ~40% designated obese in 2015-2016, and is widely
considered a major public health crisis of the current generation (Flegal MF, KruszonMoran D, Carroll MD, Fryar CD, & Ogden CL, 2016; Hales CM, Carroll MD, Fryar CD,
& Ogden CL, 2017). Overweight or obese adults are at an increased risk for the
development of type 2 diabetes mellitus and cardiovascular disease (National Institutes of
Health 1998; National Institutes of Health 2013; Centers for Disease Control and
Prevention 2017). Further, overweight or obesity-related cardiometabolic disorders may
lead to increased medical care cost to prevent or treat potential preventable disorders,
such as impaired glycemic health or cardiovascular disease risk factors (Bray GA 2004;
O’donovan G, Kearney EM, Nevill AM, Woolf-May K, & Bird SR, 2005).
It is suggested that overweight and obesity may not directly translate to increased
risk of cardiovascular disease, rather it may be the interaction of obesity-related insulin
resistance causing pathophysiological changes in the cardiovascular system that lead to
cardiovascular disease (Reaven G 2005). Further, oxidative stress increases the risk for
development of cardiovascular disease and has been shown to be elevated in overweight
and obesity (Alberti K & Zimmet PZ, 1998; Amirkhizi F, Siassi F, Minaie S, Djalali M,
Rahimi A, & Chamari M, 2007; Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E,
Di Rosa G, Gitto E, & Arrigo T, 2015). When an imbalance between accumulation and
detoxification of reactive oxygen species arises, an induction of oxidative stress occurs,
resulting in vascular endothelium-related vasoconstriction (Wu JQ, Kosten TR, & Zhang
XY, 2013; Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito
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F, Altavilla D, & Bitto A, 2017). Hyperglycemia has been mechanistically related to
increased production of oxidative stress, as increases in glucose concentrations are a
known cause of enhanced free radical activation and elevated reactive oxygen species
(Ceriello A 2000).
Additionally, glycemic variability has been utilized to determine glycemic
control, including glucose excursions, and potentially acts as a more sensitive analysis of
glycemic health compared to clinical assessments (Monnier L, Colette C, & Owens DR,
2008). Frequent or exacerbated fluctuations of glucose concentrations may contribute to
deleterious complications linked to impaired glucose metabolism, and has been found to
be increased in overweight or obese adults (Wang S, Lv L, Yang Y, Chen D, Liu G, Chen
L, Song Y, He L, Li X, Tian H, Jia W, & Ran X, 2012; Satya Krishna SV, Kota SK, &
Modi KD, 2013; Salkind SJ, Huizenga R, Fonda SJ, Walker MS, & Vigersky RA, 2014;
Suh S & Kim JH, 2015). Furthermore, glycemic variability has also been found to be
positively associated with oxidative stress in type 2 diabetes mellitus (Taniyama Y &
Griendling KK, 2003; Monnier L, Mas E, & Ginet C, 2006; Rodrigues R, de Medeiros
LA, Cunha LM, Garrote-Filho MDS, Bernardino Neto M, Jorge PT, Resende ES, &
Penha-Silva N, 2018). As technology has continued to advance, free-living glycemic
variability assessment has become a minimally invasive procedure utilizing continuous
glucose monitoring (CGM).
Overweight or obese adults tend to spend more time being sedentary and less time
performing physical activity (PA) than healthy weight adults (Tudor-Locke C, Brashear
MM, Johnson WD, & Katzmarzyk PT, 2010; Ortega FB, Artero EG, Jiménez-Pavón D,
& Ruiz JR, 2018). Evidence indicates that decreasing sedentary time and increasing PA
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of any intensity is beneficial for cardiometabolic health, including decreases in body
mass index (BMI), dyslipidemia, and fasting glucose concentrations (Chan CB, Ryan
DAJ, & Tudor-Locke CT, 2004; Van Gaal FL & Maggioni AP, 2013; Wing RR, Bolin P,
Brancati FL, Bray GA, Clark JM, Coday M, Crow RS, Curtis JM, Egan CM, Espeland
MA, Evans M, & The Look AHEAD Research Group, 2013).
Objectively-measured sedentary time, light-intensity PA (LPA), and moderate-tovigorous-intensity PA (MVPA) are each independently associated with 2-hour glucose
concentration in overweight adults not diagnosed with type 2 diabetes mellitus (Healy
GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, & Owen N, 2007). Yet, no
study has reported sedentary time and PA of varying intensities with glycemic variability.
Additionally, subjectively evaluated light-intensity, high-intensity, and total leisure-time
PA were associated with high antioxidant enzyme activity, which decreases oxidative
stress (Covas M-I, Elosua R, Fitό M, Alcántara M, Coca L, & Marrugat J, 2002).
However, whether these associations exist using objectively measured sedentary time and
PA are unclear.
Therefore, the purpose of this study was to examine the associations of time spent
sedentary time and performing PA and related PA energy expenditure (EE) with
measures of glycemic variability and biological markers of oxidative stress in sedentary,
overweight or obese adults. The overarching hypothesis was that less time spent
sedentary time and more time performing PA of any intensity would be associated with
better measures of glycemic variability and oxidative stress. A secondary hypothesis was
that decreased glycemic variability would be associated with lower oxidative stress
biological markers.
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METHODS
Data were obtained from the Weight Outlooks by Restriction of Diet and Sleep
(WORDS; NCT: 02413866) and Aerobic Treadmill Exercise and Metabolism (A-TEAM;
NCT: 03162991) studies. The WORDS study openly recruited from January 2015 to
October 2016, while the A-TEAM study openly recruited from October 2017 to
December 2018. The WORDS study was designed to examine the effects of chronic
moderate sleep restriction on body composition in individuals undergoing a hypocaloric
dietary weight loss program (Wang X, Sparks JR, Bowyer KP, & Youngstedt SD, 2018).
The A-TEAM study was designed to examine the effects of a moderate-intensity aerobic
treadmill-based exercise intervention on glucose concentrations utilizing CGM
technology in sedentary, overweight or obese adults. Study protocols were approved by
the University of South Carolina Institutional Review Board and all participants signed
an informed consent form prior to participation. There were no repeat participants
between the two studies. The present study includes 28 participants that had valid CGM
and PA data, as well as fasting blood samples available for analysis at baseline, prior to
either study’s intervention. All participant visits and testing were completed by the same
trained research staff and took place in the Clinical Exercise Research Center (CERC)
housed within the Norman J. Arnold School of Public Health at the University of South
Carolina.
Participants
Both the WORDS and A-TEAM studies had similar inclusion and exclusion
criteria with the WORDS study criteria previously described (Wang X, Sparks JR,
Bowyer KP, & Youngstedt SD, 2018). Briefly, participants were not physically active
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(reported ˂120 minutes of resistance or endurance exercise per week during the previous
3 months), overweight or obese (25≤BMI≤40 kg/m2) males and females, age 35-55 years,
weight stable (±2%) during the previous 3 months, and females were eumenorrheic or
post-menopausal for ≥1 year. Exclusion criteria included any self-reported medical
conditions such as diabetes, cardiovascular diseases, chronic or recurrent respiratory
conditions (e.g. uncontrolled asthma or chronic obstructive pulmonary disease), active
cancer, and eating or neurological disorders, medications that affect metabolism (e.g.
thyroid medications, statins), psychological issues, including but not limited to untreated
depression and attention deficit disorder, excessive caffeine use (>500 mg/day), smoking
during the past year, pregnant or lactating females, and/or unwillingness to provide
informed consent.
Measurements
Height, Body Weight, and Body Mass Index (BMI)
Height and body weight were measured at the first baseline visit using a
stadiometer and an electronic scale that was calibrated annually (CC Vaughan & Sons,
Incorporated, Columbia, SC). BMI was calculated using the following calculation: BMI
(kg/m2) = Body Weight (kg) ÷ [Height (m)]2.
Sedentary Time and Physical Activity Measures
At the first baseline visit, participants reported to the CERC and were trained on
use of the SenseWear Mini Armband device (BodyMedia®, Pittsburgh, PA), which was
initially placed by trained research staff on the posterior aspect of the left arm at the midpoint between the olecranon and acromion processes. The SenseWear device provides
objectively measured PA and has demonstrated to be reliable and valid when measuring
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energy expenditure compared to the doubly labeled water method (Johannsen DL,
Calabro MA, Stewart J, Franke W, Rood JC, & Welk GJ, 2010) and more accurate than
the standard World Health Organization Global Physical Activity Questionnaire for
estimating PA (Laermans M, Dons E, Avila-Palencia I, Carrasco-Turigas G, Orjuela JP,
Anaya E, Brand C, Cole-Hunter T, de Nazelle A, Götschi T, Kahlmeier S,
Nieuwenhuijsen M, Standaert A, Boever PD, & Panis LI, 2017). Participants wore the
device for 7 consecutive days, before either study intervention, and were instructed to
maintain their normal daily routine during monitoring. Participants recorded when they
removed the device for any activities that required water-based activities, such as
showering/bathing or swimming over the 7-day monitoring period. On the final day of
the 7-day monitoring period, participants reported back to the CERC for their second
baseline visit and returned the SenseWear device. Data were considered valid for analysis
if participants wore the monitor for at least 5 days including at least one weekend day,
with a minimum wear time of 20 hours each day.
Sedentary time and PA measures were assessed utilizing manufacture provided
software (BodyMedia® Sensewear Version 7.0). Sedentary time was established as
activity <1.5 metabolic equivalents (METs) (excluding sleep time), and time spent
performing LPA as 1.5 to <3.0 METs, MVPA as ≥3.0 METs, and total PA as ≥1.5 METs.
In addition to sedentary time and time spent performing PA of varying intensities, EE for
LPA (≥1.5 METs) and MVPA (≥3.0 METs) were obtained. Sedentary time and time
spent performing PA of varying intensity, LPA EE, and MVPA EE were obtained for
each valid day of wear time and the average of those days were calculated. Additionally,
the standard deviation (SD) of sedentary time and all PA measures across all valid days
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were calculated as a measure of day-to-day variability. Estimated PA time and EE during
non-wear times was excluded from analysis.
CGM-Assessed Glucose Concentrations and Glycemic Variability
A CGM device (Dexcom G4 Platinum Professional, San Diego, CA, USA) was
used to assess interstitial glucose concentrations throughout the same 7 consecutive days
as the SenseWear Mini Armband device monitoring. At the first baseline visit
participants reported to the CERC for placement and instruction of use for the CGM
device by trained research staff. Participants had a catheter inserted under the skin on the
preferred side of the abdomen with an attached sensor and transmitter, approximately 2
cm to the side of the umbilicus. They were instructed to carry a recording device which
received and stored interstitial glucose concentration readings every 5 minutes over the 7
days. This specific CGM device model requires participants to manually perform a
capillary blood measurement by fingerstick using a provided glucometer twice a day
during days of wear per manufacture instructions. Participants were instructed on how to
perform a capillary blood measurement and enter the glucometer readings into the CGM
device. The Dexcom G4 Platinum Professional CGM device has been validated and
proven accurate against directly evaluated blood glucose concentrations (Facchinetti A,
Favero SD, Sparacubi G, & Cobelli C, 2015). The CGM device was blinded so that
participants could not observe the live readings to deter any alterations in diet, PA, or
general lifestyle, and participants were requested to maintain their normal daily routine
during the 7-day monitoring period. On the final day of the 7-day monitoring period,
participants reported back to the CERC for their second baseline visit and the CGM
device was removed. Data was considered valid for analysis if participants wore the
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device for at least 5 days including at least one weekend day, with a minimum available
glucose measure over 20 hours each day.
Software provided by the manufacturer (Dexcom Studio 12.0.4.6) was used to
download and export CGM data. 24-hour mean, diurnal, and nocturnal glucose
concentrations were calculated for each valid day and expressed as the average of those
valid days. 24-hour mean glucose concentration was assessed from midnight to midnight
for each valid day. Diurnal and nocturnal glucose concentrations were assessed each
valid day during each participant’s self-reported time-in-bed and time-out of-bed. The
continuous overlapping net glycemic action over 1, 2, and 4 hours (CONGA-1, CONGA2, and CONGA-4) was calculated manually in Excel, while the mean amplitude of
glycemic excursion (MAGE) and mean of daily differences (MODD) measures of
glycemic variability was calculated using EasyGV Version 9.0.R2 (University of Oxford,
Oxford, England, UK), which is an Excel-enabled workbook that utilizes macros. MAGE
was calculated for each participant by taking the arithmetic mean of increased or
decreased glucose concentrations (nadirs and peaks or vice-versa) when both ascending
and descending concentration exceeds one SD from the 24-hour mean glucose
concentration for the same 24-hour monitoring period (Service FJ, Molnar GD, Rosevear
JW, Ackerman E, Gatewood LC, & Taylor WF, 1970; Service FJ & Nelson RJ, 1980;
Service FJ, O’Brien PC, & Rizza RA, 1987). CONGA-1, CONGA-2, and CONGA-4
were calculated as the SD of the differences between each observation and the previous
1-hour, 2-hour, and 4-hour observations (McDonnell CM, Donath SM, Vidmar SI,
Werther GA, & Cameron FJ, 2005; Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld
D, Heine RJ, & ADAG Study Group, 2008; Kuenen JC, Borg R, Zheng H, Schoenfeld D,
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Heine RJ, & Nathan DM, 2011). CONGA-1, CONGA-2, and CONGA-4 were chosen for
this study because the 1-hour, 2-hour, and 4-hour time periods approximate the time
intervals between different activities (CONGA-1), time between snacks (CONGA-2), and
time between meals (CONGA-4), respectively (McDonnell CM, Donath SM, Vidmar SI,
Werther GA, & Cameron FJ, 2005). MODD accounts for the mean of absolute
differences between glucose concentrations obtained at exactly the same time of day on
consecutive days and has been highly correlated with the SD for between day variability
(Rodbard D, Matsubara B, Nakamura K, Bailey T, Jovanovic L, Zisser H, Kaplan R, &
Garg SR, 2008). MAGE and CONGA-1, CONGA-2, and CONGA-4 were utilized as
measurements of within-day glycemic variability for each valid day of wear time and
averages of those days calculated, while MODD was utilized as a measurement of
between-day glycemic variability for all valid days combined.
Venous Blood Sample Collection
For the WORDS study, participants reported to the CERC and had a fasting blood
sample collected following a minimum of a 12-hour fast (not including water) at the first
baseline visit (day 1). Fasting blood samples were collected into a BD Vacutainer serum
collection tube, allowed to clot for approximately 30 minutes, and then centrifuged at
3000 rpm at 4ºC for 20 minutes. For the A-TEAM study, participants reported to the
CERC following a minimum of a 12-hour fast (not including water) at the second
baseline visit (day 7) and had a blood sample collected into a BD Vacutainer EDTA
plasma collection tube, which was immediately centrifuged at 3000 rpm at 4ºC for 20
minutes. Serum separated after centrifugation was aliquoted and stored at -80ºC until all
participants’ samples were ready for analysis. Prior to analysis, serum and plasma
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samples were thawed and re-centrifuged at 3000 rpm and 4ºC for 20 minutes to ensure
separation of any particulate.
Fasting Glucose Measurement
A YSI 2300 STAT Plus (YSI Life Sciences, Yellow Spring, OH), which was
calibrated according to manufacture instruction prior to analysis, was used to analyze
serum glucose. The time of blood sample collection was recorded and matched with the
CGM to establish the fasting glucose time point. If the fasting blood sample time point
fell between CGM glucose concentration readings, as the CGM assesses glucose
concentrations every 5 minutes, the average between the previous and following CGM
concentration readings was calculated. The CGM-assessed glucose concentrations have
been validated with venous blood glucose concentrations, which maintained an accuracy
rate between 95-99% during periods of euglycemia (Kovatchev B, Anderson S,
Heinemann L, & Clarke W, 2008).
Biological Markers of Oxidative Stress
Fasting venous blood samples were used to measure biological markers of
oxidative stress. Two biological markers of oxidative stress, nitric oxide, which acts as a
potent vasodilator (Palmer RMJ, Ashton DS, & Moncada S, 1988), and myeloperoxidase,
a potent vasoconstrictor (Klebanoff SJ 2005), were measured using two separate enzymelinked immunoabsorbant assays (ELISA). The nitric oxide ELISA kit (ThermoFisher
Scientific, Waltham, MA) quantitatively determines the concentrations of nitrate and
nitrite, with ≥90% sample recovery rate, in serum and plasma samples. The
myeloperoxidase ELISA kit (Eagle Biosciences, Inc., Nashua, NH) quantifies
myeloperoxidase utilizing a two-site “sandwich” technique that binds to different
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epitopes of myeloperoxidase. However, myeloperoxidase concentrations have been
observed to be lower in plasma compared to serum based on previous tests performed by
the manufacturer. The oxidative stress ratio was calculated by the concentration of nitric
oxide divided by the concentration of myeloperoxidase to examine balance between
vasodilation (nitric oxide) and vasoconstriction (myeloperoxidase). All assays were
performed and analyzed on the same day by the same trained research staff with an intraassay variability of <10%.
Statistical Analysis
Statistical analysis was performed using SAS version 9.4 (Cary, NC). Participant
characteristics were calculated and reported as mean and SD as a combined sample and
for each study. Descriptive statistics were calculated for sedentary time and PA of
varying intensity, measures of glycemic variability, and biological markers of oxidative
stress. Participant characteristics for each study were compared utilizing independent
sample t-tests, or chi-square test when necessary, to determine whether any variables
were different between the two studies. Pearson product correlations were performed to
examine the associations between sedentary time and PA measures, fasting and CGM
glucose concentrations, glycemic variability, and biological markers of oxidative stress.
Furthermore, the relationship between glucose concentrations, glycemic variability
measures, and biological markers of oxidative stress with the day-to-day variability in
sedentary time and PA measures, expressed as SD, was examined. Effect size
correlations were based upon standards set at r=0.1 (-0.1), 0.3 (-0.3), or 0.5 (-0.5),
representing a small, medium, or large effect size correlation, respectively (Cohen J,
1988). Partial Pearson product correlations adjusting for age and/or BMI were performed
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to determine their influence on the relationship between the outcome variables of interest.
Additionally, as time spent sedentary or performing varying intensities of PA were
primary outcomes of interest for this study, adjustments for these measures were
performed when evaluating the relationship between measures of glycemic variability
and biological markers of oxidative stress. A p value of <0.05 was considered statistically
significant.
RESULTS
Participant Characteristics
Participant characteristics are shown in Table 5.1 for all participants and
separately for the WORDS and A-TEAM studies. Overall, participants were
approximately 70% female and 57% African American with 54% considered obese (BMI
≥30 kg/m2). Between the studies, participants only differed in the oxidative stress ratio
(p=0.03), but did not differ for any participant characteristic, anthropometric, PA, glucose
concentration, glycemic variability measurements, or concentration of oxidative stress
biological markers (p≥0.05; Table 5.1.).
Association between Sedentary Time and Physical Activity Measures with Glucose
Concentrations, Measure of Glycemic variability, and Biological Markers of
Oxidative Stress
The correlation between sedentary time and PA measures with glucose
concentrations, measures of glycemic variability, and biological markers of oxidative
stress are shown in Table 5.2. We observed negative correlations between LPA EE and
fasting and diurnal glucose concentrations, MVPA minutes and EE with diurnal glucose
concentration, and total PA minutes with 24-hour mean glucose concentration. In
addition, several other negative correlations between PA variables and glucose
concentrations and glycemic variability measures were of medium effect size (absolute r
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value>0.30), although statistically not significant (0.05<p<0.10), such as LPA and
MVPA minutes and EE with 24-hour mean glucose (0.05<p≤0.07 for all).
Following adjustment for age alone, negative correlations remained between LPA
EE and MVPA minutes and EE with diurnal glucose concentration, while negative
correlations between MVPA minutes and 24-hour mean glucose concentrations were
found (p<0.05 for all). However, after adjusting for BMI alone, all prior significant
correlations were no longer significant (p≥0.05 for all). Though, after adjustment for age
and BMI combined, LPA EE was found to be negatively correlated with diurnal glucose
concentrations (r=-0.43, p=0.04).
There were no significant correlations between sedentary time or any PA measure
with any glycemic variability measure (Table 5.2.). However, there were medium effect
size negative correlations between minutes of LPA and total PA with MAGE and
CONGA-4, while LPA EE also expressed a medium effect size negative correlation with
MAGE and CONGA-2 (0.31≤absolute r≤0.33, 0.10≤p≤0.14 for all). Yet, there were no
significant correlations between sedentary time and PA measures with concentrations of
nitric oxide or myeloperoxidase, which persisted after adjustment for age and/or BMI
(p≥0.06 for all).
We further examined the day-today variability in sedentary time and PA measures
expressed as the SD across valid SenseWear monitoring days with glucose
concentrations, glycemic variability, and oxidative stress, which is shown in table 5.3.
Interestingly, there were significant negative correlations between the SD of MVPA and
total PA minutes, as well as LPA and MVPA EE, with 24-hour mean, diurnal, and
nocturnal glucose concentrations (0.40≤absolute r≤0.53, p≤0.04 for all). Additionally,
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medium effect size correlations between the SD of MVPA minutes, LPA and MVPA EE
with MODD were observed, which persisted following adjustment for age and/or BMI
(absolute r≥0.30 for all). However, there was a significant negative correlation between
SD of LPA EE with the oxidative stress ratio (r=-0.39, p=0.04).
Association between Glucose concentrations and Measures of Glycemic Variability
with Biological Markers of Oxidative Stress
Correlations between glucose concentrations and measures of glycemic variability
with biological markers of oxidative stress are shown in Table 5.4. When examining the
relationship between glucose concentrations with biological markers of oxidative stress,
nitric oxide concentration and the oxidative stress ratio were found to be positively
correlated with fasting glucose concentration, which persisted after adjustment for age or
BMI (p≤0.04 for both), but no longer significant following adjustment for age and BMI
(p=0.07). Myeloperoxidase concentration was found to be negatively correlated with
fasting glucose concentration (r=-0.41, p=0.03), which persisted after adjustment for age
and/or BMI (p≤0.03 for all). Further, the oxidative stress ratio positively correlated with
fasting glucose concentration (r=0.60, p≤0.001), which persisted after adjustment for age
and/or BMI (p≤0.004 for all).
Furthermore, we examined the relationship between measures of glycemic
variability and biological markers of oxidative stress and found that myeloperoxidase
concentration was negatively correlated with MAGE, CONGA-2 and CONGA-4, which
remained following adjustment for age and/or BMI (p≤0.02 for all). However, neither
nitric oxide or myeloperoxidase concentrations significantly correlated with CONGA-1
or MODD measure of glycemic variability. Yet, after adjustment for age and/or BMI in
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the model, the oxidative stress ratio was positively correlated with MAGE, CONGA-1,
and CONGA-2 measures of glycemic variability (p<0.05 for all).
Lastly, to examine the role of time spent sedentary and performing PA on the
relationship between glucose concentrations and glycemic variability with biological
markers of oxidative stress, adjustments for sedentary time and all intensities of PA were
performed. Following this adjustment, nitric oxide and the oxidative stress ratio remained
positively correlated with fasting glucose concentration (p=0.04 and 0.001, respectively),
while myeloperoxidase remained negatively correlated with fasting glucose concentration
(p=0.02). Moreover, a positive correlation between the oxidative stress ratio and MAGE
presented itself (p=0.03), while myeloperoxidase remained negatively correlated with
MAGE (p=0.01), CONGA-2 (p=0.04), and CONGA-4 (p=0.04).
DISCUSSION
To our knowledge, this is the first study to examine the relationship between
objectively measured sedentary time and PA with CGM-assessed glucose concentrations
and glycemic variability, and biological markers of oxidative stress in sedentary,
overweight or obese adults. Notably, MVPA and total PA minutes were found to be
negatively correlated with 24-hour mean and diurnal glucose concentrations, while LPA
and MVPA EE were found to be negatively correlated with fasting and diurnal glucose
concentrations, respectively. However, no significant correlations were found between
sedentary time or PA measures with measures of glycemic variability. Yet, day-to-day
variability in PA minutes and EE of varying intensities were significantly positively
correlated with multiple glucose concentrations, while LPA EE negatively correlated
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with the oxidative stress ratio expressed as nitric oxide concentration÷myeloperoxidase
concentration.
Relationship between Sedentary Time and Physical Activity with Glucose
Concentrations, Glycemic Variability, and Oxidative Stress
Impaired fasting glucose concentration and glycemic control have been observed
during periods of decreased PA (Lipman RL, Raskin P, Love T, Triebwasser J, Lecocq
FR, & Schnure JJ, 1972). Most previous studies examining the impact of sedentary time
and PA measures with glycemic health have found beneficial effects of increasing PA of
any intensity and decreasing sedentary time on varying glucose concentrations (Sardinha
LB, Magalhães JP, Santos DA, & Júdice PB, 2017; Swindell N, Mackintosh K, McNarry
M, Stephens JW, Sluik D, Fogelholm M, Drummen M, MacDonald I, Martinez JA,
Handjieva-Darlenska T, Poppitt SD, Brand-Miller J, Larsen TM, Raben A, & Stratton G,
2018). However, few studies have examined this relationship utilizing objective,
accelerometry measured sedentary time and PA. One study examined the cross-sectional
associations between objectively measured sedentary and PA time with cardiometabolic
disease risk biomarkers in overweight or obese adults with type 2 diabetes and found that
LPA minutes per day was favorably associated with fasting glucose concentration (Healy
GN, Winkler EAH, Brakenridge CL, Reeves MM, & Eakin EG, 2015). Additionally, a
study conducted by Hamasaki et al., examined the association between objectively
assessed daily PA with metabolic risk factors in adults with prediabetes and untreated
early type 2 diabetes mellitus and found that PA level was negatively associated with
fasting glucose concentration (Hamasaki H, Noda M, Moriyama S, Yoshikawa R,
Katsuyama H, Sako A, Mishima S, Kakei M, Ezaki O, & Yanai H, 2015). These studies
support our findings that varying intensities of PA were favorably associated with fasting
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glucose concentration; however, our study further expanded the evidence to support this
relationship exists with 24-hour mean, diurnal, and nocturnal glucose concentrations.
Additionally, there exists limited evidence regarding the relationship between
objectively measured sedentary time and PA with glycemic variability. One crosssectional study performed by Gude et al., found that glycemic variability indices, which
included MAGE, CONGA-1, and MODD, were not associated with subjective
assessment of time spent sedentary or performing PA, utilizing the International Physical
Activity Questionnaire, in adults without type 2 diabetes mellitus, regardless of
categorized PA status, which included inactive, minimally active, and high active
categories (Gude F, Díaz-Vidal P, Rúa-Pérez C, Alonso-Sampedro M, Fernández-Merino
C, Rey-García J, Cadarso-Suárez C, Pazos-Couselo M, García-López JM, GonzalezQuintela A, 2017). Another study performed in type 1 diabetic adults found that
objectively assessed total PA time did not significantly correlate with glycemic
variability assessed as the standard deviation of the 24-hour mean glucose concentration
(Martyn-Nemeth P, Quinn L, Penckofer S, Park C, Hofer V, & Burke L, 2017).
Therefore, these studies are in line with our findings that increases in PA and their related
PA EE are not necessarily related to improvement in glycemic variability. However,
though in line with our findings, the inclusion of older adults, utilization of adults with
diagnosed type 1 and 2 diabetes, or the use of subjective assessment of time spent
sedentary and performing PA, do not allow for direct translation of their findings to ours.
Previous literature has expressed that decreases in sedentary time and increases in
leisure-time PA of varying intensities relate to improvements in antioxidants known to
decrease oxidative stress (Thosar SS, Johnson BD, Johnston JD, & Wallace JP, 2012).
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Additionally, increases in sedentary behavior have been linked to decreases in
endothelium-derived nitric oxide vasodilation (Demiot C, Dignat-George F, Fortrat JO,
Sabatier F, Gharib C, Larina I, Gauquelin-Koch G, Hughson R, & Custaud MA, 2007). In
our study, no measure of sedentary time or PA of any intensity were associated with
nitric oxide or myeloperoxidase concentration, or the oxidative stress ratio. A previous
study examined the relationship between subjective leisure-time PA EE (Metminutes/day) with antioxidants related to lower oxidative stress in adult females and
found that low-intensity, high-intensity, and total-intensity PA EE were positively
associated with antioxidant concentration (Covas M-I, Elosua R, Fitό M, Alcántara M,
Coca L, & Marrugat J, 2002). This illustrates that PA of varying intensities may be
related to decreases in oxidative stress; however, their study utilized subjective evaluation
of PA which has been shown to be unreliable for reproducibility (Sallis JF & Saelens BE,
2000), rather than objective accelerometer-based measurements, which provide a more
valid examination of this relationship.
Unexpectedly, increased day-to-day variability across daily average PA and EE of
varying intensities were significantly related to decreases in glucose concentrations, as
well as expressed medium effect size, though insignificant, relationships with MODD.
These findings suggest that increases in day-to-day variability in PA relate to decreased
glucose concentrations and inter-day glycemic variability. However, increases in day-today PA variability related to a decrease in the oxidative stress ratio, which suggests that
decreased variability in PA relates to lower oxidative stress.
Most studies have primarily examined day-to-day variability to assess habitual
sedentary time and PA, as multiple days are required, but have not focused on health
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outcomes related to these variability measures (Baranowski T & de Moor C, 2000).
Additionally, previous research suggests it is difficult to account for the day-to-day
variability in sedentary time and PA in adults, but has observed that stability or
variability in daily PA and their subsequent associations with aspects of physical health,
such as chronic disease and mortality, is equivocal (Maher JP, Huh J, Intille S, Hedeker
D, & Dunton GF, 2018). Data from the Harvard Alumni Health Study found that men,
without major risk factors, who sporadically engaged in PA (1-2 days per week), but met
recommended levels of PA (≥1000 kcal per week), had a lower relative risk of mortality
compared to men who were considered inactive, but similar to those considered
insufficiently active (500-999 kcal per week) or regularly active (≥1000 kcal per week;
>2 days per week) (Lee IM, Sesso HD, Oguma Y, & Paffenbarger Jr RS, 2004).
Moreover, a longitudinal study which examined insufficiently active, sporadically active,
and regularly active participants found similar reductions in risk for all-cause and
cardiovascular disease mortality compared to inactive participants (O’Donovan G, Lee
IM, Hamer M, & Stamatakis E, 2017). Therefore, the stability or variability in PA may
not directly relate to clinical implications in health outcomes associated with glycemic or
cardiovascular health if adherence to prevailing PA guidelines are fulfilled. As the
participants in our study were achieving on average ~65.5 minutes of MVPA per day
during the 7 days of SenseWear wear time, it may be generally accepted they were
meeting current PA guidelines (Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton
JE, Galuska DA, George SM, & Olson RD, 2018) regardless of the extent of their day-today PA variability. Even though there was notable day-to-day variability in sedentary
time and PA, higher PA variability may indicate more PA being performed on certain
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days as opposed to increased sedentary time on others. This aids in supporting our
findings that general participation in PA may potentially be more important for glycemic
health, rather than PA stability.
Relationship between Glucose Concentrations and Glycemic Variability with
Oxidative Stress
The relationship between glucose concentrations and glycemic variability with
oxidative stress has been evaluated primarily in type 1 and type 2 diabetics (Saisho Y
2014). Additionally, it has been shown that there exists long-term vascular complications
in diabetic patients during periods of chronic hyperglycemia, as well as those with greater
postprandial glucose fluctuations (Giugliana D, Ceriello A, & Paolisso G, 1996; Monnier
L, Mas E, Ginet C, Michel F, Villon L, Cristol J-P, & Colette C, 2006). However, no
studies have examined the relationship between glucose concentrations, glycemic
variability, and oxidative stress in sedentary, overweight or obese, but normoglycemic
adults.
Surprisingly, our study found that nitric oxide concentration, a potent vasodilator
and measure of vascular health, was positively associated, rather than negatively
associated, with fasting glucose concentration. Current evidence suggests
contraindicatory findings when examining the relationship between fasting glucose and
nitric oxide concentrations. It has been hypothesized that chronic hyperglycemia acts to
uncouple receptor-mediated signal transduction and decrease availability of nitric oxide
synthase substrates and cofactors essential for synthesis of nitric oxide (Honing MLH,
Morrison PJ, Banga JD, Stroes ESG, & Rabelink TJ, 1998). Li et al., found that
experimentally increased activation of the nitric oxide pathway partially contributed to
skeletal muscle glucose uptake (Li J, Hu X, Selvakumar P, Russell III RR, Cushman SW,
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Holman GD, & Young LH, 2004). Furthermore, Hoshiyama et al., found that
experimentally high-level glucose exposure reduced nitrite levels and subsequently
decreased nitric oxide production, but upregulated endothelial cell nitric oxide synthase
protein expression (Hoshiyama M, Li B, Yao J, Harada T, Morioka T, & Oite T, 2003).
These studies suggest that under hyperglycemic conditions, decreased nitric oxide
production may be due to reduced nitric oxide predecessors or nitric oxide synthase
agonists, and increased activation of nitric oxide scavengers acting to inactivate nitric
oxide synthase activity. However, Cosentino et al., provided evidence that experimentally
increased glucose exposure increased nitric oxide synthase and subsequent nitric oxide
release (Cosentino F, Hishikawa K, Katusic ZS, & Lüscher TF, 1997). More recently,
Adela et al., observed a positive relationship between fasting blood glucose and nitric
oxide concentration in patients diagnosed with type 2 diabetes mellitus, while also
providing evidence that experimentally high glucose exposure increases nitric oxide
production (Adela R, Nethi SK, Bagul PK, Baui AK, Mattapally S, Kuncha M, Patra CR,
Reddy PNC, & Banerjee SK, 2015). These findings suggest that the mechanisms by
which high glucose concentration simultaneously increases nitric oxide synthase
expression and production may be due to an increase in glucose-induced endothelial cell
nitric oxide gene expression and activation related to diminished vascular function in
those with impaired glycemic health. Based on previous findings, along with the findings
in our study, it may be hypothesized that, even in the absence of glycemic dysfunction,
participants with higher fasting glucose concentration may have higher activation of
nitric oxide synthase and in turn greater nitric oxide production compared to those with
lower fasting glucose concentration.
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Unexpectedly, myeloperoxidase concentration, a potent vasoconstrictor and
measure of declined vascular health, was negatively associated with not only fasting
glucose concentration, but MAGE, CONGA-2, and CONGA-4 measures of glycemic
variability. The relationship between glycemic health and myeloperoxidase has been
previously investigated but arrived at contradicting conclusions. Zhang et al., found that
fasting glucose and myeloperoxidase concentrations were positively associated, with
increases in glucose concentration directly relating to increases in myeloperoxidase
concentration in non-diabetic adults with acute coronary syndrome (Zhang X, Dong L,
Wang Q, & Xie X, 2015). However, Uchimura et al., found that fasting glucose
concentration was higher and myeloperoxidase concentration was lower in non-insulin
dependent type 2 diabetes mellitus compared to non-diabetic controls, but found no
relationship between fasting glucose and myeloperoxidase concentrations (Uchimura K,
Nagasaka A, Hayashi R, Makino M, Nagata M, Kakizawa H, Kobayashi T, Fujiwara K,
Kato T, Iwase K, Shinohara R, Kato K, & Itoh M, 1999). Furthermore, a previous study
in adult patients with type 2 diabetes mellitus who had either poor or optimal glycemic
control found that those with poor glycemic control had decreased myeloperoxidase
activity compared to those with optimal glycemic control (Unubol M, Yavasoglu I, Kacar
F, Guney E, Omurlu IK, Ture M, Kadikoylu G, & Bolaman Z, 2015). The authors
concluded that decreases in myeloperoxidase activity found in adults with non-insulin
dependent type 2 diabetes mellitus may be caused by diabetic complications due to the
altered state of free radical concentrations. Additionally, increased protein glycation in
type 2 diabetes patients with poor glycemic control may contribute to hyperglycemicassociated negative modulating enzymatic activity and loss of physiological function,
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which may subsequently lead to decreased myeloperoxidase, as previously described
(Brownlee M 2001; de Souza Ferreira C, Araújo TH, Ángelo ML, Pennacchi PC, Okada
SS, de Araújo Paula FB, Migliorini S, & Rodrigues MR, 2012). Thus, our results are
consistent with some of the literature; however, our participants were normoglycemic and
most previous literature have suggested these findings in adults with cardiovascular
complications or diagnosed with type 2 diabetes mellitus.
Strengths and Limitations
The primary strengths of this study include the use of the SenseWear Mini
Armband accelerometer to objectively measure sedentary time and PA, as well as CGM
technology to assess glycemic variability, which allows for the observation of a “freeliving” condition as opposed to standard clinical measures. The primary limitation is that
the participants were from a convenience sample, which makes the results only
generalizable to sedentary, overweight or obese individuals without overt diabetes that
are between the ages of 35 and 55 years. Another limitation was that diet was not fully
taken into account, as only self-report dietary intake was provided. However, we
recommended that each participant attempt to maintain their daily dietary routines during
the 7-day monitoring process. Alternatively, this was also considered a strength of the
study, as not controlling for diet provides insight into each participant’s “free-living”
glucose concentrations and glycemic variability. Other limitations include the small
sample size, which does not allow for analysis between sexes and races that may be
pertinent to address the relationships between outcomes of interest related to sedentary
time and PA with glycemic variability and oxidative stress.
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Conclusion
Our hypotheses were supported as there were significant relationships between
MVPA and total PA minutes with diurnal and 24-hour mean glucose concentrations, LPA
EE with fasting and diurnal glucose concentrations, and MVPA EE with diurnal glucose
concentrations. Additionally, medium effect size correlations were found between time
spent performing LPA and total PA with MAGE and CONGA-4 and LPA EE with
MAGE and CONGA-2. However, no significant relationships were found between
sedentary time or PA measures with nitric oxide or oxidative stress. Further, the SD of
daily MVPA and total PA minutes, and LPA and MVPA EE were negatively associated
with 24-hour, diurnal, and nocturnal glucose concentrations, while the SD of LPA EE
was found to be negatively correlated with the oxidative stress ratio. Additionally, nitric
oxide, myeloperoxidase, and the oxidative stress ratio were found to be associated with
fasting glucose concentration, while myeloperoxidase was found to be associated with
MAGE, CONGA-2, and CONGA-4. After adjustment for age and/or BMI, as well as
time spent sedentary or performing PA, many of the relationships remained significant,
which leads us to support our claims that sedentary time and participation in PA,
regardless of PA consistency, play a vital role in glycemic health, while glycemic
variability is related to oxidative stress.
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Table 5.1. Participant characteristics combined and by study involvement
Combined
WORDS (n=15)
A-TEAM (n=13)
(n=28)
Participant
characteristics
Age (years)
46.0±6.1
45.4±6.5
46.7±5.8
Sex (M/F)
8/20
3/12
5/8
Race (C/AA/AAA)
11/16/1
8/7/0
3/9/1
Height (m)
1.7±0.1
1.7±0.1
1.7±0.1
Body Weight (kg)
92.6±21.4
93.3±12.0
91.8±29.3
Body Mass Index
32.3±6.3
32.6±3.9
31.9±8.4
2
(kg/m )
Average daily
sedentary time and
physical activity
measures
23.4±0.5
23.4±0.5
23.4±0.6
Wear time (hours per
day)
Sedentary Time 717.2±124.0
717.3±61.5
717.2±170.9
(minutes per day)
LPA (minutes per
247.0±94.7
249.5±81.9
244.3±110.2
day)
65.5±42.2
74.6±47.0
55.7±35.6
MVPA (minutes per
day)
Total PA (minutes 312.5±121.8
321.1±109.3
300.0±137.4
per day)
4958.5±2015.8
3810.7±1154.2
LPA EE (kilojoules 4405.9±1728.6
per day)
MVPA EE 1605.9±1230.0
1962.4±1505.4
1221.9±717.5
(kilojoules per day)
Day-to-day
variability across
average daily
sedentary time and
physical activity
measures
Sedentary Time SD
113.8±65.8
101.0±36.2
127.6±86.9
(minutes per day)
LPA SD (minutes
61.4±29.1
59.7±29.0
63.2±30.3
per day)
MVPA SD (minutes
32.5±24.3
38.9±30.5
25.6±13.2
per day)
Total PA SD
74.5±36.6
73.2±35.4
75.8±39.2
(minutes per day)
LPA EE SD 1248.1±751.6
1336.8±908.1
1152.6±558.2
(kilojoules per day)
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MVPA EE SD 854.0±750.9
1072.2±958.8
619.1±332.4
(kilojoules per day)
Glucose
concentrations and
measures of
glycemic variability
CGM observations
276.2±7.8;
277.2±7.3; 96%
275.2±8.5; 95%
per day (n; % of
96%
max)
Fasting (mg/dL)
89.1±18.3
84.8±19.3
94.1±16.4
24-hour mean
101.2±16.7
99.4±12.1
103.0±21.0
(mg/dL)
Diurnal (mg/dL)
101.8±16.0
99.0±11.2
104.7±20.0
Nocturnal (mg/dL)
103.0±16.0
103.1±10.1
102.9±21.1
MAGE (mg/dL)
43.0±12.1
40.3±12.8
45.9±11.1
CONGA-1 (mg/dL)
19.3±5.0
18.6±5.5
20.0±4.4
CONGA-2 (mg/dL)
23.3±6.3
22.5±6.9
24.1±5.6
25.5±6.6
24.4±7.0
26.1±6.3
CONGA-4 (mg/dL)
MODD (mg/dL)
19.9±4.5
19.5±4.1
20.3±4.9
Oxidative stress
biological markers
Nitric oxide
75.6±40.9
62.3±47.8
91.0±25.0
(µmol/L)
25.2±8.2
26.8±8.7
23.2±7.6
Myeloperoxidase
(ng/mL)
Oxidative stress ratio
3.3:1
2.6:1
4.2:1*
(µmol/L:ng/mL)
Data presented as Mean±SD
M=male, F=female, C=Caucasian, AA=African American, AAA=Asian/Asian
American, PA=physical activity, LPA=light-intensity physical activity,
MVPA=moderate-to-vigorous-intensity physical activity, LPA EE=light-intensity
physical activity energy expenditure, MVPA EE=moderate-to-vigorous-intensity
physical activity energy expenditure, number of observations per day (n; % of
max)=(number of CGM observations per day/maximum observations per
day)×100, CONGA-1, 2, and 4=continuous overall net glycemic action of 1-hour,
2-hour, and 4-hour, MAGE=mean amplitude of glycemic excursion,
MODD=mean of daily differences, oxidative stress ratio=nitric oxide
concentration (µmol/L)÷myeloperoxidase concentration (ng/mL)
*p<0.05 significant difference between studies
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Table 5.2. Pearson product correlations between average daily sedentary time
and physical activity measures with glucose concentrations, measures of
glycemic variability, and biological markers of oxidative stress
Energy
expenditure
Time spent sedentary time performing
and physical activity (minutes per day) (kilojoules per
day)
Sedentary

LPA

MVPA

Total
PA

LPA
EE

MVP
A EE

Fasting

0.25
(0.20)

-0.31
(0.12)

-0.36
(0.06)

-0.36
(0.06)

-0.41
(0.03)

-0.35
(0.07)

24-hour mean

0.28
(0.16)

-0.37
(0.07)

-0.39*
(0.05)

-0.41
(0.04)

-0.37
(0.06)

-0.36
(0.07)

Diurnal

0.25
(0.22)

-0.30
(0.13)

-0.42*
(0.03)

-0.36
(0.07)

-0.42*‡
(0.03)

-0.41*
(0.04)

Nocturnal

0.26
(0.21)

-0.34
(0.09)

-0.35
(0.08)

-0.37
(0.06)

-0.37
(0.06)

-0.32
(0.11)

MAGE

0.12
(0.56)

-0.33
(0.10)

-0.18
-(0.39)

-0.31
(0.12)

-0.30
(0.14)

-0.16
(0.42)

CONGA-1

0.03
(0.87)

-0.23
(0.26)

-0.10
(0.62)

-0.21
(0.30)

-0.26
(0.19)

-0.12
(0.54)

CONGA-2

0.12
(0.56)

-0.29
(0.15)

-0.17
(0.40)

-0.28
(0.16)

-0.30
(0.14)

-0.17
(0.40)

CONGA-4

0.19
(0.34)

-0.33
(0.10)

-0.19
(0.35)

-0.32
(0.12)

-0.27
(0.19)

-0.15
(0.48)

MODD

0.07
(0.73)

-0.11
(0.59)

-0.19
(0.36)

-0.15
(0.48)

-0.13
(0.53)

-0.16
(0.43)

0.18
(0.37)

-0.11
(0.60)

-0.17
(0.39)

-0.14
(0.48)

-0.14
(0.48)

-0.10
(0.61)

Glucose
concentrations
(mg/dL)

Measures of glycemic
variability (mg/dL)

Oxidative stress
biological markers
Nitric oxide
(µmol/L)
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Myeloperoxidase
(ng/mL)

0.00
(0.99)

-0.00
(0.98)

-0.05
(0.78)

-0.02
(0.91)

0.10
(0.62)

0.07
(0.71)

Oxidative stress
0.19
-0.13
-0.12
-0.14
-0.19
-0.10
ratio
(0.35)
(0.52)
(0.56)
(0.48) (0.34) (0.62)
(µmol/L:ng/mL)
Data represented as correlation coefficient (p value) with bolded entries
corresponding to significant values (p<0.05)
PA=physical activity, LPA=light-intensity physical activity, MVPA=moderate-tovigorous-intensity physical activity, LPA EE=light-intensity physical activity
energy expenditure, MVPA EE=moderate-to-vigorous-intensity physical activity
energy expenditure, METs=metabolic equivalents
*p<0.05 following adjustment for age; ‡p<0.05 following adjustment for age and
BMI

146

Table 5.3. Pearson product correlations between day-to-day variability,
expressed as SD, across daily average sedentary time and physical activity
measures with glucose concentrations, measures of glycemic variability, and
biological markers of oxidative stress
Energy
expenditure
Time spent sedentary time performing
and physical activity (minutes per day) (kilojoules per
day)
Sedentary

LPA

MVPA

Total
PA

LPA
EE

MVP
A EE

Fasting

0.26
(0.20)

-0.19
(0.35)

-0.34
(0.08)

-0.22
(0.27)

-0.37
(0.06)

-0.38
(0.05)

24-hour mean

0.01
(0.95)

-0.35
(0.08)

-0.45*
(0.02)

-0.40
(0.04)

-0.49*†‡
(0.01)

Glucose
concentrations
(mg/dL)

Diurnal

Nocturnal

-0.09
(0.64)

-0.06
(0.76)

-0.35
(0.08)

-0.37
(0.07)

-0.53*†‡
(0.01)
-0.48*†‡
(0.01)

-0.43
(0.03)

-0.41
(0.03)

-0.53*†‡
(0.01)
-0.52*†‡
(0.01)

0.43*
†

(0.03)
0.49*
†‡

(0.01)
0.45*
†‡

(0.02)
Measures of glycemic
variability (mg/dL)
MAGE

0.07
(0.73)

-0.23
(0.25)

-0.21
(0.31)

-0.19
(0.35)

-0.23
(0.27)

-0.18
(0.39)

CONGA-1

0.06
(0.79)

-0.20
(0.32)

-0.17
(0.42)

-0.14
(0.50)

-0.20
(0.32)

-0.16
(0.44)

CONGA-2

0.07
(0.72)

-0.19
(0.35)

-0.17
(0.41)

-0.15
(0.48)

-0.19
(0.36)

-0.13
(0.51)

CONGA-4

0.04
(0.86)

-0.23
(0.26)

-0.18
(0.37)

-0.18
(0.39)

-0.19
(0.34)

-0.12
(0.54)

MODD

0.10
(0.62)

-0.14
(0.49)

-0.37
(0.07)

-0.27
(0.19)

-0.39
(0.06)

-0.32
(0.11)

Oxidative stress
biological markers
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Nitric oxide
(µmol/L)

0.14
(0.50)

-0.13
(0.50)

-0.32
(0.10)

-0.21
(0.28)

-0.27
(0.17)

-0.26
(0.19)

Myeloperoxidase
(ng/mL)

-0.10
(0.63)

0.18
(0.38)

0.16
(0.41)

0.18
(0.37)

0.39†‡
(0.05)

0.31†‡
(0.11)

Oxidative stress
0.26
-0.23
-0.31
-0.32
-0.29
-0.39
ratio
(0.18)
(0.25)
(0.11)
(0.10)
(0.04) (0.14)
(µmol/L:ng/mL)
Data represented as correlation coefficient (p value) with bolded entries
corresponding to significant values (p<0.05)
PA=physical activity, LPA=light-intensity physical activity, MVPA=moderate-tovigorous-intensity physical activity, LPA EE=light-intensity physical activity
energy expenditure, MVPA EE=moderate-to-vigorous-intensity physical activity
energy expenditure, METs=metabolic equivalents
*p<0.05 following adjustment for age; †p<0.05 following adjustment for BMI;
‡p<0.05 following adjustment for age and BMI
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Table 5.4. Pearson product correlations between glucose concentrations and
measures of glycemic variability with biological markers of oxidative stress
Oxidative stress biological markers
Nitric oxide
(µmol/L)

Myeloperoxidase
(ng/mL)

Oxidative stress
ratio
(µmol/L:ng/mL)

Fasting

0.65*†§
(<0.001)

-0.41*†‡§
(0.03)

0.60*†‡§
(<0.001)

24-hour mean

0.17
(0.39)

-0.32
(0.11)

0.33
(0.09)

Diurnal

0.19
(0.34)

-0.23
(0.25)

0.28
(0.16)

Nocturnal

0.10
(0.63)

-0.34
(0.09)

0.30
(0.13)

MAGE

0.14
(0.48)

-0.46*†‡§
(0.02)

0.34*†‡§
(0.08)

CONGA-1

0.10
(0.61)

-0.35
(0.08)

0.28†‡
(0.16)

CONGA-2

0.08
(0.66)

-0.39§
(0.04)

0.27*†
(0.18)

CONGA-4

0.15
(0.46)

-0.38†‡§
(0.04)

0.30
(0.13)

MODD

0.26
(0.21)

-0.29
(0.15)

0.32
(0.11)

Glucose concentrations
(mg/dL)

Measures of glycemic
variability (mg/dL)

Data represented as correlation coefficient (p value) with bolded entries
corresponding to significant values (p<0.05)
*p<0.05 following adjustment for age; †p<0.05 following adjustment for BMI;
‡
p<0.05 following adjustment for age and BMI; §p<0.05 following adjustment for
time spent sedentary and performing LPA, MVPA, and total PA
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CHAPTER 6
MANUSCRIPT 3-EFFECT OF A 12-WEEK AEROBIC EXERCISE INTERVENTION
ON GLYCEMIC VARIABILITY, VASCULAR HEALTH, AND OXIDATIVE STRESS
IN OVERWEIGHT OR OBESE ADULTS-A PILOT STUDY3

3
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ABSTRACT
Introduction: The state of being overweight or obese leads to an increased risk of
development of cardiometabolic disease. Increases in glycemic variability have been
associated with greater induction of oxidative stress and decreased vascular health, which
may be exacerbated by higher weight status and improved through exercise. The purpose
was to examine the impact of a 12-week aerobic exercise intervention on glycemic
variability, vascular health, and oxidative stress in overweight or obese adults.
Methods: Eight overweight or obese adults (BMI=29.4±8.3 kg/m2; age=48.9±5.2 years;
mean±SD) completed a 12-week aerobic exercise intervention. Participants walked 3
times per week at moderate intensity and expended 10-12 kilocalories per kilogram of
body weight each week. All participants wore a continuous glucose monitor (CGM) and
completed a daily dietary intake diary for 7 consecutive days at baseline and postintervention. On the final day of monitoring, a fasting blood sample was collected and an
oral glucose tolerance test (OGTT) was performed. Intra- and inter-day glycemic
variability was assessed as the mean amplitude of glycemic excursions, continuous
overlapping net glycemic action of 1-, 2-, and 4-hour, and the mean observation of daily
differences. Vascular health and oxidative stress markers, plasma concentrations of nitric
oxide and myeloperoxidase, were measured, and their ratio was calculated.
Results: No OGTT glucose concentrations or measures of glycemic variability changed
from baseline to post-intervention. However, myeloperoxidase concentration decreased
(24.8±8.2 ng/mL to 16.4±4.6 ng/mL, p<0.01) and the ratio of nitric oxide concentration
to myeloperoxidase concentration improved (3.5:1 to 6.4:1, p<0.01), while average daily
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mealtime was delayed (13:30±00:40 hours to 14:00±00:39 hours, p=0.02) following the
12-week intervention.
Conclusion: Twelve weeks of aerobic exercise reduced oxidative stress and improved the
ratio of nitric oxide concentration to myeloperoxidase concentration, but not glucose
concentrations or glycemic variability in this group of overweight or obese non-diabetic
adults.
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INTRODUCTION
The prevalence of adults in the United States who are considered overweight or
obese continues to rise with ~40% of the population designated obese in 2015-2016
(Centers for Disease Control and Prevention, 2017). Obesity is widely considered a major
public health crisis of the current generation (Finkelstein EA, Trogdon JG, Cohen JW, &
Dietz, W, 2009; Flegal MF, Kruszon-Moran D, Carroll MD, Fryar CD, & Ogden CL,
2016; Centers for Disease Control and Prevention, 2017). Overweight and obesity-related
cardiometabolic disorders lead to an increased medical care cost, such as for treatment of
impaired glycemic health and diagnosed cardiovascular disease (CVD) risk factors (Bray
GA, 2004; O’donovan G, Kearney EM, Nevill AM, Woolf-May K, & Bird SR, 2005).
Previous findings from a large community-based cohort study found that body
mass index (BMI) positively correlated with circulating biological markers of oxidative
stress (Keaney Jr JF, Larson MG, Vasan RS, Wilson PWF, Lipinska I, Corey D, Massaro
JM, Sutherland P, Vita JA, & Benjamin EJ, 2003). Oxidative stress is preceded by an
increased exposure to reactive oxygen species, and damage to proteins, nucleic acids, and
cell membranes, and has been implicated in the pathogenesis related to increased CVD
risk factors, such as impaired vascular health, and subsequent CVD (Witztum JL &
Steinberg D, 1991; Ohara Y, Peterson TE, & Harrison DG, 1993; Stortz G & Imlay JA,
1999; Cooke J 2004). Previously, oxidative stress was believed to be a key regulator in
the development of diabetic complications (Baynes JW, 1991); however, evidence has
suggested that an increase in oxidative stress is triggered by exacerbated oscillations in
glucose concentrations (Hirsch IB & Brownlee M, 2005; Monnier L, Mas E, Ginet C,
Michel F, Villon L, Cristol JP, & Colette C, 2006). These exacerbated glucose
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oscillations, known as glycemic variability, act to induce stress on the vascular
endothelium and elicits endothelium-derived micro and macrovascular complications,
which potentially increases CVD risk (Johnson EL 2013). In fact, the interaction between
increased glycemic variability and elevated oxidative stress has recently been proposed as
a mechanism for increased CVD risk and CVD progression in adults with and without
diagnosed diabetes (Saisho Y 2014; Gorst C, Kwok CS, Aslam S, Buchan L,
Kontopantelis E, Myint PK, Heatlie G, Loke Y, Rutter MK, & Marna MA, 2015).
Greater glycemic variability, impaired vascular health, and increased oxidative
stress have both been observed independently in overweight or obese adults in the
presence and absence of diagnosed diabetes or CVD (Poirier P, Giles TD, Bray GA,
Hong Y, Stern JS, Pi-Sunyer X, & Eckel RH, 2006; Vincent HK, Innes KE, & Vincent
KR, 2007; Fysekidis M, Cosson E, Banu I, Duteil C, & Valensi P, 2014). Exercise is
often utilized as a therapeutic treatment for overweight or obesity related insulin
resistance and cardiovascular strain (Goodyear LJ & Kahn BB, 1998; Hawley JA, 2004;
Church T, 2011). Exercise training in overweight or obese adults in the presence or
absence of diabetes, elicits beneficial alterations in fasting glucose concentrations,
glucose tolerance during an oral glucose tolerance test (OGTT), and glucose regulation
during glycemic clamp procedures independent of changes in body weight or
cardiorespiratory fitness (CRF) (Swartz AM, Strath SJ, Bassett Jr DR, Moore JB,
Redwine BA, Groër M, & Thompson DL, 2003; Cox KL, Burke V, Morton AR, Beilin
LJ, & Puddey IB, 2004; King DS, Dalsky GP, Clutter WE, Young DA, Staten MA, Cryer
PE, Holloszy JO 1988). Yet, past studies have been largely limited to laboratory-based
assessment of glucose metabolism and tolerance. Recent advancements in continuous
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glucose monitor (CGM) technology allows for the inclusion of a free-living condition,
which enables further determination as to how exercise influences glucose concentrations
and glycemic variability throughout the day.
Using CGM, Mikus et al. (2012), found that the frequency, magnitude, and
duration of the number of glycemic excursions each day were decreased over the final 3
days of a 7-day aerobic exercise training program compared to 3 days of performing
habitual exercise in non-insulin dependent type 2 diabetes mellitus patients (Mikus CR,
Oberlin DJ, Libla J, Boyle LJ, & Thyfault JP, 2012). Another study by Farabi et al.
(2015) found that a single 30-minute bout of aerobic exercise reduced diurnal glycemic
variability and urinary isoprostanes, a biological marker of oxidative stress, in obese
adults diagnosed with type 2 diabetes mellitus or impaired glucose tolerance (Farabi SS,
Carley DW, Smith D, & Quinn L, 2015). Thus, the majority of research examining
glycemic variability and oxidative stress has focused on diabetic populations with even
fewer studies examining changes due to exercise training (Tereda T, Friesen A, Chahal
BS, Bell GJ, McCargar LJ, & Boulé NG, 2013; Van Dijk J-W, Manders RJ, Canfora EE,
van Mechelen WV, Hartgens F, Stehouwer CD & van Loon LJC, 2015).
Overweight or obese adults without diabetes may already have greater glycemic
variability and oxidative stress, and impaired vascular health, but it is unknown whether
they can be changed by exercise training in this population. Therefore, the primary
purpose of this study was to examine glucose concentrations and glycemic variability
using CGM in overweight or obese non-diabetic adults undergoing 12-weeks of
moderate-intensity aerobic exercise. A secondary purpose was to evaluate the effects of
the aerobic exercise intervention on biological markers of vascular health, nitric oxide, a
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potent vasodilator, and oxidative stress, myeloperoxidase, a potent vasoconstrictor. We
also examined changes in body weight, CRF, and dietary intake following the aerobic
exercise intervention, as changes in these measures may influence outcomes of interest
(Gaesser GA, Tucker JW, Jarrett CL, Catherine L, & Angadi SS, 2015; Pronk NP, 2015).
METHODS
Design Overview
The Aerobic Treadmill Exercise and Metabolism (A-TEAM; NCT: 03162991)
study openly recruited from October 2017 to December 2018. The study protocol was
approved by the University of South Carolina Institutional Review Board and all
participants signed an informed consent form prior to participation. All participant visits,
testing, and exercise sessions were completed and supervised by the same trained
research staff and took place in the Clinical Exercise Research Center (CERC) housed
within the Norman J. Arnold School of Public Health at the University of South Carolina.
Participants
Participants were not physically active (˂120 minutes of resistance or moderateintensity endurance exercise per week during the previous 3 months), overweight or
obese (25≤BMI≤40 kg/m2) males and females, age 35-55 years, weight stable (±2%)
during the previous 3 months, and, for females, eumenorrheic. Exclusion criteria included
any self-reported medical conditions such as diabetes or taking medications that are
known to affect metabolism (e.g. statins), CVD, chronic or recurrent respiratory
conditions, including uncontrolled asthma or chronic obstructive pulmonary disease, or
active cancer. Individuals self-reporting diagnosed eating or neurological disorders, and
psychological issues, including but not limited to untreated depression and attention
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deficit disorder were also excluded. Additionally, excessive caffeine use (>500 mg/day),
smoking during the past year, pregnant or lactating females, and/or unwillingness to
provide informed consent were other reasons for exclusion.
A total of 64 participants were initially screened by telephone (Figure 6.1.). Ten
participants began the exercise intervention, with 8 completing the 12-week exercise
intervention. The 2 participants who dropped-out during the intervention completed 1 and
11, or ~3% and 30%, of the intervention visits, respectively. These participants did not
provide specific reasons why they dropped-out and discontinued the study, as they ceased
correspondence and were unable to be contacted to reschedule their intervention visits.
Therefore, the 8 participants that completed the intervention were included in this
analysis.
Intervention
Participants walked on treadmills 3 times per week in the CERC under
supervision. Each week, participants had their body weight measured, which was utilized
to calculate weekly exercise volume by multiplying each participants’ body weight by
10-12 kilocalorie per kilogram of body weight each week (KKW). The frequency of the
intervention visits was established as increases in exercise frequency has previously been
shown to be a determinant of physiological responses to exercise training once 3 times
per week have been achieved (Shephard RJ, 1968). As the participants in our study were
not engaging in structured physical activity prior to the exercise intervention, 3 times per
week was also chosen to limit exercise-related overuse injuries. The exercise volume was
achieved by varying the duration, speed, and grade to reach each participants’ weekly
energy expenditure goal while maintaining moderate-intensity treadmill walking, which
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was closely monitored throughout the 12-week intervention. Twelve weeks of aerobic
exercise training has been previously studied and is considered a duration that
physiological adaptations to aerobic exercise tend to occur (Ho SS, Dhaliwal SS, Hills
AP, & Pal S, 2012). The prescribed training volume, 10-12 KKW, is a higher volume of
aerobic exercise energy expenditure compared to current physical activity guidelines,
which equates to 8 KKW (Morss GM, Jordan AN, Skinner JS, Dunn AL, Church TS,
Earnest CP, Kampert JB, Jurca R, & Blair SN, 2004; Sisson SB, Katzmarzyk, Earnest
CP, Bouchard C, Blair SN, & Church TS, 2009; Rosenkilde M, Reichkendler MH,
Auerbach P, Bonne TC, Sjödin A, Ploug T, & Stallknecht BM, 2015; Piercy KL, Troiano
RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, & Olson RD, 2018).
To monitor adherence to the exercise prescription, the energy expenditure of each
exercise session was calculated using the American College of Sports Medicine formula:
{0.1×(speed[miles per hour] ×26.8)+1.8×(speed[miles per hour]
×26.8)×grade(%)+3.5}×body weight(kg)÷5(L per minute)×time(minutes) (American
College of Sports Medicine, 2017).
All exercise intervention visits were completed and supervised by trained research
staff members at the University of South Carolina. Due to the physically inactive state of
the participants, the exercise intensity and weekly energy expenditure were gradually
increased to reduce risk of injury. Training intensity increased during the first 4 weeks of
the exercise intervention until the target level of 50-55% of participant’s heart rate
reserve (HRR) was met, calculated as {[(peak heart rate-resting heart rate)×intensity (5055%)]+resting heart rate}, which was determined during the baseline graded exercise
test. Participants began at a weekly energy expenditure of 6-8 KKW during the first week
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of the intervention and then progressed until week 4 when they attained their weekly
energy expenditure of 10-12 KKW. Each exercise session began and ended with a 3minute warm-up and cool-down. Heart rate (HR) monitors (FT1; Polar, Lake Success,
NY, USA) were worn to monitor exercise intensity continuously throughout each
exercise session and HR was recorded every five minutes. If HR monitors were unable to
detect HR, manual palpation at the radial artery was measured for 30-60 seconds. Blood
pressure was measured before, during warm-up, at the mid-point of the exercise session,
during cool-down, and following each exercise session.
Compliance to prescribed exercise intervention (frequency, intensity, and
duration) for each participant was reviewed weekly and any participant missing an
exercise session without notifying study personnel was contacted via phone or e-mail to
reschedule and encourage further attendance.
Measurements and Testing
Height, Body weight, and Body Mass Index (BMI)
Height and body weight were measured at the first baseline and post-intervention
visit using a stadiometer and an electronic scale that was calibrated annually (CC
Vaughan & Sons, Incorporated, Columbia, SC). Additionally, body weight was collected
weekly throughout the 12-week intervention. BMI was calculated at baseline and postintervention utilizing their respective height and body weight and the following equation:
BMI(kg/m2)=Body Weight(kg)÷[Height(m)]2.
Graded Exercise Test
All participants performed a maximal graded exercise test on a treadmill at
baseline and post-intervention. A ramped medium protocol was determined to be ideal
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for these participants as it is an incremental protocol where speed and grade increase
linearly every 30-60 seconds until each participant reached volitional fatigue (Hsia D,
Casburi R, Pradhan A, Torres E, & Porszasz J, 2009). Volume of oxygen consumed
(V̇O2) via metabolic cart (TrueOne 2400, ParvoMedics, Salt Lake City, UT) and HR
using standard 12-lead electrocardiogram (Q-Stress®; Cardiac Science, Bothell, WA,
USA) were monitored continuously during the progression of the test. Blood pressure
was measured, and rating of perceived exertion was obtained every two-minutes during
the test. Two of four generally recognizable criteria for the test to be considered
satisfactory needed to be achieved: a respiratory exchange ratio ≥1.10; a rating of
perceived exertion ≥17 on the Borg scale ranging from 6-20; achieving a maximum heart
rate >90% age-predicted maximum HR (220-age); and/or a plateau in absolute V̇O2 ≤150
ml/min with an increase in exercise intensity. Relative peak oxygen consumption
(V̇O2peak; ml/kg/min) was determined by the highest 30-second average V̇O2 value
measured during the test. All graded exercise tests took place after 12:00 hours and
minimum of 24 hours after the final day of the CGM monitoring period.
CGM Placement, Instruction, and Monitoring
A Dexcom G4 Platinum Professional CGM device (San Diego, CA, USA) was
used to assess interstitial glucose concentrations over 7 consecutive days at baseline and
post-intervention. At the first baseline and post-intervention visit participants reported to
the CERC for placement and instruction of use for the CGM device by trained research
staff. At post-intervention, the CGM device was placed a minimum of 72 hours after the
last exercise session to limit to influence of the last exercise session on glucose
concentrations. Participants had a catheter inserted under the skin, approximately 2 cm to
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the side of the umbilicus, on the preferred side of the abdomen with an attached sensor
and transmitter. They were instructed to carry a recording device which received and
stored interstitial glucose concentration readings every 5 minutes over the 7 consecutive
days. This specific CGM device model requires participants to manually perform a
capillary blood measurement by fingerstick using a provided glucometer twice a day
during days of wear per manufacture instructions. Participants were instructed on how to
perform a capillary blood measurement and enter the glucometer readings into the CGM
device.
The Dexcom G4 Platinum Professional CGM device has been validated and
proven accurate against directly evaluated blood glucose concentrations (Facchinetti A,
Favero SD, Sparacubi G, & Cobelli C, 2015). The CGM device was blinded so that
participants could not observe the live readings to deter any alterations in diet, physical
activity, or general lifestyle, and participants were requested to maintain their normal
daily routine during the 7-day monitoring period at baseline and post-intervention. On the
final day of the 7-day monitoring period, participants reported back to the CERC to
complete a 2-hour OGTT and have the device removed. Data were considered valid for
analysis if data were obtained by the device for at least 5 days including at least one
weekend day, with a minimum available glucose measure over 20 hours, which equated
to a minimum 240 out of a possible 288 glucose readings each day. Software provided by
the manufacturer (Dexcom Studio 12.0.4.6) was used to download and export CGM data
to Excel datafiles.
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Oral Glucose Tolerance Test (OGTT)
The OGTT was conducted following an overnight fast (~12 hours other than
water), participants reported to the CERC and had a venous blood sample collected. Time
was recorded and matched with the CGM to establish fasting glucose time point.
Following the venous blood collection, participants were instructed to consume a
standard 10-ounce, 75-gram glucose infused drink (Azer Scienmtific, Morgantown, PA)
within 5 minutes and the time consumption completed was recorded. Every 30-minutes
afterwards, time was recorded until 2 hours were complete (Fasting, 30-, 60-, 90-, and
120-minutes post-consumption), which is the standard procedure for a 75-gram OGTT
(Institute for Quality and Efficiency in Healthcare, 2011). During the OGTT, participants
were instructed to limit their physical movement, unless necessary, to lessen the impact
of muscle contraction on glucose concentrations. Glucose concentrations during the
OGTT were determined by the CGM device rather than from blood samples. If any of the
time points fell between CGM glucose concentration readings, as the CGM assesses
glucose concentrations every 5 minutes, the average between the previous and following
CGM concentration readings were calculated. The CGM-assessed glucose concentrations
have been validated with venous blood glucose concentrations (Kovatchev B, Anderson
S, Heinemann L, & Clarke W, 2008). OGTT AUC was calculated utilizing the equation
Glucose AUC=1/2×30×(yFasting+2y30+2y60+2y90+y120), where y represents glucose
concentration at the different time points (Tai MM, 1994). All OGTTs took place
between 06:00 and 09:00 HH:MM and at least 72 hours after the last bout of aerobic
exercise at post-intervention.
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Daily Dietary Intake
Daily dietary intake was recorded at baseline and post-intervention during the
same 7 consecutive days as the CGM monitoring and all participants were instructed to
continue their normal daily dietary routine during this time. All participants self-reported
calorie consumption, including any calorie containing beverages or snacks and time of
consumption for standard meals (breakfast, lunch, dinner, and snacks). In order to do this,
they were instructed on basic measurement of portion sizes to aid in recording of each
meal using the MyFitnessPal application (MyFitnessPal, Inc.) that is available on
smartphone devices or computer based. If a smartphone or computer was unavailable,
participants were provided a self-report paper form to record any calorie containing food
or drink consumed, including portion size, calories, and macronutrient breakdown
(carbohydrate, protein, and fat) utilizing The Calorie King® Calorie Counter (Borushek
A, 2015). Calorie intake, macronutrient breakdown, and time of consumption were
calculated for each standard meal and the total of each day’s standard meals was
calculated for each valid recording day, which was analyzed as an average of those valid
days. Additionally, the standard deviation (SD) of daily dietary intake across all valid
days were calculated as a measure of day-to-day variability.
Previously, habitual dietary intake has been related to fasting and OGTT glucose
concentrations, as well as biological markers of oxidative stress (Feskens EJ & Kromhout
D, 1990; Kleemola P, Freese R, Jauhiainen M, Pahlman R, Alfthan G, & Mutanen M,
2002). Therefore, potential changes in habitual dietary intake and their influence on
glucose concentrations, glycemic variability, and oxidative stress need to be considered.
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Glucose Concentrations
Twenty-four-hour mean, diurnal, nocturnal, pre- and post-waking, and post-meal
glucose concentrations were calculated for each valid day and expressed as the average
across those days. 24-hour mean glucose concentration was assessed from midnight to
midnight for each valid day. Diurnal and nocturnal glucose concentrations were assessed
each valid day during each participants’ self-reported time-in-bed and time out of bed.
Further, analysis of exploratory measures of glucose metabolism were performed for prewaking, waking, post-waking, and post-meal glucose concentrations.
Pre- and post-waking time-point glucose concentrations were established as 1-, 2-,
and 3-hour time points prior to and after waking time-point, while pre- and post-waking
average glucose concentrations were established as the average of over 1-, 2-, and 3-hour
periods prior to and after waking time-point. These time points and periods were chosen
as they potentially relate to episodes of nocturnal hypoglycemia and subsequent risk of
rebound hyperglycemia, also described as the Somogyi effect, previously observed in
insulin-treated diabetic patients (Campbell IW, 1976; Gale EA, Kurtz AB, & Tattersall
RB, 1980). After awakening, none of the participants consumed any calorie containing
food or drink items within the 3-hour post-waking timeframe on each valid day utilized.
However, most participants reported coffee (caffeine) consumption within 2 hours postwaking, with none reporting calorie containing additive, such as sugar, milk, or creamer.
Post-meal glucose concentrations were assessed over a 2-hour time period
following subjectively recorded time of consumption for each participants’ breakfast,
lunch, dinner, and snacks, as well as the average of all meals combined for total daily
dietary consumption. In the same fashion as the OGTT, glucose concentrations at time

174

points 0-, 30-, 60-, 90-, and 120-minutes were determined and AUC was calculated for
each valid day, with the average across those days utilized for analysis.
Glycemic Variability
The continuous overlapping net glycemic action of 1-hour, 2-hour, and 4-hour
(CONGA-1, CONGA-2, and CONGA-4) was calculated in Excel. CONGA-1, CONGA2, and CONGA-4 were calculated as the standard deviation of the difference between
each observation and the previous 1-hour, 2-hour, and 4-hour observations (McDonnell
CM, Donath SM, Vidmar SI, Werther GA, & Cameron FJ, 2005; Nathan DM, Kuenen J,
Borg R, Zheng H, Schoenfeld D, & Heine RJ, 2008; Kuenen JC, Borg R, Zheng H,
Schoenfeld D, Heine RJ, & Nathan DM, 2011). CONGA-1, CONGA-2, and CONGA-4
were chosen for this study because the 1-hour, 2-hour, and 4-hour time periods
approximates the time intervals between different activities (CONGA-1), time between
snacks (CONGA-2), and time between meals (CONGA-4), respectively (McDonnell CM,
Donath SM, Vidmar SI, Werther GA, & Cameron FJ, 2005). To calculate the mean
amplitude of glycemic excursion (MAGE) and mean of daily differences (MODD)
measures of glycemic variability the Excel data were transferred into the EasyGV
Version 9.0.R2 (University of Oxford, Oxford, England, UK), which is an Excel-enabled
workbook that utilizes macros. MAGE and CONGA-1, CONGA-2, and CONGA-4 were
measurements of intra-day glycemic variability for each valid day of wear time and
averages of those days calculated. MAGE was calculated for each subject by taking the
arithmetic mean of increased or decreased glucose concentrations (nadirs and peaks or
vice-versa) when both ascending and descending concentration exceeds one standard
deviation for the same 24-hour monitoring period (Service FJ, Molnar GD, Rosevear JW,
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Ackerman E, Gatewood LC, & Taylor WF, 1970; Service FJ & Nelson RJ, 1980; Service
FJ, O’Brien PC, & Rizza RA, 1987). MODD served as a measurement of inter-day
glycemic variability, which was calculated for each two consecutive day period and
averaged to include all valid days over the seven-day monitoring period. MODD
accounts for the mean of absolute differences between glucose concentrations obtained at
the same time of day on consecutive days (Rodbard D, Matsubara B, Nakamura K,
Bailey T, Jovanovic L, Zisser H, Kaplan R, & Garg SR, 2009).
Biological Markers of Vascular Health and Oxidative Stress
Fasting venous blood samples were collected and used to determine biological
markers of vascular health and oxidative stress. Blood samples were collected into a BD
Vacutainer EDTA plasma collection tube. Immediately following collection, blood
samples were centrifuged at 3000 rpm and 4ºC for 20 minutes immediately following
collection. Plasma separated after centrifugation were aliquoted into 1.5mL
centrifugation tubes and stored at -80ºC until all participant’s samples were ready for
analysis. Prior to analysis, plasma samples were thawed and re-centrifuged at 3000 rpm
and 4ºC for 20 minutes to ensure separation of any particulate.
Nitric oxide, which acts as a potent vasodilator and measure of vascular health
(Palmer RMJ, Ashton DS, & Moncada S, 1988), and myeloperoxidase, a potent
vasoconstrictor and measure of oxidative stress (Klebanoff SJ, 2005), were measured
using two separate enzyme-linked immunoabsorbant assays (ELISA). These biological
markers of vascular health and oxidative stress were chosen for this study as they have
previously been observed to be related to measures of glycemic health in adults
diagnosed with type 2 diabetes mellitus (Kingwell BA, Formosa M, Muhlmann M,
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Bradley SJ, & McConell GK, 2002; Unubol M, Yavasoglu I, Kacar E, Omurlu IK, Ture
M, Kadikoylu G, & Bolaman Z, 2015).
The nitric oxide ELISA kit (ThermoFicher Scientific, Waltham, MA)
quantitatively determines the concentrations of nitrate and nitrite in plasma samples. This
ELISA utilizes the enzyme nitrate reductase to convert nitrate to nitrite, which was then
detected as a colored azo dye product of the Griess reaction which absorbs light at 540
nm. The interaction of nitrate and nitrite concentrations determine the concentration of
nitric oxide in plasma (Fareed D, Tqbal O, Tobu M, Hoppensteadt DA, & Fareed J,
2004). The myeloperoxidase ELISA kit (Eagle Biosciences, Inc., Nashua, NH) quantifies
myeloperoxidase utilizing a two-site “sandwich” technique that binds to different
epitopes of myeloperoxidase. After several incubation periods and plate washed,
antibodies bound to myeloperoxidase were ready to analyze by detecting the
immunocomplex and the absorbency of the sample set at 405 nm with the reference filter
set at 620-650 nm. The ratio or nitric oxide concentration to myeloperoxidase
concentration was calculated by the concentration of nitric oxide divided by the
concentration of myeloperoxidase to examine balance between measures of vasodilation
and vasoconstriction. Proper sample dilution and preparation per manufacture product
information sheet were followed. All assays were performed and analyzed on the same
day by the same trained research staff with an intra-assay variability of <8%.
Statistical Analysis
Statistical analysis was performed using SAS version 9.4 (Cary, NC) for the 8
participants to complete the intervention. Participant characteristics were calculated and
reported as mean and standard deviation (Mean±SD). All outcome variables of interest
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were tested for normality using the Shapiro-Wilk and Kolmogorov-Smirnov tests.
Change values were calculated by subtracting baseline values from post-intervention
values. Paired sample t-tests were performed to determine if any values significantly
changed from baseline to post-intervention. A general linear model was utilized to adjust
for change in body weight and/or change in relative V̇O2peak for primary outcomes of
interest, including glucose concentrations, glycemic variability measures, and biological
markers of vascular health and oxidative stress. Pearson product correlations were
performed between changes in glucose concentrations and measures of glycemic
variability with changes in biological markers of vascular health and oxidative stress to
determine the association between these primary outcomes of interest. Lastly, as change
in body weight or V̇O2peak may influence our outcomes of interest, they were adjusted for
in the analyses. A p value <0.05 was considered statistically significant.
RESULTS
Participant Characteristics
Participant characteristics are included in table 6.1. The participants were
overweight or obese, middle-aged adults, with an even distribution between males and
females. The overall relative V̇O2peak (27.7±9.0 ml/kg/min) and relative V̇O2peak for both
men (31.1±10.9 ml/kg/min) and women (24.4±6.2 ml/kg/min) was determined to be
lower than the standard normal values for their age and sex and thus reflective of being
sedentary prior to the intervention (Myers J, Kaminsky LA, Lima R, Christle JW, Ashley
E, & Arena R, 2017).
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Exercise Intervention Effects
Data on the prescribed and actual completed exercise for participants that
completed the exercise intervention are included in table 6.2. The exercise intensity (5055% HRR), volume (10-12 kcal/kg/week), and number of sessions (36-37) were set
standards throughout the intervention. If participants missed ≥3 exercise sessions,
additional sessions were included to make-up for the missed sessions. All participants
walked 120-135 minutes per week (128.8±4.4 minutes per week).
Body Weight, BMI, and Graded Exercise Test
Body weight, BMI, and graded exercise test measurements obtained at baseline
and post-intervention are included in table 6.3. Overall, there were no significant changes
in body weight and BMI. Further, all participants met two of four generally recognizable
criteria needed to be achieved for the graded exercise test to be considered satisfactory at
baseline and post-intervention. Relative V̇O2peak, and maximal respiratory quotient, heart
rate, and blood pressure, as well as rating of perceived exertion did not change
significantly from baseline to post-intervention. Treadmill time, however, significantly
increased indicating improved exercise tolerance and performance during maximal
exercise. Additionally, individual changes from baseline to post-intervention for body
weight and V̇O2peak were included (Figures 6.2. and 6.3., respectively). Although the data
were normally distributed at baseline and post-intervention, one participant had a
noticeably greater decrease in body weight (participant 6), while another participant had a
noticeably greater increase in V̇O2peak (participant 2).
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Glucose Concentrations and Glycemic Variability Assessed by CGM
Glucose concentrations and measures of glycemic variability at baseline and postintervention are included in table 6.4. There were no significant changes in fasting and
glucose concentrations during OGTT, and OGTT AUC from baseline to postintervention. Also, there was not a significant difference from baseline to postintervention for 24-hour mean, diurnal, or nocturnal glucose concentrations. Further, no
measure of intra-day glycemic variability, MAGE, CONGA-1, CONGA-2, CONGA-4, or
inter-day glycemic variability, MODD, significantly changed from baseline to postintervention. Following adjustment for body weight and/or relative V̇O2peak, these
findings persisted as all CGM-assessed glucose concentrations and glycemic variability
measures did not significantly change from baseline to post-intervention (p≥0.05 for all).
Vascular Health and Oxidative Stress
Biological markers of vascular health and oxidative stress at baseline and postintervention are included in table 6.4. There was a significant decrease in
myeloperoxidase concentration and a significant increase in the ratio of nitric oxide
concentration to myeloperoxidase concentration, with neither remaining significant
following adjustment for change in body weight and/or relative V̇O2peak (p≥0.13 for all).
Relationship between Change in Glucose Concentrations and Glycemic Variability with
Change in Vascular Health and Oxidative Stress
The association between the change in glucose concentrations and glycemic
variability with the change in vascular health and oxidative stress measurements are
included in table 6.5. There were significant negative correlations found between change
in diurnal glucose concentration with change in nitric oxide concentration, as well as
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between change in nocturnal glucose concentration with change in myeloperoxidase
concentration.
Following adjustment for change in body weight and/or change in relative
V̇O2peak, change in nitric oxide no longer significantly correlated with change in diurnal
glucose concentrations (p=0.05). However, following adjustment for change in body
weight only, change in myeloperoxidase concentration continued to negatively correlate
with change in nocturnal glucose concentration (r=-0.97, p=0.03), while change in nitric
oxide concentration negatively correlated with change in nocturnal glucose concentration
(r=-0.97, p=0.03). Interestingly, following adjustment for relative V̇O2peak only, change in
diurnal glucose concentration negatively correlated, while MAGE and CONGA-1
measures of glycemic variability positively correlated, with myeloperoxidase
concentrations (0.97≤absolute r≤0.99, p≤0.03 for all).
Relationship between Change in Body Weight and/or V̇O2peak with Glucose
Concentrations, Glycemic Variability, Vascular Health, and Oxidative Stress
Further analyses were performed to examine the relationship between change in
body weight, relative V̇O2peak (ml/kg/min), and absolute V̇O2peak (ml/min) with change in
glucose concentrations, glycemic variability, vascular health, and oxidative stress (Table
6.6). Change in body weight negatively correlated with change in nocturnal glucose
concentration, while change in relative V̇O2peak did not correlate with any glucose
concentration, glycemic variability measure, or biological marker of oxidative stress.
Further, change in absolute V̇O2peak negatively correlated with change in nocturnal
glucose concentration, as well as MAGE and CONGA-1 measures of glycemic
variability.
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Waking Status and Post-Meal Glucose Concentrations
Exploratory analysis for post-meal and pre-/post-waking glucose concentrations
were performed and are included in table 6.7. There were no differences in post-meal
glucose concentrations following breakfast, lunch, dinner, or snacks; therefore, the daily
total post-meal glucose concentrations and AUC were examined. The majority of the
post-meal glucose concentrations and AUC did not significantly change other than an
observable increase in 30-minute post-meal glucose concentration (p=0.03), which was
lost following adjustment for change in body weight and/or relative V̇O2peak (≥0.07 for
all). Similarly, there were no changes in pre-waking, waking, or post-waking glucose
concentrations (p≥0.25 for all), which persisted following adjustment for change in body
weight and/or relative V̇O2peak (p≥0.18 for all).
Daily Dietary Intake
Further evaluation of changes daily dietary intake was analyzed and presented in
table 6.8. The average total daily mealtime when combining all meals, which included
breakfast, lunch, dinner, and snacks, was found to be significantly later following the
intervention when compared to baseline. Similar results were found when examining the
day-to-day variability for meal measurements, including no changes in variability in
mealtime, calories consumed, or grams per day of carbohydrate, protein, and fat.
DISCUSSION
To our knowledge this is one of the first studies to examine the effect of chronic
center-based aerobic exercise on glucose concentrations and glycemic variability
assessed by CGM with the inclusion of biological markers of vascular health and
oxidative stress in overweight or obese non-diabetic adults. The primary findings were
that myeloperoxidase concentration significantly decreased while the ratio of nitric oxide
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concentration to myeloperoxidase concentration, significantly increased, suggesting
reduced oxidative stress and improved ability to vasodilate compared to vasoconstrict
following the intervention. However, there were no observable changes in CGM-assessed
glucose concentrations or glycemic variability. Yet, average total daily mealtime was
found to be significantly later following the 12-week intervention.
Effect of Aerobic Exercise Intervention on Biological Markers of Vascular Health
and Oxidative Stress
A purpose of our study was to examine the effect of chronic exercise on
circulating concentrations of nitric oxide, a potent vasodilator and measure of vascular
health, and myeloperoxidase, a potent vasoconstrictor and measure of oxidative stress.
Our study found a significant decrease in myeloperoxidase concentration and a
significant increase in the ratio of nitric oxide concentration to myeloperoxidase
concentration. A previous study aimed to assess whether a 12-week endurance exercise
program could reduce biological markers of oxidative stress in adults at an increased risk
of coronary events and found that myeloperoxidase concentration significantly decreased
after training (Richter B, Niessner A, Penka M, Grdić M, Steiner S, Strasser B, Ziegker S,
Zorn G, Maurer G, Simeon-Rudolf V, Wojta J, & Huber K, 2005). Another study
examined the effect of 16 weeks of aerobic exercise, which incorporated 2 different
intensities (30-40% V̇O2max or 55-65% V̇O2max) for 30 minutes each session, 3 times per
week in sedentary, obese males that were non-diabetic (30-40% V̇O2max: n=6; 55-65%
V̇O2max: n=6) or type 2 diabetics (30-40% V̇O2max: n=6; 55-65% V̇O2max: n=7) (Krause M,
Rodrigues-Krause J, O’Hagan C, Medlow P, Davison G, Susta D, Boreham C,
Newsholme P, O’Donnell M, Murphy C, & De Vito G, 2014). They found that skeletal
muscle nitric oxide expression, but not circulating serum nitric oxide concentration,
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increased following the 16 weeks of aerobic exercise at 55-65% V̇O2peak in only nondiabetic participants, with no alterations in those performing lower-intensity aerobic
exercise, or in adults diagnosed with type 2 diabetes following either exercise intensity.
Therefore, our findings are in line with previous evidence that aerobic exercise training
alters circulating biological markers of vascular health and oxidative stress, specifically
decreasing myeloperoxidase concentration and increasing the potential to vasodilate.
Effect of Aerobic Exercise Intervention on CGM-Assessed Glucose Concentrations
and Glycemic Variability
Unexpectedly, there were no significant changes in any glucose concentration or
measure of glycemic variability from baseline to post-intervention. Mikus et al. (2012)
examined the differences in glycemic variability during 3 days of habitual PA and during
the final 3 days of a 7 day aerobic exercise program in obese adults diagnosed with type 2
diabetes mellitus that were not currently taking exogenous insulin (Mikus CR, Oberlin
DJ, Libla J, Boyle LJ, & Thyfault JP, 2012). Their study found that 24-hour mean
glucose concentration was not different during the final 3 days of aerobic exercise
compared to the 3 days of habitual exercise. Further, a randomized control trial examined
the effects of a 4-month free-living continuous walking or interval-walking training on
CGM-assessed glycemic control in adults diagnosed with type 2 diabetes (Karstoft K,
Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, & Solomon TPJ, 2013).
Their study found elevated 24-hour mean glucose concentration in the control group, who
underwent no exercise, while 24-hour mean glucose concentration decreased in the
interval-walking group with no changes noted in the continuous-walking group. A more
recent clinical trial in type 2 diabetics examined the effects of 12 weeks of low-volume
high-intensity interval training (HIIT), including both aerobic- and resistance-based
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exercise, on cardiometabolic outcomes (Francois ME, Durrer C, Pistawka KJ, Halperin
FA, Chang C, & Little JP, 2017). Their study found significant decreases in 24-hour
mean glucose concentration and MAGE following the 12 weeks of HIIT training. These
studies provide evidence that 24-hour glucose concentration and glycemic variability are
potentially lowered by acute and chronic exercise in type 2 diabetics. However, findings
from previous studies examining the influence of exercise on glucose concentrations and
glycemic variability are not in line with findings from our study in overweight or obese
non-diabetic adults undergoing chronic exercise training.
Confounders to Our Findings
Reasons behind the absence of reductions in free-living glucose concentrations
and glycemic variability in our study may be explained. Our study was designed for the
CGM monitoring period to begin and subsequent fasting blood sample collection and
OGTT to occur ≥72 hours after the last exercise session. This timeframe was determined
in order to limit the acute effect of the last bout of exercise on glucose concentrations,
glycemic variability, and oxidative stress, as even a single bout of exercise could
influence our outcomes of interest (Mikines KJ, Sonne B, Farrell PA, Tronier B, & Galbo
H, 1988; Radak Z, Chung HY, Koltai E, Taylor AW, & Goto S, 2008). Although this
timing was within the time frame before potential detraining effects on biological
markers of oxidative stress occur (Maeda S, Miyauchi T, Kakiyama T, Sugawara J,
Iemitsu M, Irukayama-Tombe Y, Murakami H, Kumagi Y, Kuno S, & Matsuda M,
2001), the effects of exercise on glucose homeostasis-related insulin sensitivity begins to
be lost within 5-10 days following cessation of exercise training (Heath GW, Gavin III
JR, Hinderliter JM, Hagberb JM, Bloomfield SA, & Holloszy JO, 1983). Therefore,

185

timing of CGM placement and subsequent first monitoring day may be a limiting factor
as to why we observed no changes in glucose concentration or glycemic variability.
Further, previous evidence has suggested that alterations and potential
compensation in dietary intake exists in adults following acute exercise and undergoing
chronic aerobic exercise training (Church TS, Martin CK, Thompson AM, Earnest CP,
Mikus CR, & Blair SN, 2009; Melzer K, Renaud A, Zurbuchen S, Tschopp C, Lehnman
J, Malatesta D, Ruch N, Schutz Y, Kayser B, & Mäder U, 2016). This potential
confounder may provide further insight into why we found no differences in glucose
concentrations or glycemic variability as dietary caloric intake has been shown to
influence glucose metabolism (Young LL 1984). Moreover, previous evidence has
suggested that meal-timing potentially influences glucose metabolism (Sensi S & Capani
F, 1987). In our study, average total daily mealtime was significantly later at postintervention compared to baseline. A recent study examined the impact of a shift in
mealtime at lunch for a week on postprandial glucose metabolism and glucose tolerance
in healthy young women (Bandín C, Scheer FAJL, Luque, Ávila-Gandía V, Zamora S,
Madrid JA, Gómez-Abellán P, & Garaulet M, 2015). Their study found that glucose
concentrations were higher at 90- and 120-minutes post-meal consumption, and total
post-meal glucose AUC was greater following consumption of a standardized lunch later
in the afternoon (16:30 hours) compared to early afternoon (13:30 hours). The authors
concluded that a shift in mealtime negatively influenced glucose tolerance in healthy
young women. Although, we did not find any differences in the calorie amount or timing
of each individual meal (i.e. breakfast, lunch, and dinner) or their respective glucose
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concentrations following specific meals, the overall later mealtime may aid in the
explanation of our findings.
Strengths and Limitations
The primary strength of this study was that all exercise sessions were monitored
by trained research staff in the CERC, which controlled for the structure and environment
of the exercise intervention. Another strength was the use of CGM to assess free-living
glucose concentrations and glycemic variability for multiple days. Further, evaluation of
changes in biological markers of vascular health and oxidative stress in conjunction with
glycemic variability, while also exploring the relationship between changes in the
primary outcomes of interest, were strengths of this study.
However, there exist several limitations. The primary limitation was the small
sample size (n=8). Yet, there were significant changes observed in myeloperoxidase
concentration and the ratio of nitric oxide concentration to myeloperoxidase
concentration. Our study was initially designed to serve as a pilot and feasibility study to
use CGM to assess glucose concentrations and glycemic variability in exercise training
studies. We successfully used CGM in our study; however, the timing of placement of the
CGM and collection of fasting blood samples may have influenced our findings. Even
though we were attempting to limit the impact of the last bout of exercise on our
outcomes of interest, we may have limited ourselves to evaluation of glucose
concentrations during a de-training state as opposed to a trained state. Thus, placement of
the CGM device earlier, even the same day as the last exercise bout, may provide greater
insight into the effect of exercise training on free-living glucose concentrations and
glycemic variability. Additionally, the exercise intensity (50-55% HRR), volume (10-12
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KKW), or duration (12 weeks) may not have been sufficient to observe changes in
clinical or free-living measures of glucose concentrations and glycemic variability.
Lastly, the inclusion of a free-living condition where we did not test the results of a
standardized diet on glucose concentrations was a potential limitation. Yet, this was also
believed to be a strength, as not completely controlling for diet allows for a greater
insight and potential dietary changes in adults incorporating exercise training into their
daily life.
Conclusion
Although we found a significant decrease in myeloperoxidase concentration and
an improvement in the ratio of nitric oxide concentration to myeloperoxidase
concentration, there were no changes in any clinical-based or free-living glucose
concentrations or measure of glycemic variability. This may partially be explained by an
overall delay in total daily meal-timing from baseline to post-intervention, timing of
placement and subsequent monitoring of CGM glucose concentrations and glycemic
variability following exercise training, exercise intensity and volume during the
intervention, as well as the overall duration of the intervention. Future studies should
consider timing of the CGM device and a higher intensity of exercise to determine
changes in glucose concentrations and glycemic variability in sedentary, overweight or
obese adults undergoing aerobic exercise training.
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Table 6.1. Participant baseline characteristics (n=8)
Variable
Age (years)
48.9±5.2
Height (m)
1.7±0.1
Body weight (kg)
86.2±32.9
Body mass index (BMI; kg/m2)
29.4±8.3
Sex (M/F)
4/4
Race (C/AA/AAA)
3/4/1
College graduate [n (%)]
6 (75)
Employed for wages [n (%)]
7 (87.5)
Income ≥$80,000.00 [n (%)]
4 (50)
Married [n (%)]
4 (50)
Number of children ≥1 [n (%)]
3 (37.5)
Data presented as Mean±SD or number (n) and percent (%) of participants
M=male, F=female, C=Caucasian, AA=African American,
AAA=Asian/Asian-American
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Table 6.2. Exercise prescription and intervention adherence for
participants who completed the study
Intervention average
Exercise intensity
Prescribed heart rate range (50 to 55% HRR, bpm) 124.9±8.8 to 129.2±9.1
Actual heart rate (bpm)
127.7±1.9
Exercise volume
843.6±292.6 to
Prescribed exercise volume range (10 to 12 KKW)
1012.3±351.1
Actual exercise volume* (KKW)
863.8±225.6
Exercise compliance
Prescribed number of exercise sessions‡
36 to 37
Actual number of exercise sessions
34.9±1.1
Data presented as Mean±SD
HRR=heart rate reserve; bpm=beats per minute; KKW=kilocalories per
kilogram of body weight each week
*, exercise volume calculated using the American College of Sports Medicine
formula (American College of Sports Medicine, 2017)
‡, 36 to 37 is dependent on inclusion of introductory exercise visit for
exercise intervention

190

Table 6.3. Participant body weight, BMI, and graded exercise test
measurements at baseline and post-intervention
Postp value
Baseline
intervention
Body weight (kg)
86.2±32.9
83.5±27.4
0.27
BMI (kg/m2)
29.4±8.3
28.5±6.7
0.26
Graded exercise test
measurements
Relative V̇O2peak
27.7±9.0
29.6±8.5
0.21
(ml/kg/min)
Maximal respiratory
1.2±0.1
1.2±0.2
1.00
quotient
Maximal rating of perceived
18.3±1.1
18.3±0.9
0.83
exertion
71.3±15.1
71.3±11.4
1.00
Resting heart rate (bpm)
Resting systolic blood
123.6±11.5
119.3±7.2
0.29
pressure (mmHg)
79.3±7.5
79.9±7.5
0.82
Resting diastolic blood
pressure (mmHg)
Maximal heart rate (bpm)
174.0±15.5
176.0±15.5
0.49
Maximal systolic blood
171.0±26.7
171.0±14.9
1.00
pressure (mmHg)
76.5±9.5
80.8±6.8
0.25
Maximal diastolic blood
pressure (mmHg)
Treadmill time (minutes)
10.6±2.7
11.8±2.3
0.04
Data presented as Mean±SD
BMI=body mass index, V̇O2peak=peak volume of oxygen consumed
p values are for comparisons between baseline and post-intervention
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Table 6.4. OGTT glucose concentrations, glycemic variability measures, and
vascular health and oxidative stress biological markers at baseline and postintervention
Baseline
Post-intervention
p value
CGM observations per day
271.3±11.2
270.4±9.1 (93.9%)
0.92
(n; % of max)
(94.2%)
Glucose concentrations
Fasting (mg/dL)
88.1±9.0
92.9±11.3
0.38
30-minute (mg/dL)
125.2±28.8
138.4±33.8
0.31
60-minute (mg/dL)
139.1±25.6
137.6±29.2
0.92
90-minute (mg/dL)
126.5±19.5
130.7±19.7
0.73
105.3
120-minute (mg/dL)
117.0±18.0
0.95
(102.0-153.0)
OGTT AUC (mg/dL∙2-hour) 14810.4±2334.8
15353.6±2603.5
0.69
24-hour mean (mg/dL)
100.5±13.5
103.4±9.7
0.29
Diurnal (mg/dL)
101.1±13.9
106.4±7.8
0.19
Nocturnal (mg/dL)
98.7±12.5
100.8±11.8
0.26
Measures of glycemic
variability
MAGE (mg/dL) 42.3 (36.8-60.9)
43.3±7.6
0.67
CONGA-1 (mg/dL)
18.7±3.9
20.3±3.4
0.56
CONGA-2 (mg/dL)
21.7±4.6
23.0±3.6
0.68
CONGA-4 (mg/dL)
22.9±4.8
25.4±3.3
0.34
MODD (mg/dL)
19.4±3.5
22.5±6.2
0.31
Vascular health and
oxidative stress biological
markers
Nitric oxide (µmol/L)
83.4±23.8
102.9±33.7
0.09
Myeloperoxidase (ng/mL)
24.8±8.2
16.4±4.6
<0.01
Nitric oxide to
3.5±1.1
6.4±1.7
<0.01
myeloperoxidase ratio
Data presented as Mean±SD, non-normally distributed data presented as median
(lower quartile-upper quartile)
OGTT=oral glucose tolerance test, mg/dL=milligram per deciliter, AUC=area
under the curve, MAGE=mean amplitude of glycemic excursion, CONGA-1, -2,
and -4=continuous overlapping net glycemic action of 1-hour, 2-hour, and 4-hour,
MODD=mean of daily differences
p values are for comparisons between baseline and post-intervention
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Table 6.5. Pearson product correlations between change in glucose
concentrations and measures of glycemic variability with change in biological
markers of vascular health and oxidative stress
Vascular health and oxidative stress biological markers
Nitric oxide to
Nitric oxide
Myeloperoxidase
myeloperoxidase
ratio
Glucose concentrations
-0.33
0.15
-0.46
Fasting
(0.42)
(0.73)
(0.25)
-0.09
-0.34
-0.06
120-minute
(0.85)
(0.46)
(0.89)
0.75
0.12
0.77
24-hour mean
(0.08)
(0.82)
(0.08)
-0.15‡
-0.64
-0.92
Diurnal
(0.78)
(0.17)
(0.01)
-0.02*
0.36
-0.98*
Nocturnal
(0.97)
(0.48)
(<0.001)
Measures of glycemic variability
0.50
-0.47‡
0.69
MAGE
(0.32)
(0.35)
(0.13)
0.55
-0.42‡
0.72
CONGA-1
(0.26)
(0.40)
(0.10)
0.49
-0.32
0.59
CONGA-2
(0.32)
(0.54)
(0.21)
0.53
-0.05
0.51
CONGA-4
(0.28)
(0.92)
(0.30)
0.29
-0.19
0.46
MODD
(0.58)
(0.72)
(0.36)
Data represented as correlation coefficient (p value) with bolded entries
corresponding to significant values
MAGE=mean amplitude of glycemic excursion, CONGA-1, -2, and -4=continuous
overlapping net glycemic action of 1-hour, 2-hour, and 4-hour, MODD=mean of
daily differences
*, p<0.05 following adjustment for change in body weight; ‡, p<0.05 following
adjustment for change in relative V̇O2peak
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Table 6.6. Pearson product correlations between change in body
weight, relative V̇O2peak, and absolute V̇O2peak with change in glucose
concentrations and measures of glycemic variability with change in
biological markers of vascular health and oxidative stress
Body
Relative
Absolute
weight
V̇O2peak
V̇O2peak
Glucose concentrations
-0.02
0.16
-0.02
Fasting
(0.96)
(0.70)
(0.97)
-0.26
-0.16
0.10
120-minute
(0.58)
(0.74)
(0.83)
-0.00
-0.11
-0.03
24-hour mean
(1.00)
(0.84)
(0.96)
0.29
0.23
0.19
Diurnal
(0.58)
(0.66)
(0.72)
0.00
-0.90
-0.86
Nocturnal
(0.99)
(0.02)
(0.03)
Measures of glycemic
variability
-0.81
0.42
-0.88
MAGE
(0.05)
(0.40)
(0.02)
-0.78
0.37
-0.83
CONGA-1
(0.07)
(0.47)
(0.04)
-0.72
0.39
-0.76
CONGA-2
(0.11)
(0.44)
(0.08)
-0.52
0.44
-0.58
CONGA-4
(0.29)
(0.38)
(0.23)
-0.48
0.46
-0.56
MODD
(0.33)
(0.35)
(0.25)
Vascular health and
oxidative stress
biological markers
-0.01
-0.28
0.06
Nitric oxide
(0.97)
(0.50)
(0.88)
0.62
0.02
0.57
Myeloperoxidase
(0.10)
(0.96)
(0.14)
Oxidative stress
0.02
-0.17
0.05
ratio
(0.96)
(0.69)
(0.90)
Data represented as correlation coefficient (p value) with bolded entries
corresponding to significant values
MAGE=mean amplitude of glycemic excursion, CONGA-1, -2, and 4=continuous overlapping net glycemic action of 1-hour, 2-hour, and 4hour, MODD=mean of daily differences
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Table 6.7. Participant post-meal and wake status glucose concentrations
at baseline and post-intervention
p
Baseline
Post-intervention
value
Post-meal glucose
concentrations
0-minute (mg/dL)
94.4±17.5
105.1±16.1
0.08
30-minute (mg/dL)
99.7±16.5
113.0±12.8
0.03
60-minute (mg/dL)
107.8±13.6
114.7±9.4
0.32
90-minute (mg/dL)
110.0±15.0
115.3±10.7
0.41
120-minute (mg/dL)
106.2±13.5
108.9±11.3
0.55
Post-meal AUC (mg/dL∙2- 12557.0±1542.2 13593.5±1274.9 0.08
hour)
Pre- and post-waking glucose
concentrations
3-hour pre-wake time-point
95.0±12.0
99.0±16.6
0.29
(mg/dL)
93.7±12.3
96.1±14.2
0.32
3-hour pre-wake average
(mg/dL)
2-hour pre-wake time-point
94.5±12.4
96.1±15.0
0.43
(mg/dL)
93.6±12.7
95.4±13.8
0.34
2-hour pre-wake average
(mg/dL)
1-hour pre-wake time-point
93.1±11.9
96.3±11.4
0.30
(mg/dL)
1-hour average (mg/dL)
93.2±12.6
94.8±13.8
0.37
91.8±13.4
93.0±11.9
0.38
Waking time-point (mg/dL)
1-hour post-wake time-point
92.1±13.1
90.3±10.7
0.97
(mg/dL)
1-hour post-wake average
92.6±16.9
92.5±8.7
0.48
(mg/dL)
95.6±15.1
93.2±11.8
0.25
2-hour post-wake time-point
(mg/dL)
2-hour post-wake average
93.6±13.5
92.7±8.7
0.64
(mg/dL)
3-hour post-wake time-point
98.5±15.8
94.9±14.7
0.61
(mg/dL)
3-hour post-wake average
95.3±13.4
94.9±8.8
0.36
(mg/dL)
Data Presented as Mean±SD
p values are for comparisons between baseline and post-intervention
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Table 6.8. Participant daily dietary intake at baseline and post-intervention
Baseline
Post-intervention p value
Average mealtime
13:30±00:40
14:00±00:39
0.02
(HH:MM)
Average mealtime SD
01:12±00:50
01:11±00:33
0.44
(HH:MM)
Calories per day
1366.0±389.4
1499.5±423.5
0.31
Calories per day SD
404.2±225.0
382.6 (55.00.35
374.8)
Carbohydrate (grams per
163.7±32.3
183.4±72.7
0.41
day)
Carbohydrate SD (grams per
60.7±12.3
56.1±13.8
0.46
day)
Protein (grams per day)
57.1±14.2
59.6±14.1
0.61
Protein SD (grams per day)
24.6±8.9
21.6±9.4
0.29
Fat (grams per day)
57.6±17.6
65.4±14.8
0.22
Fat SD (grams per day)
23.0±13.6
32.3±18.7
0.27
Data presented as Mean±SD, non-normally distributed data presented as
median (lower quartile-upper quartile)
Time expressed in a 24-hour system as HH:MM=hour and minute
p values are for comparisons between baseline and post-intervention
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Figure 6.1. A-TEAM Study Participant Flow Diagram
The A-TEAM study participant flow diagram from initial contact at eligibility phone
screening to completion of post-intervention testing.
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Figure 6.2. Individual Participant ∆ Body Weight
Body weight changes for each individual participant from baseline to post-intervention in
kilograms (kg) with mean body weight change denoted in the figure.
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Figure 6.3. Individual Participant ∆ V̇O2peak
V̇O2peak changes for each individual participant from baseline to post-intervention in
milliliters per kilogram of body weight per minute (ml/kg/min) with mean V̇O2peak
change denoted in the figure.
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CHAPTER 7
OVERALL DISCUSSION
The prevalence of adults in the United States classified as overweight or obese
continues to increase (Flegal MF, Kruszon-Moran D, Carroll MD, Fryar CD, & Ogden
CL, 2016; Hales CM, Carroll MD, Fryar CD, & Ogden CL, 2017). As overweight and
obesity status has been linked to the development of cardiometabolic disorders, such as
impaired glucose tolerance and CVD risk factors (Clinical Guideline on the
Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The
Evidence Report 1998; Managing Overweight and Obesity in Adults: Systematic
Evidence Review from the Obesity Expert Panel 2013; Centers for Disease Control and
Prevention 2017), the number of adults treated for cardiometabolic disorders will
potentially trend similarly (Centers for Disease Control and Prevention 2017). Recently,
glycemic variability has been introduced as a sensitive measurement of glycemic health
and has been observed to be greater in overweight or obese adults compared to normal
weight adults (Monnier L, Colette C, & Owens DR, 2008; Satya Krishna SV, Kota SK, &
Modi KD, 2013; Suh S & Kim JH, 2015; Wang S, Lv L, Yang Y, Chen D, Liu G, Chen
L, Song Y, He L, Li X, Tian H, Jia W, & Ran X, 2012; Salkind SJ, Huizenga R, Fonda
SJ, Walker MS, & Vigersky RA, 2014). Additionally, greater glycemic variability has
been associated with induction of increased endothelium-derived oxidative stress
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commonly associated with diabetic complications and CVD (Hirsch IB & Brownlee M,
2005; Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, & Colette C, 2006;
Johnson EL 2013).
Sedentary behavior and PA of varying intensities have previously been associated
with metabolic function and CVD risk factors, independent of diagnosed cardiometabolic
disease status, such as type 2 diabetes and CVD (Covas M-I, Elosua R, Fitό M, Alcántara
M, Coca L, & Marrugat J, 2002; Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE,
Zimmet PZ, & Owen N, 2007). Furthermore, exercise, which is a common component of
daily PA, has been established as a modifiable lifestyle factor which positively influences
compromised health outcomes associated with overweight or obesity status and
cardiometabolic complications found in adults diagnosed with type 2 diabetes or CVD
(Goodyear LJ & Kahn BB, 1998; Hawley JA 2004; Church T 2011). As findings are
limited in how sedentary behavior and PA relate to glycemic variability and oxidative
stress, as well as the influence of exercise on these outcomes of interest, in overweight or
obese adults, without diagnosed type 2 diabetes or CVD, there remains a critical gap in
the literature which remains to be addressed.
Recent evidence examining the relationship between sedentary behavior and PA
with glycemic variability and oxidative stress has produced mixed findings. This could
potentially be due to populations incorporated, as well as methodology utilized to
specifically assess sedentary behavior and PA and glycemic variability, and delineating
which biological markers of oxidative stress may be best to evaluate in their given
population. Previous literature suggests that decreases in sedentary time and increases in
leisure-time PA of varying intensities relate to improvements in antioxidants known to
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decrease oxidative stress (Thosar SS, Johnson BD, Johnston JD, & Wallace JP, 2012).
Additionally, increases in sedentary behavior have been linked to decreases in
endothelium-derived nitric oxide vasodilation (Demiot C, Dignat-George F, Fortrat JO,
Sabatier F, Gharib C, Larina I, Gauquelin-Koch G, Hughson R, & Custaud MA, 2007).
Further, subjectively assessed low-intensity, high-intensity, and total-intensity PA EE
have been shown to positively associated with antioxidant concentration (Covas M-I,
Elosua R, Fitό M, Alcántara M, Coca L, & Marrugat J, 2002). However, as evidenced in
previous large sample cross-sectional studies, health status may be a key regulator of the
relationship between sedentary time and PA with glycemic variability, as there is
currently no support to substantiate that a relationship exists between these variables in
non-diabetic adults (Gude F, Díaz-Vidal P, Rúa-Pérez C, Alonso-Sampedro M,
Fernández-Merino C, Rey-García J, Cadarso-Suárez C, Pazos-Couselo M, García-López
JM, Gonzalez-Quintela A, 2017). Yet, in medically compromised adults diagnosed with
type 1 and type 2 diabetes, sedentary time and PA of any intensity has been shown to
possess a direct relationship with glycemic variability (Wadén J, Tikkanen H, Forsblom
C, Fagerudd J, Pettersson-Fernholm K, Lakka T, Riska M, Groop PH, & FinnDiane
Study Group, 2005; Bohn B, Herbst A, Pfeifer M, Krakow D, Zimny S, Kopp F, Melmer
A, Steinacker JM, Holl RW, the DPV Initiative, 2015; Paing AC, McMillan KA, Kirk
AF, Collier A, Hewitt A, & Chastin SFM 2018). Therefore, the population utilized to
address the specific relationship between sedentary behavior and PA of varying
intensities with glycemic variability and oxidative stress should be considered and
accounted for when interpreting findings.
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Even though glycemic variability has been proposed a prominent mechanism
acting to induce oxidative stress, findings have been fairly constant as to what type of
relationship they possess with each other in a variety of populations, including nondiabetic, type 1, and type diabetic adults (Saisho Y 2014). Previous studies examining
experimentally exacerbated glucose concentration oscillations found that the higher the
oscillating glucose concentrations, the greater induction of oxidative stress that occurred
in both normoglycemic and type 2 diabetic adults (Ceriello A, Esposito K, Piconi L, Ihnat
MA, Thorpe JE, Testa R, Boemi M, & Giugliano D, 2008). Additionally, evidence has
suggested the both intra-day and inter-day measures of glycemic variability exhibit strong
positive associations with induction of oxidative stress in adults diagnosed with type 2
diabetes (Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, & Colette C, 2006;
Di Flaviani A, Picconi F, Di Stefano P, Giordani I, Malandrucco I, Maggio P, Palazzo P,
Sgreccia F, Peraldo C, Farina F, Frajese G, & Frontoni S, 2011). This is promising as
intra-day and inter-day glycemic variability may present different etiologies for the
induction of oxidative stress (Wentholt IME, Kulik W, Michels RPJ, Hoekstra JBL, &
DeVries JH, 2008); however, whether these relationships exist in overweight or obese
non-diabetic adults has yet to be elucidated.
Exercise is commonly utilized as therapeutic treatment for impaired glucose
tolerance and CVD risk factors in the presence or absence of diabetes or CVD (Goodyear
LJ & Kahn BB, 1998; Hawley JA 2004; Church T 2011). Exercise-induced
improvements in oxidative stress has been previously studied, and chronic exercise
training has been shown to decrease myeloperoxidase concentration and increase skeletal
muscle nitric oxide synthase release (Richter B, Niessner A, Penka M, Grdić M, Steiner
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S, Strasser B, Ziegker S, Zorn G, Maurer G, Simeon-Rudolf V, Wojta J, & Huber K,
2005; Krause M, Rodrigues-Krause J, O’Hagan C, Medlow P, Davison G, Susta D,
Boreham C, Newsholme P, O’Donnell M, Murphy C, & De Vito G, 2014). However,
there exists limited evidence to suggest that exercise training improves glycemic
variability in adults without diagnosed type 2 diabetes (Tereda T, Friesen A, Chahal BS,
Bell GJ, McCargar LJ, & Boulé NG, 2013; Van Dijk J-W, Manders RJ, Canfora EE, van
Mechelen WV, Hartgens F, Stehouwer CD & van Loon LJC, 2015). Yet, evidence has
suggested that, regardless of modality, that exercise training improves glycemic
variability in type 2 diabetic adults, if moderate intensity during exercise is achieved
(Karstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, & Solomon
TPJ. 2013; Francois ME, Durrer C, Pistawka KJ, Halperin FA, Chang C, & Little JP,
2017). Therefore, findings from previous studies necessitate the further exploration as to
how glycemic variability may be influenced by exercise training. Further, the less than
ideal literature available regarding alterations in glycemic variability in sedentary,
overweight or obese adults, potentially at an increased risk for the development of type 2
diabetes mellitus, undergoing an aerobic exercise intervention remains to be addressed.
The overall study goals of this dissertation were to (study 1) evaluate the current
known relationship glycemic variability possesses with sedentary behavior and PA, and
how a single bout of exercise or repeated bouts of exercise, as well as exercise training
influences glycemic variability in a variety of populations, (study 2) examine the crosssectional relationships between sedentary time and PA measures with glycemic
variability and oxidative stress in non-diabetic overweight or obese adults, and (study 3)
determine the influence of chronic aerobic exercise training on glycemic variability and
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oxidative stress in non-diabetic overweight or obese adults. The first study was a critical
review of the known literature revolving around the relationship between sedentary
behavior and PA measures with, and the influence of single bout of exercise or repeated
bouts of exercise and exercise training on, glycemic variability. The second study utilized
data collected at baseline from the WORDS and A-TEAM prior to either study’s
intervention, while the third study utilized data collected from the A-TEAM study alone.
The WORDS study (ClinicalTrials.gov identifier: NCT02413866) was designed to
examine the effects of chronic moderate sleep restriction on body composition and
energy expenditure in individuals undergoing a hypocaloric dietary weight loss program,
while the A-TEAM study (ClinicalTrials.gov identifier: NCT03162991) examined the
effects of a moderate-intensity aerobic treadmill-based exercise intervention on glucose
concentrations utilizing CGM technology in sedentary, overweight or obese adults.
The second and third studies comprising this dissertation utilized cross-sectional
and intervention study design to evaluate varying lifestyle factors, including sedentary
time and PA and exercise, respectively, that potentially influence glycemic variability
and oxidative stress. Specifically, the second study included a sample of adults from the
WORDS and A-TEAM study (n=28) who had a fasting blood sample, and valid
SenseWear and CGM data available over 5 consecutive days including 1 weekend day. In
the third study, non-diabetic overweight or obese adults enrolled in the A-TEAM study
(n=8) were included if they completed the intervention and had valid CGM data and a
fasting blood sample at baseline and post-intervention. Sedentary time and PA measures
were measured as time spent sedentary and performing LPA and MVPA, as well as EE
for LPA or greater, and MVPA or greater. Glycemic variability was assessed as MAGE,
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CONGA-1, CONGA-2, CONGA-4, and MODD. Oxidative stress was measured as nitric
oxide and myeloperoxidase concentration, while the oxidative stress ratio was calculated
as nitric oxide concentration÷myeloperoxidase concentration.
The first study found that the current literature utilizing CGM technology has
demonstrated that potential relationships exist between glycemic control and glycemic
variability with habitual sedentary behavior and PA. Additionally, a single bout of
exercise or repeated bouts of exercise, regardless of modality, may reduce the
prevalence of glycemic excursions and hyperglycemia immediately following, and over
an extended period upon completion of, exercise in non-diabetic, as well as type 1 and
type 2 diabetic adults. Lastly, exercise training has been suggested to improve glycemic
control and glycemic variability in type 2 diabetic adults.
The second study found that there were significant relationships between PA
minutes and EE with glucose concentrations, but not glycemic variability, while fasting
glucose concentration was significantly associated with nitric oxide concentration,
myeloperoxidase concentration, and the oxidative stress ratio. This led us to supports our
claims that participation in PA, play a vital role in glycemic health, while glycemic
variability is related to oxidative stress in non-diabetic overweight obese adults.
However, the third study found no observable changes in glycemic variability, but
a significant decrease in myeloperoxidase concentration and improvement in the
oxidative stress ratio. The results of the third study led us to conclude that the aerobic
exercise training program improved oxidative stress, but not glycemic variability in nondiabetic overweight or obese or obese adults. Yet, following examination of average daily
dietary intake, total daily mealtime was significantly later post-intervention compared to
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baseline, which may explain no reductions in glycemic variability (Bandín C, Scheer
FAJL, Luque, Ávila-Gandía V, Zamora S, Madrid JA, Gómez-Abellán P, & Garaulet M,
2015). Additionally, as exercise-induced improvements in insulin sensitivity and glucose
tolerance begin to be lost within 5-10 days of cessation of exercise, the timing of CGM
potentially played a role in our results (Heath GW, Gavin III JR, Hinderliter JM, Hagberb
JM, Bloomfield SA, & Holloszy JO, 1983).
When considering the results from the three studies combined, there are several
interesting findings and questions that arise. Specifically, population choice may be
pertinent to evaluate the relationship between sedentary time and PA with glycemic
variability and oxidative stress, as findings in type 1 and type 2 diabetics did not
generally agree with findings in non-diabetic adults. Further, in the second study,
although the findings between PA and glucose concentrations were in agreeance with
previous literature, the participants in our study may have been generally too healthy
and/or active to observe relationships between PA and glycemic variability and oxidative
stress. This is evident as participants completing the baseline assessment for study two
performed on average ~65.5 minutes of MVPA per day. Therefore, it could be assumed
they were not only meeting current PA guidelines but exceeding them (Piercy KL,
Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, George SM, & Olson RD,
2018). Lastly, oxidative stress findings from the third study provided evidence that the
aerobic exercise intervention was effective for decreasing oxidative stress as
myeloperoxidase concentration decreased and the oxidative stress ratio improved. Yet,
non-significant findings in glucose concentrations and glycemic variability suggests that
the aerobic exercise intervention did not influence glycemic health. However, this led us
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to wonder whether timing of CGM placement may play a significant role. Even though
the fasting blood plasma sample was within the timeframe before detraining takes effect
on biological markers of oxidative stress (Maeda S, Miyauchi T, Kakiyama T, Sugawara
J, Iemitsu M, Irukayama-Tombe Y, Murakami H, Kumagi Y, Kuno S, & Matsuda M,
2001), placement and monitoring of the CGM was well within the timeframe of
detraining effects on glucose metabolism (Heath GW, Gavin III JR, Hinderliter JM,
Hagberb JM, Bloomfield SA, & Holloszy JO, 1983). Thus, when considering future
studies examining the relationship between sedentary time and PA with glycemic
variability and oxidative stress, as well as the influence of chronic aerobic exercise
training on glycemic variability and oxidative stress, practical considerations for sample
population and timing of CGM placement are warranted.
In conclusion, this dissertation found that habitual participation in PA of varying
intensities are associated with glucose concentrations, but not glycemic variability, and
oxidative stress in non-diabetic overweight or obese adults. Additionally, glucose
concentrations and glycemic variability expressed a relationship with nitric oxide and
myeloperoxidase concentrations, although opposite from what was expected. These
findings suggest that PA potentially possesses a key role in glycemic health, while further
exploration into the mechanisms of the relationship between oxidative stress and
glycemic variability is necessary. Additionally, myeloperoxidase concentration
decreased, and the oxidative stress ratio improved with exercise training, while there
were no observable changes in glucose concentrations or glycemic variability. These
findings lead us to believe that the exercise intervention positively influenced oxidative
stress but did not impact glycemic health in non-diabetic overweight or obese adults. Yet,
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findings on meal timing, as well as placement of CGM lead us to suggest that
consideration for the effect of detraining and influence of other lifestyle factors, such as
diet, should be addressed during study design.
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